Method and system for evaluation and monitoring of muscle hemodynamic performance during a cyclical locomotor activity

Abstract

Method for monitoring and evaluating muscle hemodynamic performance during a cyclical locomotor activity that includes the stages of providing one or more NIRS sensors, placing the sensors on muscle tissues, providing a heart rate monitor and a locomotor intensity meter, obtaining data relative to the SmO2 % and tHb of each of the muscle tissues, the heart rate (bpm) and the locomotor intensity data, calculating the values of SmO2 %, O2HHb and HHb, ΦO2HHb and ΦHHb, tHb and ΦtHb, calculating the general trend line, calculating and obtaining the physiological thresholds of each muscle tissue and the general thresholds, and evaluating and / or comparing the evolution and trend between two or more of the muscle tissues to determine the performance of the physiological sub-factors that make up the performance of the muscle oxidative capacity and / or the capacity for delivery of oxygen-rich and oxygen-poor blood.

Description

OBJECT OF THE INVENTION The present invention relates to a monitoring and evaluation method of muscle hemodynamic performance, in particular a monitoring and evaluation method based on the use of near infrared sensors (NIRS). The object of the present invention is to provide a method and a muscle hemodynamic monitoring and evaluation system that allows to evaluate and analyze the performance of muscle tissues in an analytical way and a global way overall performance of all muscle tissues during a cyclical locomotor activity. BACKGROUND OF THE INVENTION Nowadays, a lot of many assessment methods and devices, both invasive and non-invasive, are used to assess the physiological performance of the human body in a multitude of locomotor movements and in a wide variety of conditions. One of the most used methods to evaluate the physiological performance during exercise is the measurement of indirect calorimetry, from which derive variables relating to the exchange of gases in the human body. Indirect calorimetry is a representation of the joint performance of all muscle tissues. On the other hand, this evaluation method doesn’t allow to know what the performance of each one of the muscular tissues has been like. Blood Lactate [La +] measurements are also widely very used in the research and sports world to correlate them with locomotor performance, since certain levels and increases in Blood Lactate values are associated with certain work intensities. The closest method that allows to partially measure the performance of the muscular tissues during a Locomotor Activity or Cyclic Physical Activity (AFM) is the use of electromyography, 2021307653   16 Sep 2026 whether invasive or surface. However, this method only allows obtaining the electrical activation values of each muscle tissue (TM). Currently athletes and coaches use one to three NIRS devices to evaluate the physiological performance of an athlete in a physical activity. In these studies, only Muscular Oxygen Saturation (SmO2) and Capillary Hemoglobin (ThB) values are used to establish in a very generic way what the athlete's performance limitation has been during exercise. Thus, the data obtained from one or two muscle tissues are used to determine that the subject evaluated has a general physiological limitation of this nature in his muscles, without taking into account the performance of other muscle tissues. Likewise, state-of-the-art studies use only 1 or 2 NIRS devices to evaluate highly analytical aspects of the hemodynamic performance (%SmO2, ThB, O2HHb, HHb) of one or two muscle tissues (mainly: deltoid, vast lateral & rectus femoris). Data obtained from muscle tissues are used to represent the hemodynamic performance of all muscle tissues, assuming that there is symmetry in all active tissues. SUMMARY OF THE INVENTION In an aspect of the invention, there is provided a monitoring and evaluation method of the physical performance of a subject that includes the stages of: a. providing two or more Near-Infrared Spectroscopy sensors (NIRS), a cardiac monitoring device, an activity monitoring device and a locomotor work intensity device or monitor; b. placing or adhering the NIRS sensors on the muscle tissues (TM) to be evaluated, placing the cardiac monitoring device on the subject's chest, and placing the activity monitoring device and the locomotor work intensity device or monitor; c. starting data recording of all the devices, minimally from the start of the locomotive activity evaluated and sending it to a data processing system; d. recording, through the data processing system, the data captured, during the development of at least one Cyclical Locomotive-Physical Activity (AFC), where: - the Monitored Cyclical Physical Activity (AFCM) is continuous or interval, - the activity monitoring device records the entire time scale from the beginning to the end of the AFCM, including the multiple intervals of work and / or rest if performed, - the recording frequency of the data for each device is less than 6 seconds, 2021307653   16 Sep 2026 - the AFCM is stable, incremental, decreasing, variable locomotor intensity or a combination of the above, - the AFCM includes a period of previous warm-up, - if the AFCM does not include at least one Rest interval (ID), the data recording will end 1 minute after the AFC ceases and that minute will be counted as an ID, - the Locomotor Work Intensity (INTTL) or the average Locomotor Work Intensity Range (R-INTTL) is greater than or equal to the Minimum Activation Threshold (UAmin); e. obtaining at least the following monitored data from all devices with their respective temporary registration: - Muscular Oxygen Saturation (SmO2% - %) and Absolute Capillary Hemoglobin (ThB - g / dL) of each of the monitored muscle tissues (TMM) that participate in AFCM, through NIRS devices, - Heart rate (HR - bpm), through the cardiac monitoring device, - Power (Watts), Running Speed (Km / h), through the locomotor work intensity device or monitor, - time record or timescale of the AFCM, with all the time records of the start or end of AFCM, and the start and end of the different intervals developed during the AFCM, through the activity monitoring device, - cadence (rpm) or acceleration, through external locomotor performance devices and / or monitors, - analysis of metabolic gases (VO2 / CO2), lactate measurements, and data from thermographic cameras, using physiological locomotor performance devices and / or monitors; f. synchronizing, linking and joining the data obtained in a single time scale of joint data from the time record scale collected by the activity monitoring device during the AFCM and the time record of each device, through the data processing system; g. calculating, through the data processing system, at least the following values for each Monitored Muscle Tissue (TMM) that participates in the AFCM from the recorded data of SmO2% and ThB of: Oxygen-Charged Capillary Hemoglobin - g / dL (O2HHb), through the formula: % (SmO2) * g / dL (ThB) = g / dL (O2HHb) Oxygen Discharged Capillary Hemoglobin - g / dL (HHb), through the formula: g / dL (ThB) - g / dL (O2HHb) = g / dL (HHb) Muscle Blood Flow of Muscle Hemoglobin - g / dL / s (0ThB), through the formula: [g / dL (ThB) * (HR)] / 60 = g / dL / seg ($ThB) 2021307653   16 Sep 2026 Muscular Blood Flow of Oxygen Charged Hemoglobin - g / dL / s (0O2HHb), through the formula: [g / dL (O2HHb) * (HR)] / 60 = g / dL / seg (0O2HHb) Muscular Blood Flow of Oxygen Discharged Hemoglobin - g / dL / s (0HHb), through the formula [g / dL (HHb) * (HR)] / 60 = g / dL / seg ($HHb) h. filtering and excluding, through the data processing system, the data obtained erroneously and / or due to registration error by devices during AFCM; i. filtering and excluding, through the processing system, the values that are not within the following ranges, as well as the data obtained from the calculation of any of them: -  SmO2% [Between 1% SmO2 and 99% SmO2] - ThB [Between 9.5 g / dL and 14,9 g / dL] - HR [Between 40bpm and 230bpm]; j. filtering and excluding, through the processing system, the values that present a difference greater than that established in the following parameters between the temporary records of the analyzed value with respect to the previous value and the temporally subsequent value, as well as all the data obtained from the calculation of any of them: - Difference of SmO2% [> ±10% SmO2%] - Difference of ThB [> ±0.3 g / dL] - Difference of HR [> ±7bpm]. In some aspects, the evaluation and monitoring method further comprises the steps of: k. filtering and excluding all values obtained, calculated and / or recorded during all ID or without AFC, l. filtering and excluding all values obtained, calculated and / or recorded during the first minute of each work interval (IT), m. filtering and excluding all values obtained, calculated and / or registered when the value of the INTTL or R-INTTL in the same temporary register is equivalent to “0”, n. filtering and excluding all the values obtained, calculated and / or registered when the value of Muscle Contraction Frequency (FCM) or Muscle Contraction Frequency Range (R-FCM) in the same time register is equivalent to "0", o. selecting and performing one of the following procedures: - a first procedure comprising the steps of: o calculating the statistical median value (Y) of the values SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, 0HHb of each TMM, during AFCM, in each registered 2021307653   16 Sep 2026 Locomotor Work Intensity (INTTL) or in each Intensity Range of Locomotor Work (R-INTTL), that participates in the AFCM; o calculating and establishing the Trend Line (LinTrend) of the median values (Y -INTTL) or (Y - R-INTTL) obtained from YSmO2%, YThB, Y0ThB, YO2HHb, Y 0O2HHb, Y HHb and Y 0HHb, in each TMM; - a second procedure comprising the steps of: _ _ _ o calculating the statistical average value (Y) of the values of SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, $HHb, of each TMM, during AFCM, in each INTTL or R- INTTL, registered during the AFCM; o calculating and establishing the LinTrend of the average values (Y-INTTL) or (Y-R-INTTL) obtained from Y SmO2%, Y ThB, Y$ThB, YO2HHb, Y^HHb, Y HHb and Y 0HHb, in each TMM; - a third procedure comprising a step of: o calculating and establishing the LinTrend (Value / INTTL) or (Value / R-INTTL), from all filtered values of SmO2%, ThB, $ThB, O2HHb, 0O2HHb, HHb, $HHb, in each TMM; p. calculating all values of LinTrend |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|0HHb, of each TMM, for each INTTL or R- INTTL; q. calculating the Slope (p) between each of the values of |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|$HHb, from each TMM; r. calculating, analyzing and determining all the trend changes of (p) in each of the LinTrend, of all the values |Y|SmO2%, |Y|ThB, |Y|$ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb and |Y|0HHb, of each TMM; s. calculating, analyzing and establishing between which two values of INTTL or R- INTTL occurs the 1st, 2nd and 3rd Change in each TMM of the trend of the slope (p) of each LinTrend, through the combining at least 4 of the 7 possible (p) changes of |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb and |Y|$HHb; t. establishing the Physiological Thresholds of each TMM equivalent to the trend changes: 1st Change (p)      2nd Change (p)      3rd Change (p) UAmin Individual                  UAe Individual                   UAna Individual Rank|X| (Watts)       Rank|X| (Watts)       Rank|X| (Watts) TMM       |X| (Watts)            |X| (Watts)            |X| (Watts) u. establishing the INTTL or R- INTTL of the General Physiological Thresholds from the median of the values of the individual thresholds of all TMSM: 2021307653   16 Sep 2026 1st General         2nd General         3rd General Change (p)         Change (p)         Change (p) UAmin                   UAe                    UAna Rank|X| (Watts)      Rank|X| (Watts)      Rank|X| (Watts) TMM |X| (Watts)            |X| (Watts)            |X| (Watts) In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating, analyzing and determining the CSV, between at least two sets of values |Y|SmO2%,  |Y|ThB,  |Y|0ThB, |Y|O2HHb,  |r|0O2HHb,  |Y|HHb or  |Y|$HHb, established between two determined INTTL or R- INTTL, between at least two determined TMSM: Standard Deviation (a) of the values of \Y\ A verage of the values of |Y| - establishing the Symmetry Level (NSCSV) from the CSV value calculated from the values |Y|SmO2%, |Y|ThB, |Y|$ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb or |Y|$HHb, between two INTTL or two R- INTTL determined, between at least two TMSM determined: - establishing the Symmetry Level (NSCSV) from the CSV value, where: Symmetry Level (NSCSV ) CSV SmO2% O2HHb - HHb 0O2HHb - 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01 < 0,05 > 0,001 < 0,005 > 0,01 < 0,05 Minimal > 0,05 < 0,20 > 0,005 < 0,02 > 0,05 < 0,2 Asymmetry > 0,20 > 0,02 > 0,2 - calculating, analyzing and determining the slope-trend (p)|Y| of at least |Y|SmO2%, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and / or |Y|0HHb, between two INTTL or two R-INTTL, of at least two TMSM: (^) = iri2.-.ini (P)   \X\2-\X\1 where (p) is the slope-trend; |Y| 1 the determined value of SmO2%, O2HHb, 0O2HHb, HHb o 0HHb, of the first LNTTL or R-INTTL and |Y|2 of the second INTTL or R-INTTL; |X| 1 is the first LNTTL or R-INTTL and |X| 2 the second INTTL or R-INTTL; - calculating, analyzing and establishing the Coef-(jf) of (p)|Y|SmO2%, (p)|Y|O2HHb, (p)|Y|0O2HHb, (p)|Y|HHb and / or (p)|Y|0HHb between two INTTL or two R-INTTL, of one TMM determined with respect to the trend of (p)|Y|SmO2%, (p)|Y|O2HHb, (p)|Y|0O2HHb, (p)|Y|HHb and / or (p)|Y|0HHb of another TMM or a set of values 2021307653   16 Sep 2026 trends of (p)|y|SmO2%, (p)|y|O2HHb, (p)M$O2HHb, (p)|y|HHb and / or (p)|y|$HHb of two or more TMSM: _ _ <-------» _<-------». . _ _<---------». Coef- (p) = [(p)|y|] - [(pi)|y|] wherein (?)|y| is the median slope-trends of the compared TMsm and (p1)|y| is the slope-trend of the analyzed TMM; - establishing the Symmetry Level (NS Coef-(p)) from the calculated value of Coef-(p) (p)|y|SmO2%, (?)|y|O2HHb, (?)|y|0O2HHb, (p)|y|HHb o (p)|y|0HHb of the analyzed TMM: Symmetry Level (NS Coef-(p)) Coef- (p) SmO2% O2HHb - HHb 0O2HHb- 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01   < 0,05 > 0,001  < 0,005 > 0,01  < 0,05 Minimal > 0,05   < 0,15 > 0,005  < 0,015 > 0,05  < 0,15 Asymmetry > 0,15 > 0,015 > 0,15 In some aspects, the monitoring and evaluation method further comprises the steps of: - evaluating the value of |y|SmO2% in each INTTL or R-INTTL, INTTL greater than or equal to UAmin and less than or equal to UAna; - calculating, comparing, evaluating and establishing the Coefficient of Symmetry between Values (CSV) and the Level of Symmetry (NScsv) between |y|SmO2%, |y|O2HHb and |y|0O2HHb of each TMM and his Contralateral Muscle Tissue Monitored (TMCM), in each INTTL or R-INTTL INTTL greater than or equal to UAmin and less than or equal to UAna; - calculating, comparing and evaluating the General Trend of the Values (TGV [(p)]) |y|SmO2%, |y|0O2HHb and |y|O2HHb, of all TMsm, in the R-INTTL (UAmin - UAe) and (UAe - UAna); - calculating, comparing and establishing the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)|y|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb, between the combination of at least 70-75% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna); - determining that the following criteria are met to establish a limitation in a structural factor of oxidative capacity (A1): 1) the value of |y|SmO2% in each INTTL or R-INTTL INTTL greater or equal than UAmin and less than or equal to UAna, is >70% SmO2%, in at least 70-75% of TMsm; 2021307653   16 Sep 2026 2) the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb of each TMM and TMCM, have at least one optimal symmetry, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna, in at least the 70-75% of TMSM; 3) the TGV of de (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is symmetric between the combination of at least 70-75% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna); 4) the TGV of de (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is symmetric between each TMM and his TMCM, in at least 80-85% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna). In some aspects, the monitoring and evaluation method, in addition to comprising steps f) to u), also comprises the steps of: - evaluating the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating and evaluating the difference of SmO2% between the value of | / |SmO2% of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin; - comparing, evaluating and determining the CSV and NSCSV between the values of | / |SmO2%, | / |0O2HHb and | / |O2HHb of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, comparing and evaluating the TGV [(p) of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna); - calculating, comparing and establishing the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, between the combination of at least 50-55% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna); - determining that the following criteria are met to establish a limitation in a functional factor of oxidative capacity by general fatigue (A2): 1) the difference between the value of | / |SmO2% of each TMM and his TMCM is >5% SmO2%, in the 95% of INTTL or R-INTTL greater than or equal to UAmin, in at least the 70-75% of TMSM; 2) the value of | / |SmO2% is >55% SmO2%, in the 80% of TMsm, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna; 3) the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb are asymmetric in at least the 50% of INTTL or R-INTTL greater than or equal to UAmin, between one TMM and his TMCM, in at least the 70 -75% of TMSM; 2021307653   16 Sep 2026 4) the TGV of de (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is asymmetric between the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin -UAe) and (UAe - UAna). In some aspects, the monitoring and evaluation method further comprises the steps of: - evaluating the value of | / |SmO2% of at least one TMM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculate, comparing and evaluating the value of | / |SmO2%, | / |O2HHb and | / |0O2HHb of at least one TMM with the values of his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, evaluating and determining the value of CSV and NSCSV of | / |SmO2%, | / |0O2HHb and | / |O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, comparing and evaluating the TGV [(p)] of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna); - calculating, evaluating and determining the lowest value of Coef-ty) and the equivalent NSCoef-p between the values of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, of at least the combination of the 50-55% TMSM; - determining that the following criteria are met to establish a limitation on a functional factor of oxidative capacity by muscle inhibition (A3): 1) the value of | / |SmO2% is >50% SmO2% in the TMM analyzed, in the 95% of INTTL or R-INTTL greater than or equal to UAmin; 2) the values of | / |SmO2%, | / |O2HHb | / |y 0O2HHb of the TMM analyzed are greater than the values of his TMCM, in the 95% of INTTL or R-INTTL greater than or equal to UAmin; 3) the TGV of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is asymmetric between the TMM analyzed and his TMCM, in the R-INTTL (UAmin - UAe) and (UAe -UAna); 4) the TGV of (p)|y|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb is symmetric between the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin -UAe) and (UAe - UAna). In some aspects, the monitoring and evaluation method further comprises the steps of: - evaluating the value of | / |SmO2%, | / |0O2HHb and | / |O2HHb, of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin; 2021307653   16 Sep 2026 - calculating, evaluating and determining the value of CSV and the equivalent NSCSV of de | / |SmO2%, | / |0O2HHb and | / |O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, comparing and evaluating the TGV [(p)]) of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna); - calculating, evaluating and determining Coef-(p) and the equivalent NSCoef-(p) between the values (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, of each TMM and his TMCM, in the R-INTTL (UAmin- UAe) and (UAe - UAna); - determining that the following criteria are met to establish a limitation on a neuromuscular factor of oxidative capacity, being intermuscular coordination, (A4): 1) the value of | / |SmO2% of the TMM analyzed and of his TMCM is greater than or equal to 65% SmO2%, in each INTTL or R-INTTL greater than or equal to UAmin; 2) the trend of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb,in the 70% of TMsm and their TMSCM are minimally symmetric, in the R-INTTL (UAmin - UAe) and (UAe -UAna); 3) the values of | / |SmO2%, | / |0O2HHb and | / |O2HHb of the TMM analyzed and his TMCM are greater than the values of at least the 70-75% of the remaining TMSM, in each INTTL or R-INTTL greater than or equal to UAmin; 4) the values of | / |SmO2% of at least the 50-55% of TMsm is ^45% SmO2%, in any INTTL or R-INTTL greater than or equal to UAe. In some aspects, the monitoring and evaluation method, in addition to the TMSM to be evaluated, one or more TMSM that participate in the breathing process are evaluated, and where they also comprise the steps of: - calculating, analyzing and evaluating the value of | / |SmO2% of at least one TMM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, analyzing and evaluating the trend (p) of the SmO2% and 0O2HHb values of all TMSM, on the initial 5 and 10 seconds of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe; - determining that the following criteria are met to establish a limitation on a pulmonary structural factor (B1.1): 1) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMsm; 2021307653   16 Sep 2026 2) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 10 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UANA, is less than [(p) < 0000,5], in at least 70% of TMsm; 3) the value of |y|SmO2% is >50% SmO2% in the TMsm that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin. In some aspects, the monitoring and evaluation method, in addition to the TMSM to be evaluated, one or more TMSM that participate in the breathing process are evaluated, and where they also comprise the steps of: - calculating, analyzing and evaluating the value of |y|SmO2% of at least one TM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin; - calculating, analyzing and evaluating the trend (p) of the SmO2% and 0O2HHb values of all TMSM, in the initial 5 seconds, of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe; - determining that the following criteria are met to establish a limitation on a pulmonary functional factor of the respiratory muscles (B1.2): 1) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMsM; 2) the value of |y|SmO2% is <50% SmO2% in the TMsM that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin. In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating the value of |y|SmO2%, |y|O2HHb, |y|0O2HHb, of each TMM, in at least one INTTL or R-INTTL greater than or equal to UAmin. - calculating the values of SmO2%, O2HHb and 0O2HHb of the Upper Limit of the Optimal Zone (|limsup| Zona0p) and the Lower Limit of the Optimal Zone Him in / | Zona0p, in the determined INTTL or R-INTTL, from the following calculation: llimsupl Zona0? = (Median of {|y|i;|r|2;|y|s;..,}) + (o {|y|i;|y|2;|y|3;...,,}) / 2 Him inf\ Zona0? = (Median of {|y|i;|y|2;|y|3;...,}) - (o {|y|i;|y|2;|y|3;...,,}) / 2 wherein |y| is the value (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity; (a) is the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity; 2021307653   16 Sep 2026 - comparing and evaluating the values of | / |SmO2%, \y\O2HHb and \y\0O2HHb, of at least one TMM with the values of SmO2%, O2HHb and 0O2HHb of \lim inf\ ZonaOp and of \lim sup\ Zona0p, in analyzed INTTL or R-INTTL greater than or equal to UAmn; - determining the type of performance of a composition of muscular blood flow (B.2.1.1) that develops at least one TMM analyzed, in the analyzed INTTL or R-INTTL, based on the following criteria: o excessive Muscle Oxygen Amount if: ■ the value of \ / \SmO2% of the TMM is <80% SmO2% in the analyzed INTTL or R-INTTL; ■ the value of  \ / \SmO2%  of the analyzed TMM is greater than SmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL; ■ the difference between the value of \ / \SmO2% of the analyzed TMM and SmO2% \limsup\ZonaOp is >15% SmO2%, in the analyzed INTTL or R-INTTL; o greater Amount of Muscular Oxygen if: ■ the value of  \ / \SmO2%  of the analyzed TMM is greater than SmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL; ■ the difference between the value of \ / \SmO2% of the analyzed TMM and SmO2%\lim sup \ Zona0p, is <15% SmO2%, in the analyzed INTTL or R-INTTL; o optimal Amount of Muscular Oxygen if: ■ the value of \ / \SmO2% of the analyzed TMM is equal or less than SmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL; ■ the value of \ / \SmO2% of the analyzed TMM is equal or greater than SmO2% \lim inf\ Zona0p, in the analyzed INTTL or R-INTTL; o lower Amount of Muscular Oxygen if: ■ the value of  \ / \SmO2%  of the analyzed TMM is greater than SmO2%\lim inf \ Zona0p, in the analyzed INTTL or R-INTTL; ■ the value of \ / \SmO2% of the analyzed TMM is >20% SmO2%, in the analyzed INTTL or R-INTTL; o inefficient or Low Amount of Muscular Oxygen if: ■ the value of  \ / \SmO2%  of the analyzed TMM is greater than SmO2%\lim inf \ Zona0p, in the analyzed INTTL or R-INTTL; ■ the value of \ / \SmO2% of the analyzed TMM is <20% SmO2%, in the analyzed INTTL or R-INTTL; - determining the type of performance of a volume of muscle hemoglobin delivery (B.2.1.2) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria: 2021307653   16 Sep 2026 o higher Hemoglobin Delivery Volume if: ■ the value of \y\O2HHb of the analyzed TMM is greater than O2HHb \limsup\ Zona0p, in the INTTL or R-INTTL analyzed; o optimal Hemoglobin Delivery Volume if: ■ the value of \y\O2HHb of the analyzed TMM analyzed is equal or less than O2HHb \lim sup\ Zona0p, in the analyzed INTTL or R-INTTL; ■ the value of \y\O2HHb of the analyzed TMM is equal or greater than O2HHb llim in / \ Zona0p, in the analyzed INTTL or R-INTTL; o lower Hemoglobin Delivery Volume if: ■ the value of \y\O2HHb of the analyzed TMM a is less than O2HHb llim in / | Zona0p, in the analyzed INTTL or R-INTTL; - determining the type of performance of a velocity or rate of blood flow delivery (B.2.1.3) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria: o higher Blood Flow Delivery Rate if: ■ the value of | / |0O2HHb of the analyzed TMM is greater than the value of 0O2HHb|lim sup| Zona0p, in the analyzed INTTL or R-INTTL; o optimal Blood Flow Delivery Rate if: ■   the value of | / |0O2HHb of the analyzed TMM is equal or less than of 0O2HHb|lim sup| Zona0p, in the analyzed INTTL or R-INTTL; ■   the value of | / |0O2HHb of the analyzed TMM is equal or greater than 0O2HHb llim inf\Zona0p, in the analyzed INTTL or R-INTTL; o lower Blood Flow Delivery Rate if: ■ the value of \y\0O2HHb of the analyzed TMM is less than 0O2HHb \lim in / \ Zona0p, in the analyzed INTTL or R-INTTL. In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating, comparing and evaluating the maximum value of SmO2%, O2HHb and 0O2HHb of all TMsm, in at least one ID; - calculating, evaluating and determining the value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, of all TMsm, in at least one ID; - calculating, evaluating and determining the lowest value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, from the combination of at least the 70-75% of the TMSM, in at least one ID; 2021307653   16 Sep 2026 - determining the type of performance of a functional sympatholysis factor for blood flow redistribution (B2.2), just at the moment of cessation of locomotor work, based on the following criteria: o perfect performance if: ■ the maximum values of SmO2%, O2HHb and 0O2HHb are symmetrically perfect, between all TMSM, in the analyzed ID; o optimal performance if: ■ the maximum values of SmO2%, O2HHb and 0O2HHb, are symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID; o asymmetric Performance if: ■ the maximum values of SmO2%, O2HHb and 0O2HHb, are not symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID. In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating, comparing and evaluating the maximum value of SmO2% between two ID, separated by at least one IT of at least one TMM; - determining the type of performance of an evolution factor of analytical cardiovascular performance (B2.3) that develops, at least one analyzed TMM, between two ID, separated by a IT, based on the following criteria: o Significant increase: ■ increase >5% SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID; o Slight Increase: ■ increase between [2,01 - 5 %] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID; o Slight decrease if: ■ decrease between [2,01 - 5%] SmO2% in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID; o Significant decrease if: ■ decrease >5% SmO2%, in the maximum value of SmO2% of the analyzed TMM, in the 2nd ID in compared to the 1st ID; o Maintenance if: ■ decrease or increase of between [0-2%] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID. 2021307653   16 Sep 2026 In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating, comparing and evaluating the TGV [(p)] of (p)\y\ThB of at least one TMM, in the R-INTTL (UAe-UANA) and (UANA-Maximum Intensity [IntMax]); - the value of \y\SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin; - determining if the following criteria are met to establish a limitation in a muscle pumping factor of blood flow for venous return (B2.4): o the TGV (p)\y\ThB of the analyzed TMM is [(p)>0,0005], in the R-INTTL (UAe-UANA) or (UANA-Maximum Intensity [IntMax]); o the value of \y\SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin. In some aspects, the monitoring and evaluation method further comprises the steps of: - evaluating the value \y\SmO2%, \y\O2HHb and \y\0O2HHb, of at least one TMM, in at least one INTTL or R-INTTL greater or equal than UAmin; - calculating the SmO2%, O2HHb and 0O2HHb values of the Upper Limit of the Optimal Zone (\limsup\ Zona0p) and the Lower Limit of the Optimal Zone (\lim inf \ Zona0p), in the determined INTTL or R-INTTL, from the following calculation: \limsup\Zona0? = (Mediana de {\y\1;|y|2;|y|3;...,}) + (a {\y\i;|y|2;^...,^) / 2 \lim mf\ Zona0? = (Mediana de {\y\i;\y\2;^...,}) - (a {\y\i;\y\2;\y\3;..,,}) / 2 where \Y\ is the value (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL and (a) the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL; - comparing and evaluating the values of \y\SmO2%, \y\O2HHb and \y\0O2HHb, of at least one TMM with the values of (SmO2%, O2HHb and 0O2HHb of the \lim sup\ Zona0? and the \lim mf\ Zona0p, in at least one determined INTTL or R-INTTL greater or equal than UAmin; - determining the level of Neuromuscular Activation performed by at least one TMM (neuromuscular activation factor, being intermuscular coordination, (B3.1)), based on the following criteria: o Null or Very Low Neuromuscular Activation if: ■ the value of \y\SmO2%, \y\O2HHb and \y\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and QO2HHb\lim sup\Zona0p, in the determined INTTL or R-INTTL; ■ the value of \y\SmO2% of the TMM analyzed, is >75% SmO2% in the determined INTTL or R-INTTL; 2021307653   16 Sep 2026 o Less or Low Neuromuscular Activation if: ■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and QO2HHb\lim sup\ Zona0p, in the determined INTTL or R-INTTL; ■ the value of \Y\SmO2% of the TMM analyzed, is <75% SmO2%, in the determined INTTL or R-INTTL; o Optimal Neuromuscular Activation if: ■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \limsup\ Zona0p, in the determined INTTL or R-INTTL; ■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMM analyzed,  is greater than SmO2%,  O2HHb and  0O2HHb \lim in / \ Zona0p, in the determined INTTL or R-INTTL; o Excessive or Priority Neuromuscular Activation if ■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \lim in / \ Zona0p, in the determined INTTL or R-INTTL; ■ the value of \Y\SmO2% of the TMM analyzed is <25% SmO2%, in some INTTL or R-INTTL; o High Neuromuscular Activation if: ■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \lim in / \ Zona0p, in the determined INTTL or R-INTTL; ■ the value of \Y\SmO2% of the TMM analyzed is >25% SmO2%, in all the INTTL or R-INTTL greater than or equal to UAmin. In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating the median value of ThB (Y ThB), of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin; - calculating the standard deviation (0) of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin; - calculating the minimum value of ThB in at least one ID perform after an IT analyzed, of average INTTL or R-INTTL greater than or equal to UAmin; - calculating and evaluate the difference between [(YThB) - 0] of at least one IT and the minimum value of ThB of his posterior / successive ID; 2021307653   16 Sep 2026 - determining if the following criteria are met to establish a limitation in a neurovascular structural factor, being speed and power of muscle contraction, (B3.2) in at least one TMM: o the value [Median F ThB - oThB] of the analyzed TMM, of the analyzed IT of INTTL or R-INTTL greater than or equal to UAmin, is greater than the minimum value of ThB of the successive ID to the analyzed IT. In some aspects, the monitoring and evaluation method further comprises the steps of: - calculating, comparing and evaluating the median value (F) of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb, of each TMM, in at least one determined INTTL or R-INTTL, in each one of the developed FCM, during the AFCM; - determining all the Optimal FCM or Optimal R-FCM, of at least one determined INTTL or R-INTTL, during AFCM, based on the fulfilment of the following criteria established for a muscle contraction speed factor (B3.3): o have the highest value of FSmO2% or a difference < (±2.5%) SmO2% with respect to the highest value FSmO2%, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM; o have the highest value of F O2HHb % or a difference < (±0,30 g / dL) O2HHb with respect to the highest value F O2HHb, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM; o have the highest value of F 0O2HHb % or a difference < (±1,00 g / dL) 0O2HHb with respect to the highest value F 0O2HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM; o have the lowest value of F HHb % or a difference < (±1,00 g / dL) HHb with respect to the lowest value F HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM; o have the lowest value of F 0HHb % or a difference < (±1,00 g / dL) 0HHb with respect to the lowest value F 0HHb, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. 2021307653   16 Sep 2026 In another aspect of the invention, there is provided a monitoring and evaluating system for the physical performance of one subject that comprises: - two or more near infrared sensors (NIRS); - a cardiac monitoring device; - a locomotor work intensity device or monitor; and - a data processing system connected to the two or more near infrared sensors (NIRS), the cardiac monitoring device and the locomotor work intensity device or monitor and configured to carry out the steps of the method in accordance with the method described above. DESCRIPTION OF THE INVENTION The present invention refers to a method of monitoring and evaluating of muscle hemodynamic performance, in a non-invasive way, through the use of near-infrared spectroscopy (NIRS) devices, to establish the hemodynamic performance of multiple muscles tissues (TMs) of simultaneously during a Locomotor Activity or Cyclic Physical Activity (AFM) determined. In general, the monitoring and evaluation method of the invention analyses three aspects of muscle hemodynamic performance which are: 1. The Physiological Thresholds: From the monitoring and evaluation of the redirection of blood flow developed in the TM, the Minimum Activation Threshold (UAmin), the Aerobic Threshold (UAe) and the Anaerobic Threshold (UAna) can be established. 2. The Muscle Oxidative Capacity: The performance in the capacity that has each TM for consuming the oxygen that is delivered by the cardiovascular system for production of the energy necessary to develop locomotor movement. 3. The Delivery of Oxygen Loaded and Oxygen Discharged Blood: The performance in the capacity to deliver the oxygen-loaded blood necessary for TMs to be able to consume it and produce the energy necessary for locomotor movement. It also includes hemodynamic performance in the ability to maintain blood flow and venous return necessary for each work intensity. Each one of these aspects determine the general hemodynamic performance of each muscle tissue and at the same time report a collective performance of the muscular system as a whole. Oxidative capacity and blood delivery have a series of sub-factors that determine 2021307653   16 Sep 2026 specific aspects of their activity, offering information on the level of performance of each TM individually and collectively, in addition to the link with other physiological systems. The method of the invention comprises in general the following differentiated parts: 1. Capture of hemodynamic data during locomotor performance: while the user that is evaluated, perform an AFM with certain characteristics, the NIRS devices are adhered to the human skin in each of the TMs involved in AFM, additionally they can be included other TMs involved in the inspiration and expiration phases. The hemodynamic values are registered by these devices and also the heart rate (HR) values can be registered with a monitor of HR. Also, record data on external locomotor performance developed during AFC, such as power or cadence data. 2. Data Management: Doing a process of downloading, synchronization, linking and filtering of the data obtained is carried out, through a data processing system. 3. Analysis and Evaluation of the Hemodynamic Data Obtained During Monitored Locomotor Activity or Cyclic Physical Activity (AFCM): The hemodynamic data obtained with the NIRS devices and the other devices during the AFCM are evaluated and analysed analytically for each TM, and jointly for to establish which has been the physiological performance of the all TMs during the AFCM, the physiological thresholds of each TM, the general physiological thresholds, the performance of each subfactor and the physiological factors limiting muscle hemodynamic performance during the developed AFCM. The invention refers to a Muscle Hemodynamic Monitoring and Evaluation Method that allows the evaluation and analysis of locomotor performance during AFCM, allowing to analysis and determination of the systemic or analytical physiological factors that limit or impede the perfect locomotor performance of human muscle tissues. Figure 1 shows the general scheme of all the factors that allows to evaluate and analyze. In the first place, data capture is carried out, which refers to procedures prior to data recording of the evaluation and monitoring method of the invention. 1. The evaluation and monitoring method comprises a first stage of providing the subject to be evaluated of: o Two or more near infrared sensors (NIRS). o One Heart Rate (HR) monitor. o  One physical activity monitor or data recording device. o  One intensity meter or device (GPS, power meter, ...). 2021307653   16 Sep 2026 Complementarily they can be provided of devices or meters of locomotor performance parameters (meter of cadence, pedometers, ..) or meters of other physiological variables (VO2 / CO2 gas analyzers, surface electromyography,...). 2. The NIRS are placed or adhered on the muscle tissues (TM) that will be evaluated and will participate in the Monitored Locomotor Activity or Cyclic Physical Activity (AFMM). Likewise, the HR band will be placed on the subject's chest and any other monitor, devices and / or intensity and / or locomotor and / or physiological performance meter that requires it to obtain data will be placed or added. 3. The data recording of all devices and activity monitors begins, minimally from the start of the AFM. The AFMM comprises one or more of the following characteristics: o The subject to be evaluated will carry out a AFCM, such as running, swimming, pedalling, rowing, ... o  The devices record the data they capture and / or monitor during AFCM. o  The activity monitor records the full-time scale from the beginning to the end of the AFCM, including the multiple intervals of work and / or rest if performed. o Complementary and / or necessary tools can be used for the development of AFCM. o The data recording frequency of each device must be less than 6 seconds. o The AFCM can be continuous or intervallic. o The AFCM can be of stable, incremental, decreasing or variable locomotive intensity. o The AFCM may or may not include a warm-up / prior preparation, and if it does not include it, the AFCM may contain a warm-up exercise prior to monitoring without the need to be recorded. o The minimum number of records for each device will be equivalent to the minimum number of records to be able to generate the trend line of the variables that the device is monitoring. o The characteristics of locomotor exercise (volume, duration, density, intensity, number of intervals, intensity of each interval, properties of the environment, ...) will depend on the physiological factor or factors of muscle performance that want to be evaluated, having a composition, structure and own characteristics in each case. o External accessories or materials that participate in the locomotive activity may be introduced, such as a bicycle, a canoeing paddle or skis. The processing system takes care of the data management stage, which includes downloading, synchronization, data filtering, and data analysis. 2021307653   16 Sep 2026 Thus, once the AFCM is finished, the following steps will be carried out: 1. Download all the data from each device with his temporary record of each value. The values downloaded by each device: a. NIRS: Muscular Oxygen Saturation (% - SmO2%) and Capillary Hemoglobin (g / dL -ThB). b. Heart Rate Monitor: Heart Rate (bpm - HR) c. Activity Monitor and / or computing device: temporal scale of AFCM d. Intensity device or monitor: Power (Watts) / Speed (Km / h) / Pace (min / Km) / Any locomotor intensity measurement e. External locomotor performance devices and / or monitors: Cadence (rpm) / Accelerometer / Pedometer / Any other type of device that provides data on external locomotor performance f. Devices and / or monitors of Physiological Locomotor Performance: Metabolic gas analyzers (VO2 / CO2), lactate meters, thermal imaging cameras ... 2. Sync, link and pair all values on a single grouped data timescale starting from the timescale collected by the activity monitor during AFCM 3. Calculate the values for each Monitored Muscle Tissue (TMM) that participate in the AFCM from the recorded data of SmO2% and ThB of: o Oxygen-Charged Capillary Hemoglobin - g / dL (O2HHb) % (SmO2) * g / dL (ThB) = g / dL (O2HHb) o Oxygen Discharged Capillary Hemoglobin - g / dL (HHb) g / dL (ThB) - g / dL (O2HHb) = g / dL (HHb) o Muscle Blood Flow of Muscle Hemoglobin - g / dL / s (0ThB). [g / dL (ThB) * (HR)] / 60 = g / dL / seg ($ThB) o Muscular Blood Flow of Oxygen-Charged Hemoglobin - g / dL / s (0O2HHb). [g / dL (O2HHb) * (HR)] / 60 = g / dL / seg (0O2HHb) o Muscular Blood Flow of Oxygen Discharged Hemoglobin - g / dL / s (0HHb). [g / dL (HHb) * (HR)] / 60 = g / dL / seg ($HHb) 4. Filter and exclude the data obtained erroneously and / or by registration error by the devices during AFCM. Exclude the data that are not within the following ranges and all the data obtained from the calculation of any of them: a. SMO2% [Between 1% SmO2 and 99% SmO2] b. ThB [Between 9.5 g / dL and 14,9 g / dL] 2021307653   16 Sep 2026 c. HR [Between 40ppm and 230ppm] 5. Filter and exclude the data that present a difference greater than that established in the following parameters, between the temporary records of the same previous and subsequent value, and all the data obtained from the calculation of any of them will also be excluded: a. Difference of SmO2% [> ±10% SmO2%] b. Difference of ThB [> ±0.3 g / dL] c. Difference of HR [> ±7ppm] Then, through the processing system, an analysis and an evaluation of the data obtained during the AFCM is carried out. Previously to the analysis of the physiological factors, the intensity or range of locomotor intensity equivalent to the Minimum Activation Threshold (UAmin), the Aerobic Threshold (UAe) and the Anaerobic Threshold (UAna) that the user has developed during the AFCM will be established. To be able to establish each of the thresholds mentioned, it will require that intensities above these thresholds have been developed in the AFCM, in order to be monitored. Previous calculating the physiological thresholds, the trend line of each value obtained and / or calculated, for each TMM will be established. Thus, it proceeds to perform, through the processing system, an analysis and evaluation of physiological thresholds and the calculation of a trend line of the values obtained. To the Physiological Thresholds are obtaining from combination of all the data of SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, 0HHb of all TMM. The procedure for calculating the Thresholds, through the processing system, has got the following steps: 1. Filter and exclude all values obtained, calculated and / or recorded during all Rest Intervals (ID) or without AFC. 2. Filter and exclude all values obtained, calculated and / or recorded during the first minute of each work interval (IT). 3. Filter and exclude all the values obtained, calculated and / or registered when the value of locomotor intensity in the same time register is equivalent to “0”. 2021307653   16 Sep 2026 4. Filter and exclude all the values obtained, calculated and / or registered when the value of locomotor movement frequency in the same time register is equivalent to “0”. 5. Choose and perform at least one of the following procedures: Procedure A A1. Calculate the statistical median value (Y) of the values SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, 0HHb of each TMM, during AFCM, in each Locomotor Work Intensity (INTTL) or in each Intensity Range of Locomotor Work (R-INTTL), that participates in the AFCM. A2. Establish the Trend Line (LinTrend) of the median values (Y - INTTL) or (Y - R-INTTL) obtained from YSmO2%, YThB, Y$ThB, YO2HHb, Y$O2HHb, YHHb and Y$HHb, in each TMM. Procedure B B1. Calculate the statistical average value (Y) of the values of SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, $HHb, of each TMM, during AFCM, in each INTTL or R-INTTL, which participates in the AFCM. B2. Establish the LinTrend of the average values (Y-INTTL) or (y-R-INTTL) obtained from YSmO2%, YThB, Y$ThB, YO2HHb, Y^HHb, YHHb and Y$HHb, in each TMM. Procedure C C1. Establish the LinTrend (Value / INTTL) or (Value / R-INTTL), from all filtered values of SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, $HHb, in each TMM. 6.  Calculate all values of LinTrend |Y|SmO2%, |Y|ThB, |Y|$ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb and |Y|$HHb, of each TMM, for each INTTL or R- INTTL. 7.  Calculate the Slope (p) between each of the values of |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|$HHb, from each TMM. 8. Calculate, analyze and determine all the trend changes of (p) in each of the LinTrend, of all the values |Y|SmO2%, |Y|ThB, |Y|$ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb and |Y|$HHb, of each TMM. 9. Calculate, analyze and establish between which two values of INTTL or R- INTTL occurs the 1st, 2nd and 3rd General Change of the trend of the slope (p) of LinTrend |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|$O2HHb, |Y|HHb and |Y|$HHb, in each TMM. 10. Establish the intensity range in which the 1st General Change of the slope (p) trend occurs, of each TMM, through the combining at least 4 of the 7 INTTL or R- INTTL, analyzed and established in the previous step (9), for each TMM. 11. Establish the intensity range in which the 2nd General Change of the slope (p) trend occurs, of each TMM, through the combining at least 4 of the 7 INTTL or R- INTTL, analyzed and established in the previous step (9), for each TMM. 2021307653   16 Sep 2026 12. Establish the intensity range in which the 3rd General Change of the slope (p) trend occurs, of each TMM, through the combining at least 4 of the 7 INTTL or R- INTTL, analyzed and established in the previous step (9), for each TMM. 13. Establish the Physiological Thresholds of each TMM from the data calculated and established in the previous points: 1st General         2nd General         3rd General Change (p)        Change (p)        Change (p) UAmin Individual                 UAe Individual                 UAna Individual Rank|X| (Watts)      Rank|X| (Watts)      Rank|X| (Watts) TMM       |X| (Watts)           |X| (Watts)           |X| (Watts) 14. Establish the central INTTL or R- INTTL of the General Physiological Thresholds from the median of the values of the individual thresholds of all TMSM: 1st General         2nd General         3rd General Change (p)        Change (p)        Change (p) UAmn                 UAe                 UAna Rank|X| (Watts)      Rank|X| (Watts)      Rank|X| (Watts) TMM       |X| (Watts)           |X| (Watts)           |X| (Watts) 15. Coming up next, the processing system can then also determine the level of symmetry or asymmetry that has been obtained between at least two groups of values and / or trend of the values |F|SmO2%, |r|ThB, |F|$ThB, |F|O2HHb, |F|$O2HHb, |F|HHb and / or |F|$HHb, between two INTTL or two R- INTTL, between at least two TMsM: A) Coefficient of Symmetry between Values (CSV) To set whether a set of values |Z|SmO2%, |K|ThB, |F|0ThB, |F|O2HHb, |F|0O2HHb, |F|HHb and / or |F|0HHb, between two INTTL or two R- INTTL, of at least two TMsm have some level of symmetry or asymmetry, the following procedure must be carried out: - Calculate, analyze and determine the CSV of the values of |Z|SmO2%, |K|ThB, |F|0ThB, |F|O2HHb, |F|0O2HHb, |F|HHb or |F|$HHb, between two INTTL or two R- INTTL determined, between at least two determined TMSM: Standard Deviation (a) of the values of |F| A verage of the values of |F| - Establish the Symmetry Level (NSCSV) from the CSV value calculated from the values |F|SmO2%, |F|ThB, |F|$ThB, |F|O2HHb, |F|0O2HHb, |F|HHb or |F|$HHb, between two INTTL or two R- INTTL determined, between at least two TMSM determined: 2021307653   16 Sep 2026 Symmetry Level (NSCSV ) CSV SmO2% O2HHb - HHb 0O2HHb - 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01 < 0,05 > 0,001 < 0,005 > 0,01 < 0,05 Minimal > 0,05 < 0,20 > 0,005 < 0,02 > 0,05 < 0,2 Asymmetry > 0,20 > 0,02 > 0,2 B) Symmetry Coefficient between the Trends of the Values - TGV (Coef-(p)) To establish whether the trend of the values |Y|SmO2%, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and / or |Y|0HHb, between two INTTL or two R- INTTL determined, of a TMM have some level of symmetry or asymmetry with the trend of the values |Y|SmO2%, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and / or |Y|0HHb, between two INTTL or two R- INTTL determined, of at least one other TMM or a set of TMSM, the following procedure must be carried out: - Calculate, analyze and determine the slope-trend (p)|Y| of at |Y|SmO2%, |Y|O2HHb, |F|0O2HHb, |Y|HHb and / or |Y|0HHb, between two INTTL or two R-INTTL determined, of at least two TMSM determined: 7rj) = ^2 - ^1 ■ (p)    |X|2-|X|1 ; where (p) is the slope-trend; |Y|1 the determined value of SmO2%, O2HHb, 0O2HHb, HHb o 0HHb, of the 1ST LNTTL or R-INTTL determined and |Y|2 of the 2nd INTTL or R-INTTL determined; |X| 1 is the 1ST LNTTL or R-INTTL and |X| 2 the 2nd INTTL or R-INTTL determined. - Calculate, analyze and establish the Coef-(p) of (p)|Y|SmO2%,  (p)|Y|O2HHb, (p)|Y|0O2HHb, (p)|Y|HHb and / or (p)|Y|0HHb between two INTTL or two R-INTTL determined, of one TMM determined with respect to the trend of the values (p)|y|SmO2%, (p)|Y|O2HHb, (p)|Y|0O2HHb, (p)|K|HHb and / or (p)|Y|0HHb of another TMM or a set of trends of values (p)|Y|SmO2%, (p)|Y|O2HHb, (p)|Y|0O2HHb, (p)|Y|HHb and / or (p)|y|0HHb of two or more TMsm determined: Coef-(^ = [(D|y|] - [Or] Where (p) |Y| is the median slope-trends of the compared TMsm and (p1)|F'| is the slopetrend of the analyzed TMM. - Establish the Symmetry Level (NS Coef-(p)) from the calculated value of Coef-(p) (p)|y|SmO2%, (p)|Y|O2HHb, (p)|y|$O2HHb, (p)|Y|HHb o (p)|Y|0HHb of the analyzed TMM: 2021307653   16 Sep 2026 Symmetry Level ( NS Coef-p) Coef- (p) SmO2% O2HHb - HHb 0O2HHb- 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01   < 0,05 > 0,001  < 0,005 > 0,01  < 0,05 Minimal > 0,05   < 0,15 > 0,005  < 0,015 > 0,05  < 0,15 Asymmetry > 0,15 > 0,015 > 0,15 16. The processing system coming up next determines if there are limitations on the performance of the subject to be analyzed and of what type these limitations are. To do this, a series of values and ranges of the measured and calculated variables are determined that indicate the presence of different types of limitations. The types of limitations that may exist and the steps to follow in determining the presence of each one in the subject's performance are explained below. A. MUSCLE OXIDATIVE CAPACITY The oxidative capacity is the potential of the muscular tissues to consume the oxygen delivered in the muscular capillaries and with the objective of producing an amount of adenosine triphosphate (ATP) necessary for the locomotor movement. When evaluating the hemodynamic performance, the performance of the global muscle oxidative capacity is established, that is, the global or average level of the entire locomotor system, and at the same time the individual performance level of each muscle tissue is established. Since there are multiple factors that can affect to the ability of consume oxygen of only one muscle tissue while the consumption potential remains intact in the other muscle tissues. A perfect global or general muscle oxidative capacity occurs when each muscle tissue that participates in locomotor activity is capable of consuming all the oxygen delivered by the cardiovascular system. On the contrary, limitations can occur with respect to the maximum potential of oxidative capacity when in at least one, a group or all the muscular tissues do not express the maximum capacity or potential to consume all the oxygen delivered by the cardiovascular system. 2021307653   16 Sep 2026 A1. Structural Factor of Oxidative Capacity Factor (A1) is that factor that analyzes and evaluates the performance of the level of mitochondrial density and / or oxidative enzymes available to muscle tissues. Oxygen is consumed within the mitochondria and the enzymes participate in this process and establish the speed at which it is consumed, a low level of both means a low capacity to consume oxygen and produce high amounts of energy per unit of time. A limitation in this factor means a general limitation of oxidative capacity in practically almost all muscle fibers. To establish that there is a Limitation in Factor A1, the following steps and criteria must be met: - Evaluate the value of |Z|SmO2% in each INTTL or R-INTTL, INTTL greater than or equal to UAmin and less than or equal to UAna. - Calculate, compare, evaluate and establish the Coefficient of Symmetry between Values (CSV) and the Level of Symmetry (NSCSV) between |Z|SmO2%, |F|O2HHb and |F|0O2HHb of each TMM and his Contralateral Muscle Tissue Monitored (TMCM), in each INTTL or R-INTTL INTTL greater than or equal to UAmin and less than or equal to UAna. - Calculate, compare and evaluate the General Trend of the Values (TGV [(p)]) |y|SmO2%, |y|0O2HHb and |F|O2HHb, of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe -UAna). - Calculate, compare and establish the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)|y|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb, between the combination of at least 70-75% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Determine that the following criteria are met to establish a limitation in Factor (A1): 1. The value of |Z|SmO2% in each INTTL or R-INTTL INTTL greater or equal than UAmin and less than or equal to UAna, is >70% SmO2%, in at least 70-75% of TMsM. 2. The values of |Z|SmO2%, |F|O2HHb and |F|0O2HHb of each TMM and TMCM, have at least one optimal symmetry, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna, in at least the 70-75% of TMSM. 3. The TGV of de (p)|F|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb is symmetric between the combination of at least 70-75% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna). 4. The TGV of de (p)|Z|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb is symmetric between each TMM and his TMCM, in at least 80-85% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna). 2021307653   16 Sep 2026 A2. Functional Factor of Oxidative Capacity by General Fatigue The functional factor of oxidative capacity is that factor that analyzes and evaluates whether the muscle tissues have the potential or the capacity to consume large amounts of oxygen delivered by the cardiovascular system, but due to factors of general fatigue, the muscle tissues lose part or all its consumption potential. Once the general fatigue disappears, this limitation disappears, it is a temporary limitation of the performance of the oxidative capacity and it is observed in practically all the muscular tissues at the same time. To establish a Limitation on Factor (A2) the following steps and criteria must be met: - Evaluate the values of |Z|SmO2%, |F|O2HHb and |F|0O2HHb of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate and evaluate the difference of SmO2% between the value of |Z|SmO2% of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Compare, evaluate and determine the CSV and NSCSV between the values of |Z|SmO2%, |F|0O2HHb and |F|O2HHb of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, compare and evaluate the TGV [(p) of |Z|SmO2%, |F|0O2HHb and |F|O2HHb of all TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Calculate, compare and establish the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)|y|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb, between the combination of at least 5055% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Determine that the following criteria are met to establish a limitation in Factor (A2): 1. The difference between the value of |Z|SmO2% of each TMM and his TMCM is >5% SmO2%, in the 95% of INTTL or R-INTTL greater than or equal to UAmin, in at least the 70-75% of TMSM. 2. The value of |Z|SmO2% is >55% SmO2%, in the 80% of TMsm, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna. 3. The values of |Z|SmO2%, |F|O2HHb and |F|0O2HHb are asymmetric in at least the 50% of INTTL or R-INTTL greater than or equal to UAmin, between one TMM and his TMCM, in at least the 70 -75% of TMSM. 4. The TGV of de (p)|y|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb is asymmetric between the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna). 2021307653   16 Sep 2026 If a second evaluation is carried out after a recovery period where the general fatigue disappears, it could be observed how all the muscular tissues regain their oxygen consumption potential and the asymmetries generated by the general fatigue also disappear and the muscle saturation would return to being symmetric in each muscle tissue compared with his contralateral muscle tissue. A3. Functional Factor of Oxidative Capacity by Muscle Inhibition The functional factor of the oxidative capacity due to Muscle Inhibition is that factor that analyzes each muscle tissue individually to assess whether the analyzed muscle tissue loses its potential or the ability to consume large amounts of oxygen temporarily due to a muscle inhibition. This factor is usually observed in isolated tissues, which lose their potential while the rest of the muscle tissues keep their oxygen consumption potential intact, unlike what happens in the functional factor due to general fatigue. To establish a Limitation on Factor A3, the following steps and criteria must be met: - Evaluate the value of |Z|SmO2% of at least one TMM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, compare and evaluate the value of |F|SmO2%, |F|O2HHb and |F|0O2HHb of at least one TMM with the values of his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, evaluate and determine the value of CSV and NSCSV of |y|SmO2%, |F|0O2HHb and |F|O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, compare and evaluate the TGV [(p)] of |Z|SmO2%, |F|0O2HHb and |F|O2HHb of all TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Calculate, evaluate and determine the lowest value of Coef- (p) and the equivalent NSCoef-(p) between the values of (p)|y|SmO2%, (p)|y|0O2HHb and (p)|F|O2HHb, of at least the combination of the 50-55% TMSM. - Determine that the following criteria are met to establish a limitation on Factor (A3): 1. The value of |Z|SmO2% is >50% SmO2% in the TMM analyzed, in the 95% of INTTL or R-INTTL greater than or equal to UAmin. 2. The values of |Z|SmO2%, |F|O2HHb |F|y 0O2HHb of the TMM analyzed are greater than the values of his TMCM, in the 95% of INTTL or R-INTTL greater than or equal to UAmin. 2021307653   16 Sep 2026 3. The TGV of (p)|Z|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb is asymmetric between the TMM analyzed and his TMCM, in the R-INTTL (UAmin - UAe) and (UAe -UAna). 4. The TGV of (p)|y|SmO2%, (p)|y|0O2HHb and (p)|F|O2HHb is symmetric between the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna). A4. Neuromuscular Factor of Oxidative Capacity (Intermuscular Coordination) The Neuromuscular factor of Oxidative Capacity (Intermuscular Coordination) is that factor that analyzes and evaluates whether the muscle tissues have the potential or the ability to consume large amounts of oxygen delivered by the cardiovascular system, but certain evaluated muscle tissues that participate in the activity locomotive, they do not, while the other muscular tissues do develop their potential. This occurs mainly due to two aspects, the muscle recruitment pattern by the nervous system and, on the other hand, the biomechanical pattern performed by the subject during locomotor movement. The pattern of muscle recruitment by the nervous system (Intermuscular Coordination) refers to the level of activation and participation in locomotor activity, a perfect muscle recruitment would mean that all the muscle tissues that participate in said movement have the same level of metabolic activation and therefore, the same muscle oxygen consumption. The level of performance of this aspect is determined by the ability of the nervous system to recruit and activate all muscle tissues symmetrically during locomotor movement. When the nervous system is not efficient in muscle recruitment, it activates differently and to a greater or / or lesser degree the different muscle tissues involved in locomotor activity. It should be noted that when this happens, a symmetry is usually observed between muscle tissues and their contralateral muscle tissues in the hemodynamic and activation values. When a lesser degree of recruitment occurs in muscle tissues and its contralateral muscle for the reasons mentioned above, they may present a limitation in oxidative capacity, as they have the potential to consume large amounts of oxygen, but do not develop said potential during locomotor activity due to less nervous activation. The biomechanical pattern refers to the physical movement carried out by the evaluated subject, any type of incorrect and / or inefficient biomechanical pattern may mean that the 2021307653   16 Sep 2026 nervous system must recruit some muscle tissues to a greater or / or lesser extent than other muscle tissues that participate in locomotor activity to be able to cope with said alterations or inefficient biomechanical patterns. When a muscle tissue and its contralateral muscle tissue are affected by this factor and their level of nerve activation is reduced, these muscle tissues do not express their maximum potential for oxygen consumption due to low nerve activation The two previous patterns or factors are the cause of a limitation of the Neuromuscular factor of Oxidative Capacity (Intermuscular Coordination). To establish a Limitation on Factor A4, the following steps and criteria must be met. - Evaluate the value of |Z|SmO2%, |F|0O2HHb and |F|O2HHb, of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, evaluate and determine the value of CSV and the equivalent NSCSV of de |y|SmO2%, |F|0O2HHb and |F|O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, compare and evaluate the TGV [(p)]) of |F|SmO2%, |F|0O2HHb and |F|O2HHb of all TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Calculate, evaluate and determine Coef-(p) and the equivalent NSCoef-(p) between the values (p)|y|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb, of each TMM and his TMCM, in the R-INTTL (UAmin- UAe) and (UAe - UAna). - Determine that the following criteria are met to establish a limitation on Factor (A4): 1. The value of |Z|SmO2% of the TMM analyzed and of his TMCM is greater than or equal to 65% SmO2%, in each INTTL or R-INTTL greater than or equal to UAmin. 2. The trend of (p)|y|SmO2%, (p)|F|0O2HHb and (p)|W2HHb, in the 70% of TMsm and their TMSCM are minimally symmetric, in the R-INTTL (UAmin - UAe) and (UAe -UAna). 3. The values of |Z|SmO2%, |F|0O2HHb and |F|O2HHb of the TMM analyzed and his TMCM are greater than the values of at least the 70-75% of the remaining TMSM, in each INTTL or R-INTTL greater than or equal to UAmin. 4. The values of |Z|SmO2% of at least the 50-55% of TMsm is <45% SmO2%, in any INTTL or R-INTTL greater than or equal to UAe. 2021307653   16 Sep 2026 B. OXYGEN-LOADED BLOOD DELIVERY CAPACITY IN THE VENOUS RETURN The Capacity to Deliver Oxygen-Loaded Blood Flow and the Venous Return is a performance performed jointly, dependently, harmonically and synchronized by the different vascular, muscular and nervous tissues together with the multiple organs of the body involved in gas exchange, the maintenance of blood pressure, supply and redistribution of oxygen-laden blood flow throughout the body, the level of metabolic activation of each tissue, and venous return during locomotor movement. To fully analyze and evaluate the performance of Oxygen-Charged Blood Delivery Capacity and Venous Return, the limiting factors for performance are divided according to the physiological system that interacts with some aspect of blood flow. The 3 systems into which the factors are divided are the pulmonary system, the cardiovascular system and the nervous system. B1. Pulmonary System B1.1. Pulmonary Structural Factor The Structural Factor of the Pulmonary System is that factor that analyzes and evaluates if there is any type of limitation in the exchange of gases produced in the lung, negatively affecting and reducing the delivery of oxygen-charged haemoglobin to the muscle tissues. The Pulmonary Structural Factor indirectly represents the state and performance of the pulmonary structures involved in gas exchange (for example, the pulmonary alveoli). Any deficiency in these structures can affect to the uptake of oxygen O2 and the expulsion of CO2 and H2O from the bloodstream. Any limitation related to problems in gas exchange or oxygen uptake is observed mainly in greater delays in terms of post-effort recovery periods and in oxygen replenishment in muscle tissues. In people without any type of alteration in this factor, the recovery or replenishment of oxygen is almost immediately, but in people with a certain limitation of this factor, the delay in replenishment can exceed 10 seconds or even reach half a minute in very evident cases. This limitation is mainly observed in people with respiratory diseases diagnosed as COPD, people with 1 lung, asthmatics, or smokers generally. 2021307653   16 Sep 2026 To establish if there is a limitation of the Pulmonary Structural Factor, the following steps must be followed, and the established criteria must be met: - Calculate, analyze and evaluate the value of |Z|SmO2% of at least one TMM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, analyze and evaluate the trend (p) of the SmO2% and 0O2HHb values of all TMSM, on the initial 5 and 10 seconds of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe. - determine that the following criteria are met to establish a limitation on Factor (B1.1): 1. The trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMSM. 2. The trend of the values (p)SmO2% and (p)0O2HHb in the initial 10 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to Uana, is less than [(p) < 0000,5], in at least 70% of TMSM. 3. The value of |Z|SmO2% is >50% SmO2% in the TMsm that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin. . B1.2. Pulmonary Functional Factor (Respiratory Muscles) The Pulmonary Functional Factor (Respiratory Muscles) is that factor that analyzes and evaluates if there is any type of limitation in the exchange of gases in the lungs produced by the inefficiency and / or incapacity of the muscular tissues in charge of the biomechanical phases of respiration [inspiration and expiration]. When there is an inefficiency in the performance of these muscle tissues, the maximum potential to introduce the greater volume of oxygen (L / min) into the lungs through negative pressure is reduced, which is generated by the contraction and elevation of the rib cage. The effects are the same as the Pulmonary System Structural Factor, but with a different limiting cause. The magnitude of the limitation depends on the level of deconditioning or inefficiency of performance by the respiratory muscle tissues. Even any muscle blockage or 2021307653   16 Sep 2026 "muscle contracture" in muscle tissues that limits the range of motion of the rib cage can prevent the maximum volume of oxygen introduced into the lungs from being generated. To establish whether there is a limitation of the Pulmonary Functional Factor, the following steps must be followed and the established criteria must be met: - Calculate, analyze and evaluate the value of |Z|SmO2% of at least one TM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin. - Calculate, analyze and evaluate the trend (p) of the SmO2% and 0O2HHb values of all TMSM, in the initial 5 seconds, of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe. - determine that the following criteria are met to establish a limitation on Factor (B1.1): 1. The trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMsm 2. The value of |Z|SmO2% is <50% SmO2% in the TMsm that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin. B2. Cardiovascular System B2.1. Exercise blood flow analytical delivery performance factor The Performance Factor of Analytical Delivery of Blood Flow during exercise is that factor that analyzes and evaluates cardiovascular performance in each of the muscle tissues that participate in locomotor activity. This factor analyzes how the cardiovascular system satisfies the demands of blood flow from the muscle and determines how the characteristics of the flow delivered to each muscle are. In many cases, the delivery of blood flow is totally different in each of the muscle tissues, for that reason the characteristics of blood flow are analyzed individually, allowing to identify if there is some type of hierarchy of preference between muscle tissues in terms of the delivery of blood. - Composition of Muscular Blood Flow [% of Blood Flow Charged with Oxygen] (Factor B.2.1.1): It is the aspect or qualitative component of blood flow, it represents 2021307653   16 Sep 2026 how much haemoglobin is charged with oxygen in the blood flow of said muscle tissue and whether the blood flow is rich or poor in oxygen. - Volume of Muscle Hemoglobin Delivery [Oxygen Charged (O2HHb) or Discharged (HHb)] (Factor B.2.1.2): It is the absolute quantitative aspect of blood flow. The absolute amount of hemoglobin that is oxygen-loaded and discharged is determined. This aspect serves to know if the muscle tissue receives the correct amount of hemoglobin during locomotor work in the intensity or range of intensities analyzed. - Velocity / Rate of Blood Flow Delivery [Charged (QO2HHb - Oxygen Discharged (QHHb)] (Factor B.2.1.3): It is the aspect of intensity or speed with which a certain volume of oxygen charged or discharged hemoglobin is delivered This parameter is important to fully analyze the individual cardiovascular performance of muscle tissue because a tissue may have a blood flow with a lower "quality" and "quantity" of oxygenladen blood delivery, but if the speed at which the blood is delivered is high enough, it may be sufficient to satisfy the metabolic oxygen demands during locomotor work in the intensity or range of intensities analyzed. In order to evaluate and establish the performance of Factor (B2.1), the following steps must be followed and the established criteria must be met: - Calculate the value of |y|SmO2%, |y|O2HHb, |y|0O2HHb, of each TMM, in at least one INTTL or R-INTTL greater than or equal to UAmin. - Calculate the values of SmO2%, O2HHb and 0O2HHb of the Upper Limit of the Optimal Zone (\limsup\ ZonaOp) and the Lower Limit of the Optimal Zone \liminf\ ZonaOp, in the determined INTTL or R-INTTL, from the following calculation: llimsupl ZonaOp = (Median of {|r|1;|r|2;|r|3;..,}) + (o {\y\1;\y\2;\y\3;...,,}) / 2 Him inf\ ZonaOp = (Median of {|F|i;Wh;|r|3;...,}) - (o {|F|i;^h;m;...,,})^ where |F| is the value (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity; (a) is the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity. 2021307653   16 Sep 2026 - Compare and evaluate the values of |Z|SmO2%, |F|O2HHb and |F|0O2HHb, of at least one TMM with the values of SmO2%, O2HHb and 0O2HHb of lliminfl ZonaOp and of llimsupl ZonaOp, in INTTL or R-INTTL greater than or equal to UAmn analyzed. - Determine the type of performance of the Factor (B.2.1.1) that develops at least one TMM analyzed, in the analyzed INTTL or R-INTTL, based on the following criteria: o Excessive Muscle Oxygen Amount if: ■ The value of |Z|SmO2% of the TMM is <80% SmO2% in the analyzed INTTL or R-INTTL. ■ The value of  |Z|SmO2%  of the analyzed TMM is greater than SmO2%llimsupl ZonaOp, in the analyzed INTTL or R-INTTL. ■ The difference between the value of |Z|SmO2% of the analyzed TMM and SmO2% llimsupl ZonaOp is >15% SmO2%, in the analyzed INTTL or R-INTTL. o Greater Amount of Muscular Oxygen if: ■  The value of |Z|SmO2% of  the analyzed TMM is greater  than SmO2%llimsupl ZonaOp, in the analyzed INTTL or R-INTTL. ■  The difference between the value of |Z|SmO2% of the analyzed TMM and SmO2%llimsupl ZonaOp, is <15% SmO2%, in the analyzed INTTL or R-INTTL. o Optimal Amount of Muscular Oxygen if: ■  The value of |Z|SmO2% of the analyzed TMM is equal or less than SmO2%llimsupl ZonaOp, in the analyzed INTTL or R-INTTL. ■  The value of lZlSmO2% of the analyzed TMM is equal or greater than SmO2% llim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. o Lower Amount of Muscular Oxygen if: ■ The value of  lFlSmO2%  of the analyzed TMM is greater than SmO2%llim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. ■ The value of lFlSmO2% of the analyzed TMM is >20% SmO2%, in the analyzed INTTL or R-INTTL. o Inefficient or Low Amount of Muscular Oxygen if: ■ The value of  lFlSmO2%  of the analyzed TMM is greater than SmO2%llim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. ■ The value of \y\SmO2°^ of the analyzed TMM is <20% SmO2%, in the analyzed INTTL or R-INTTL. - Determine the type of performance of the Factor (B.2.1.2) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria: 2021307653   16 Sep 2026 o Higher Hemoglobin Delivery Volume if: ■ The value of \y\O2HHb of the analyzed TMM is greater than O2HHb \limsup\ ZonaOp, in the INTTL or R-INTTL analyzed. o Optimal Hemoglobin Delivery Volume if: ■ The value of \y\O2HHb of the analyzed TMM analyzed is equal or less than O2HHb llimsupl ZonaOp, in the analyzed INTTL or R-INTTL. ■ The value of \y\O2HHb of the analyzed TMM is equal or greater than O2HHb \lim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. o Lower Hemoglobin Delivery Volume if: ■ The value of \y\O2HHb of the analyzed TMM a is less than O2HHb \lim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. - Determine the type of performance of the Factor (B.2.1.3) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria: o Higher Blood Flow Delivery Rate if: ■ The value of \F\0O2HHb of the analyzed TMM is greater than the value of 0O2HHb\ltmswp\ ZonaOp, in the analyzed INTTL or R-INTTL. o   Optimal Blood Flow Delivery Rate if: ■ The value of \F\0O2HHb of the analyzed TMM is equal or less than of 0O2HHb\ltmswp\ ZonaOp, in the analyzed INTTL or R-INTTL. ■ The value of \F\0O2HHb of the analyzed TMM is equal or greater than 0O2HHb \lim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. o Lower Blood Flow Delivery Rate if: ■ The value of \F\0O2HHb of the analyzed TMM is less than 0O2HHb \lim inf\ ZonaOp, in the analyzed INTTL or R-INTTL. B2.2. Functional Sympatholysis Factor for Blood Flow Redistribution During exercise, the active muscles contract and vasodilation occurs due to various mechanical, nervous and metabolic factors. If this vasodilation occurs excessively, it can “threaten” the systemic regulation of blood pressure throughout the body, for that reason the sympathetic nervous system does a vascular vasoconstriction to maintain blood pressure and blood flow levels in order to maintain regular oxygen supply to the brain and vital organs (Functional Sympatholysis). 2021307653   16 Sep 2026 Regulation of blood flow to skeletal muscle is closely linked to metabolic oxygen demand and with a change in oxygen requirement leading to a proportional change in blood flow. The precise control of the regulation of blood flow serves to minimize the work of the heart, while ensuring an adequate supply of oxygen to the working muscles. The need for this precise control of blood flow to the muscle becomes apparent when you consider that active skeletal muscle comprises about ~40% of body mass and that muscle-specific blood flow can increase nearly 100-fold from rest to intense exercise. Given the limitation in maximum cardiac output, the heart can only supply a fraction of the active muscles with maximum blood flow and during high intensity exercises involving greater muscle mass, vascular conductance has to be well regulated or pressure blood pressure could drop. This factor evaluates and analyzes the performance of Functional Sympatholysis, that is, the performance of the nervous system on cardiovascular function in the redistribution of blood flow. In order to analyze this factor, rest intervals are used, since once the exercise ceases, the vasoconstrictive effect of the nervous system ceases, but the opposing vasodilator effects at the muscular level remain active as they are slower. This allows to analyze the magnitude of their performance during the exercise that was previously carried out. In order to evaluate and establish the performance of Factor (B2.2), the following steps must be followed and the established criteria must be met: - Calculate, compare and evaluate the maximum value of SmO2%, O2HHb and 0O2HHb of all TMSM, in at least one ID. - Calculate, evaluate and determine the value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, of all TMsm, in at least one ID. - Calculate, evaluate and determine the lowest value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, from the combination of at least the 70-75% of the TMSM, in at least one ID. - Determine the type of performance of the Factor (B.2.2), just at the moment of cessation of locomotor work, based on the following criteria: o Perfect performance if: ■ The maximum values of SmO2%, O2HHb and 0O2HHb are symmetrically perfect, between all TMSM, in the analyzed ID. o Optimal performance if: ■ The maximum values of SmO2%, O2HHb and 0O2HHb, are symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID. o Asymmetric Performance if: 2021307653   16 Sep 2026 ■ The maximum values of SmO2%, O2HHb and 0O2HHb, are not symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID. B2.3. Evolution Factor of Analytical Cardiovascular Performance When multiple work intervals are performed with their respective rest intervals, the evolution of cardiovascular performance in the delivery / demand of blood flow of a muscle tissue can be evaluated. This factor analyzes the evolution of this performance and for this a comparison is made between the values of the analyzed muscle tissue, in the rest intervals analyzed. In order to evaluate and establish the performance of Factor (B2.3), the following steps must be followed and the established criteria must be met: - Calculate, compare and evaluate the maximum value of SmO2% between two ID, separated by at least one IT of at least one TMM. - Determine the type of performance of the Factor (B.2.3) that develops, at least one analyzed TMM, between two ID, separated by a IT, based on the following criteria: o Significant increase: ■ Increase >5% SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1ST LD. o Slight Increase: ■ Increase between [2,01 - 5 %] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1ST LD. o Slight decrease if: ■ Decrease between [2,01 - 5%] SmO2% in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1ST LD. o Significant decrease if: ■ Decrease >5% SmO2%, in the maximum value of SmO2% of the analyzed TMM, in the 2nd ID in compared to the 1ST LD. o Maintenance if: ■ Decrease or increase of between [0-2%] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1ST LD 2021307653   16 Sep 2026 B2.4. Muscle Pumping Factor of Blood Flow The Muscle Blood Flow Pumping Factor is that factor that analyzes and evaluates the performance of each muscle tissue during locomotor movement to perform muscle contraction and compress the blood vessels located in said muscle tissues. This compression of the blood vessels causes the venous return of blood flow to the heart. Each muscle tissue must be able to generate sufficient mechanical stress on the blood vessels to drive blood flow through the venous system. The collective performance of this factor is important to maintain efficient venous return. The cardiovascular system is a closed circuit system, any alteration of the maximum venous return potential affects the entire cardiovascular system, because if the maximum volume of blood that returns to the heart through the venous return decreases, cardiac filling will decrease, then the stroke volume will be lower, and later the arterial pressure will drop, since the volume of blood ejected by the heart will be lower. To establish a Limitation on Factor (B2.4) in at least one TMM, the following steps and criteria must be met: - Calculate, compare and evaluate the TGV [(p)] of (p)|F|ThB of at least one TMM, in the R-INTTL (UAe-UANA) and (UANA-Maximum Intensity [IntMax]). - The value of |Z|SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin. - Determine if the following criteria are met to establish a limitation in Factor (B2.4): o The TGV (p)|F|ThB of the analyzed TMM is [(p)>0,0005], in the R-INTTL ^-Uana) or (UANA-Maximum Intensity [IntMax]). o The value of |Z|SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin. B3. Neurovascular System B3.1. Neuromuscular Activation Factor (Intermuscular Coordination) The Neuromuscular Activation Factor (Intermuscular Coordination) is that factor that analyzes and evaluates the performance of the nervous system to activate each muscle tissue during locomotor movement. This factor includes the analysis, evaluation and comparison between 2021307653   16 Sep 2026 the different levels of metabolic activation generated by the nervous system between the muscular tissues that participate in locomotor activity (Intermuscular Coordination). A perfect or efficient neuromuscular activation of all muscle tissues is one in which all muscle tissues involved in locomotor activity have the same level of metabolic activation to cope with the demands of locomotor movement. When there are multiple levels of activation, an optimal (efficient) activation range is established to be able to assess the activation level of each muscle tissue individually. A muscle tissue that is below or above said optimal activation zone can be interpreted that that tissue has a higher u / or lower muscle activation and therefore the metabolic efficiency of the set of muscle tissues decreases. A greater symmetry in the levels of muscle activation during locomotor work translates into a lower energy cost to cope with said locomotor work / movement, on the other hand, a greater asymmetry of the whole and / or a muscle tissue means a higher energy cost for cope with locomotor work / movement [Running Economy]. Therefore, there is an individual muscle activation level of each muscle tissue and a global muscle activation of all muscle tissues for each intensity of locomotor work of an evaluated subject, that is, multiple neuromuscular activation factors. To establish a Factor Performance Level (B3.1) of at least one TMM, the following steps and criteria must be met: - Evaluate the value \Y\SmO2%, \y\O2HHb and \Y\0O2HHb, of at least one TMM, in at least one INTTL or R-INTTL greater or equal than UAmin. - Calculate the SmO2%, O2HHb and 0O2HHb values of the Upper Limit of the Optimal Zone (\lim swp\ ZonaOp) and the Lower Limit of the Optimal Zone (Him inf\ ZonaOp), in the determined INTTL or R-INTTL, from the following calculation: \limsup\ZonaOp = (Mediana de {\y\1;\y\2;\Y\3;...,}) + (a {\Y\i;\yh;|y|3;...,,}) / 2 Him inf\ ZonaOp = (Mediana de {\Y\ 1;\yh;m;...,}) - (a {\Y\i;\yh;\Y\3;...,,}) / 2 where \Y\ is the value (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL and (a) the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL. 2021307653   16 Sep 2026 - Compare and evaluate the values of \Z\SmO2%, \y\O2HHb and \F\0O2HHb, of at least one TMM with the values of (SmO2%, O2HHb and 0O2HHb of the \limsup\ ZonaOp and the llim inf\ ZonaOp, in at least one determined INTTL or R-INTTL greater or equal than UAmin. - determine the level of Neuromuscular Activation performed by at least one TMM (Factor B3.1), based on the following criteria: o Null or Very Low Neuromuscular Activation if: ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and 0O2HHb\ltmswp\ ZonaOp, in the determined INTTL or R-INTTL. ■ The value of \Z\SmO2% of the TMM analyzed, is >75% SmO2% in the determined INTTL or R-INTTL. o Less or Low Neuromuscular Activation if: ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and 0O2HHb\ltmswp\ ZonaOp, in the determined INTTL or R-INTTL. ■ The value of \Z\SmO2% of the TMM analyzed, is <75% SmO2%, in the determined INTTL or R-INTTL. o Optimal Neuromuscular Activation if: ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \limsup\ZonaOp, in the determined INTTL or R-INTTL. ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb, of the TMM analyzed, is greater than SmO2%, O2HHb and 0O2HHb \liminf\ ZonaOp, in the determined INTTL or R-INTTL. o Excessive or Priority Neuromuscular Activation if ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \lim inf\ ZonaOp, in the determined INTTL or R-INTTL. ■ The value of \Z\SmO2% of the TMM analyzed is <25% SmO2%, in some INTTL or R-INTTL. o High Neuromuscular Activation if: ■ The value of \Z\SmO2%, \y\O2HHb and \F\0O2HHb, of the TMM analyzed, is less than SmO2%, O2HHb and 0O2HHb \lim inf\ ZonaOp, in the determined INTTL or R-INTTL. 2021307653   16 Sep 2026 ■ The value of |Z|SmO2% of the TMM analyzed is >25% SmO2%, in all the INTTL or R-INTTL greater than or equal to UAmin. B3.2. Neurovascular Structural Factor (Speed and Power of Muscle Contraction) The Neurovascular Structural Factor (Speed and Power of Muscle Contraction) is that factor that analyzes and evaluates the potential of [vasodilation vs vasoconstriction] in each muscle tissue evaluated. When the action potential is produced in the muscle tissue to produce the muscle contraction necessary for locomotor movement, this nerve potential also has an inhibitory effect and some chain responses that cause an inhibition of the vasoconstrictive effect of the sympathetic nervous system. On the other hand, it causes marked vasodilation in the arteriolar tissues close to the place where the action potential is produced. Therefore, vasodilation in muscle tissues is directly correlated with the speed of muscle contraction and / or the level of activation of said muscle tissue. Muscle tissue must have an optimal level of vasodilation to allow optimal oxygen-laden blood flow to arrive. Excessive vasodilation may mean that excessively vasodilated muscle tissue receives a greater volume of blood flow, more than is necessary to meet the metabolic oxygen demands that muscle tissue requires. This fact causes an inefficiency in the delivery of oxygen-laden blood flow by not being able to deliver this excess blood flow to other muscle tissues that do require it, causing a deficit in the delivery of oxygen-laden blood flow. To establish a Limitation on Factor (B3.2) in at least one TMM, the following steps and criteria must be met: - Calculate the median value of ThB (FThB), of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin. - Calculate the standard deviation (a) of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin. - Calculate the minimum value of ThB in at least one ID perform after an IT analyzed, of average INTTL or R-INTTL greater than or equal to UAmin. Ila         i       i a II      fff             i a           r / w^^i \      _ n r a I      a         it       i al - Calculate and evaluate the difference between [(KThB) - a] of at least one IT and the minimum value of ThB of his posterior / successive ID. - Determine if the following criteria are met to establish a limitation in Factor (B3.2) in at least one TMM: 2021307653   16 Sep 2026 o The value [Median YThB - aThB] of the analyzed TMM, of the analyzed IT of INTTL or R-INTTL greater than or equal to UAmin, is greater than the minimum value of ThB of the successive ID to the analyzed IT. B3.3. Muscle Contraction Speed The Muscle Contraction Speed Factor is that factor that analyzes and evaluates the frequency at which muscle contractions occur during locomotor activity. To produce a muscle contraction, the nervous system produces an electrical impulse that causes alterations in cellular metabolism to generate the contraction of muscle fibers. Said electrical impulse also has an inhibiting effect on the local vasoconstrictor receptors of the arteriolar network of the muscle. A high production of these impulses produces a high inhibition of vasoconstrictors and consequently increases the vasodilation of the arteries in the TM. At a certain point, an excessive vasodilation produces an excess delivery of blood flow, whereas a low frequency of electrical impulse discharge in the muscle will produce a low vasodilation and a greater vasoconstriction, producing an arterial occlusion mediated by the sympathetic nervous system. For this reason, this factor is in charge of evaluating muscle performance as a whole to establish which muscle contraction frequency (FCM) or Muscle Contraction Frequency Range (R-FCM) is optimal for the hemodynamic performance of the cardiovascular system. To evaluate and establish the performance of Factor (B3.3) in the set of TMM, the following steps and criteria must be met: - Calculate, compare and evaluate the median value (Y) of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb, of each TMM, in at least one determined INTTL or R-INTTL, in each one of the developed FCM and in the determined environmental conditions, during the AFCM. - Determine all the Optimal FCM or Optimal R-FCM, of at least one determined INTTL or R-INTTL, under certain environmental conditions, during AFCM, based on the fulfillment of the following criteria established for the factor (B3.3): 2021307653   16 Sep 2026 o Have the highest value of FSmO2% or a difference < (±2.5%) SmO2% with respect to the highest value FSmO2%, of all FCM or R-FCM, in at least the 78-81 % of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. o  Have the highest value of FO2HHb % or a difference < (±0,30 g / dL) O2HHb with respect to the highest value FO2HHb, of all FCM or R-FCM, in at least the 78-81 % of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. o  Have the highest value of F$O2HHb % or a difference < (±1,00 g / dL) 0O2HHb with respect to the highest value F$O2HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. o Have the lowest value of FHHb % or a difference < (±1,00 g / dL) HHb with respect to the lowest value FHHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. o Have the lowest value of F$HHb % or a difference < (±1,00 g / dL) 0HHb with respect to the lowest value F$HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM. The method of the invention described is of particular interest in the following practical applications, in which its advantages are evident: 1) Sports and Physical Activity Area o Evaluation of sports performance and / or physical activity: • The method of the invention makes it possible to individually evaluate the hemodynamic performance of each TMM during an AFC and establish an individual performance level for each TMM. It also allows you to analyze the global performance of all TMSM developed during the AFC. • It allows identifying the physiological factor and / or factors that limit locomotor performance or affect positively and / or negatively, to a greater and / or lesser extent to performance. • It allows to quantify the economy / efficiency of locomotor performance and establish which factor or factors affect positively and negatively. • It allows to evaluate and monitor the fatigue of the sympathetic nervous system • It allows to evaluate, monitor and establish the multiple physiological thresholds associated to one INTTL or R-INTTL. 2021307653   16 Sep 2026 • It allows to evaluate, monitor and establish the optimal muscle contraction frequencies for the AFC performed. o Applications in Biomechanical Evaluations, performance evaluations of technical gestures and / or aerodynamic evaluations: • The described method allows to evaluate the performance of the TMSM in different AFC conditions (modification of biomechanical patterns, technical gestures, body posture ...) and to establish which of the different conditions developed reports a better muscular hemodynamic performance for the analyzed subject. o Nutritional and pharmacological applications: • The method of the invention also makes it possible to evaluate the effect produced by the intake of nutritional supplements, the different dietary habits or the application of subcutaneous substances on muscle hemodynamic performance during AFC. o Applications in Rehabilitations, return to sport and injury prevention • The method of the invention makes it possible to evaluate, monitor and establish the performance of TMSM during evolution or recovery within a rehabilitation program, readaptation (return to sport) of one or more TMSM after an injury, accident and / or illness. • It allows to evaluate, monitor and establish the performance of the TMSM and detect possible alterations, decreases or inefficiencies in muscle performance during AFC that may pose a risk of injury during the next AFCM o Monitoring the hemodynamic performance of TMSM continuously during training plans: • The method of the invention makes it possible daily to evaluate performance during a training or physical activity plan to determine the evolution of the hemodynamic performance of at least some performance factors 2) Area of medicine, physiotherapy, dietetics and research: o Evaluate the effect of the application or introduction of medications, drugs, nutritional supplements, ergogenic or similar on muscle hemodynamic performance during locomotor exercise. o The method described allows to evaluate the variation in the hemodynamic performance due to the effect of the substance, either the immediate effect, evaluating the alterations 2021307653   16 Sep 2026 that it produces immediately, or for a determined time by means of pre & post evaluation procedure. o Scientific studies: The method described allows to evaluate the effect caused by the application of invasive or non-invasive intervention protocols on the hemodynamic performance of muscle tissues during locomotor actions. 3) Industrial and textile area: o Evaluation of the effect produced by the use of different textile fabrics on muscle hemodynamic performance during locomotor exercise, either through variations in sizes, shapes, composition of materials, colours and / or others. o Adjustment of the dimensions and technical measurements of devices or tools that are used in AFC from the patterns obtained in the hemodynamic evaluation. For example, in the manufacture of bikes, prostheses or materials with which physical activity is carried out, adjusting the dimensions and measurements to each person. The monitoring method of the invention described makes it possible to evaluate and monitor the muscle hemodynamic performance of all TMSM analytically, globally and both at the same time, during a AFC. This evaluation includes TMSM that are not directly involved in locomotor work, such as the muscular tissues responsible for respiratory movements. Likewise, the method of the invention allows the generation of an individualized physiological profile, as it offers complete information on the factors that affect or limit the analytical hemodynamic performance of each TMM and, at the same time, the general hemodynamic performance of all TMSM as a whole. Thus establishing, in a very analytical way, the physiological factors that limit the performance of subject. On the other hand, the method of the invention allows the analysis to be carried out in the training sessions themselves without the need to make any modification of the AFC that the subject is developing, or any specific protocol, or any environmental or environmental conditions. On the contrary, the usual evaluation methods generally require a controlled environment, in laboratories or closed places, moving away from the reality of the AFC developed by the majority of subjects. The method of the invention also makes it possible to quantify the running economy or efficiency of work of TMSM from an analytical physiological point of view. By analyzing the individual performance of each TMM separately, then jointly with other TMSM, it allows 2021307653   16 Sep 2026 quantifying the running economy or efficiency of work to be able define it, as well as establishing the specific tissues and / or factors that positively affect and / or negatively to the economy of work. The evaluation methods, up to now, measured and quantified the efficiency of locomotor performance from general values of the whole body such as the analysis of metabolic gases or blood lactate concentrations, or using external variables such as power development values or measurements of strength in exercises. However, with the method of the invention, the performance performed by each of the muscle tissues is directly evaluated and at the same time the global work, allowing to identify the muscle tissues that are negatively affecting the economy of work and, at the same time, evaluate how the performance is being in the set of muscular tissues. By identifying the factors that negatively affect or limit performance, the method of the invention makes it possible to establish action or training protocols to specifically improve said factors optimally and improve locomotor performance. Currently, there is no other monitoring method that allows offering analytical and global information on hemodynamic performance in a non-invasive way, with the advantages of the method of the invention. The invention also refers to a monitoring and evaluation system of the physical performance of a subject comprising: - two or more near infrared sensors (NIRS); - a cardiac monitoring device; - a locomotor work intensity device or monitor; - a data processing system connected to the two or more near infrared sensors (NIRS), the cardiac monitoring device and the locomotor work intensity device or monitor and configured to carry out the steps of the method of the invention previously described. DESCRIPTION OF THE DRAWINGS To complement the description that is being made and in order to help a better understanding of the characteristics of the invention, according to a preferent example of a practical embodiment thereof, a set of drawings is attached as an integral part of said description, in which, for illustrative and non-limiting purposes, the following has been represented: 2021307653   16 Sep 2026 - Figure 1 shows the general scheme of all the factors that allows evaluating and analyzing the muscle hemodynamic performance of all muscle tissues as a whole or the analytical performance of each muscle tissue. - Figure 2 graphically represent the cyclical Physical Activity performed by the subject and the values of (1) Heart Rate [bpm], (2) Pedalling Cadence [rpm] and (3) Power [Watts]. - Figure 3 graphically represent the relationship between the values of SmO2% (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 4 graphically represent the relationship between the values of SmO2% (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 5 graphically represent the relationship between the values of SmO2% (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 6 graphically represent the relationship between the values of SmO2% (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 7 graphically represent the relationship between the values of SmO2% (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 8 graphically represent the relationship between the values of SmO2% (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 9 graphically represent the relationship between the values of SmO2% (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 10 graphically represent the relationship between the values of ThB (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 11 graphically represent the relationship between the values of ThB (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 12 graphically represent the relationship between the values of ThB (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). 2021307653   16 Sep 2026 - Figure 13 graphically represent the relationship between the values of ThB (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 14 graphically represent the relationship between the values of ThB (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 15 graphically represent the relationship between the values of ThB (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 16 graphically represent the relationship between the values of ThB (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 17 graphically represent the relationship between the values of 0ThB (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 18 graphically represent the relationship between the values of 0ThB (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 19 graphically represent the relationship between the values of 0ThB (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 20 graphically represent the relationship between the values of 0ThB (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 21 graphically represent the relationship between the values of 0ThB (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 22 graphically represent the relationship between the values of 0ThB (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 23 graphically represent the relationship between the values of 0ThB (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 24 graphically represent the relationship between the values of O2HHb (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). 2021307653   16 Sep 2026 - Figure 25 graphically represent the relationship between the values of O2HHb (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 26 graphically represent the relationship between the values of O2HHb (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 27 graphically represent the relationship between the values of O2HHb (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 28 graphically represent the relationship between the values of O2HHb (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 29 graphically represent the relationship between the values of O2HHb (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 30 graphically represent the relationship between the values of O2HHb (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 31 graphically represent the relationship between the values of HHb (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 32 graphically represent the relationship between the values of HHb (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 33 graphically represent the relationship between the values of HHb (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 34 graphically represent the relationship between the values of HHb (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 35 graphically represent the relationship between the values of HHb (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 36 graphically represent the relationship between the values of HHb (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). 2021307653   16 Sep 2026 - Figure 37 graphically represent the relationship between the values of HHb (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 38 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 39 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 40 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 41 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). - Figure 42 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 43 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 44 graphically represent the relationship between the values of 0O2HHb (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 45 graphically represent the relationship between the values of 0HHb (Axis Y) of the RF L (1) and RF R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of RF L (3) and RF R (4). - Figure 46 graphically represent the relationship between the values of 0HHb (Axis Y) of the VL L (1) and VL R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VL L (3) and VL R (4). - Figure 47 graphically represent the relationship between the values of 0HHb (Axis Y) of the ST L (1) and ST R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of ST L (3) and ST R (4). - Figure 48 graphically represent the relationship between the values of 0HHb (Axis Y) of the GM L (1) and GM R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GM L (3) and GM R (4). 2021307653   16 Sep 2026 - Figure 49 graphically represent the relationship between the values of 0HHb (Axis Y) of the VI L (1) and VI R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of VI L (3) and VI R (4). - Figure 50 graphically represent the relationship between the values of 0HHb (Axis Y) of the GA L (1) and GA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of GA L (3) and GA R (4). - Figure 51 graphically represent the relationship between the values of 0HHb (Axis Y) of the TA L (1) and TA R (2) and the values of power (Axis X - Watts), in addition to the representation of the Line of Trend of TA L (3) and TA R (4). - Figure 52 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X -Watts). - Figure 53 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X -Watts). - Figure 54 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X -Watts). - Figure 55 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X -Watts). -  Figure 56 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X- Watts). -  Figure 57 graphically represent the relationship between the values of the slope (P)|y|SmO2% (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X -Watts). - Figure 58 graphically represent the relationship between the values of the slope (p)|y|SmO2% (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X -Watts). - Figure 59 graphically represent the relationship between the values of the slope (p)|F| ThB (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X - Watts). - Figure 60 graphically represent the relationship between the values of the slope (p) |K| ThB (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X - Watts). - Figure 61 graphically represent the relationship between the values of the slope (p)|F| ThB (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X - Watts). 2021307653   16 Sep 2026 - Figure 62 graphically represent the relationship between the values of the slope (p) |K| ThB (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X - Watts). - Figure 63 graphically represent the relationship between the values of the slope (p) |K| ThB (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X - Watts). - Figure 64 graphically represent the relationship between the values of the slope (p) |K| ThB (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X - Watts). - Figure 65 graphically represent the relationship between the values of the slope (p) |K| ThB (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X - Watts). -  Figure 66 graphically represent the relationship between the values of the slope (p)|y|0ThB (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X- Watts). -  Figure 67 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X- Watts). -  Figure 68 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X- Watts). -  Figure 69 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X -Watts). -  Figure 70 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X - Watts). -  Figure 71 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X- Watts). -  Figure 72 graphically represent the relationship between the values of the slope (p)|F|0ThB (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X- Watts). -  Figure 73 graphically represent the relationship between the values of the slope (p)|y|O2HHb (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X -Watts). -  Figure 74 graphically represent the relationship between the values of the slope (p)|F|O2HHb (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X- Watts). -  Figure 75 graphically represent the relationship between the values of the slope (p)|F|O2HHb (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X -Watts). - Figure 76 graphically represent the relationship between the values of the slope (p)|y|O2HHb (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X -Watts). 2021307653   16 Sep 2026 -  Figure 77 graphically represent the relationship between the values of the slope (p)|F|O2HHb (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X- Watts). -  Figure 78 graphically represent the relationship between the values of the slope (p)|F|O2HHb (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X -Watts). - Figure 79 graphically represent the relationship between the values of the slope (p)|F|O2HHb (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X -Watts). - Figure 80 graphically represent the relationship between the values of the slope (p)|y|HHb (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X - Watts). - Figure 81 graphically represent the relationship between the values of the slope (p) |F| HHb (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X - Watts). - Figure 82 graphically represent the relationship between the values of the slope (p) |F| HHb (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X - Watts). - Figure 83 graphically represent the relationship between the values of the slope (p)|y| HHb (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X - Watts). - Figure 84 graphically represent the relationship between the values of the slope (p) |K| HHb (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X - Watts). - Figure 85 graphically represent the relationship between the values of the slope (p) |K| HHb (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X - Watts). - Figure 86 graphically represent the relationship between the values of the slope (p)|y| HHb (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X - Watts). - Figure 87 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X -Watts). - Figure 88 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X -Watts). - Figure 89 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X -Watts). - Figure 90 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X -Watts). 2021307653   16 Sep 2026 - Figure 91 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X -Watts). - Figure 92 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X -Watts). - Figure 93 graphically represent the relationship between the values of the slope (p)|F|0O2HHb (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X -Watts). -  Figure 94 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the RF L (1) and RF R (2), and the values of power (Axis X- Watts). -  Figure 95 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the VL L (1) and VL R (2), and the values of power (Axis X- Watts). -  Figure 96 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the ST L (1) and ST R (2), and the values of power (Axis X- Watts). -  Figure 97 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the GM L (1) and GM R (2), and the values of power (Axis X -Watts). -  Figure 98 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the VI L (1) and VI R (2), and the values of power (Axis X- Watts). -  Figure 99 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the GA L (1) and GA R (2), and the values of power (Axis X -Watts). - Figure 100 graphically represent the relationship between the values of the slope (p)|F|0HHb (Axis Y) of the TA L (1) and TA R (2), and the values of power (Axis X- Watts). PREFERENTIAL REALIZATION OF THE INVENTION - Subject Evaluated o  Age: 25 years o  Height: 178 cm o  Gender: Male o  Weight: 68 Kg o  Sport: Cycling 2021307653   16 Sep 2026 - Material Used for the Activity or Monitored Locomotor Exercise o  14 NIRS devices o  1 Power Sensor o 1 Direct drive roller o  1 Cadence Sensor o  1 Heart Rate Band o  1 Activity Monitor o  1 Road Bike of the subject's own - Data Recording Procedures for the Evaluation and Monitoring Method 1. Place and adhere 12 near-infrared spectroscopy (NIRS) devices on each monitored muscle tissue that involved in locomotor activity during cycling (TMM): a. Right Vastus Lateral (VL R) and Left Vastus Lateral (VL L) b. Right Rectus Femoris (RF R) and Left Rectus Femoris (RF L) c. Right Vast Internal (VI R) and Left Vast Internal (VI L) d. Right Semitendinosus (ST R) and Left Semitendinosus (ST L) e. Right Gluteus Maximus (GM R) and Left Gluteus Maximus (GM L) f.  Right Gastrocnemius (GA R) and Left Gastrocnemius (GA L) g.  Right Tibialis Anterior (AT R) and Left Tibialis Anterior (TA L) 2.  Place the heart rate band superficially under the user's chest. 3.  Start the data logging of all devices and activity monitors when the activity starts, recording of (hour: minute: second) exact of the start of the locomotive activity. 4. Locomotive Activity Monitored and Recorded (AFCM): a. In the Table 1 shows the characteristics of the locomotor work session carried out and the data related to external locomotor performance parameters. In Figure 2, can see the graphic representation of the external locomotor performance values developed by the subject during the session. Table 1. The data of the session carried out Work Interval Duration (hh:mm:ss) Start Time (hh:mm:ss) Power (Watts) Cadence (rpm) HR (ppm) Average Median Desv Est Max Average Median Desv Est Max Average Median Desv Est Max IT 01 0:10:00 0:00:00 88 84 20 221 77 79 12 87 109 109 5,7 119 ID 01 0:03:00 0:10:00 98 93 11 IT 02 0:04:00 0:13:00 148 150 15 175 34 0 45 95 127 131 12 137 ID 02 0:01:00 0:17:00 116 123 15 IT 03 0:04:00 0:18:00 150 150 20 315 66 69 15 73 122 126 11 131 ID 03 0:01:00 0:22:00 116 123 12 IT 04 0:04:00 0:23:00 148 150 14 163 84 90 22 95 126 130 11 137 2021307653   16 Sep 2026 ID 04   0:01:00   0:27:00 120  120  7,6 IT 05   0:04:00  0:28:00   148   150   16   160    73  76   15   79    124  127  8,2  132 ID 05 0:01:00 0:32:00 108 102 12 IT 06 0:04:00 0:33:00 149 150 12 163 82 85 15 90 127 130 9,5 134 ID 06 0:01:00 0:37:00 114 110 9,9 IT 07 0:04:00 0:38:00 149 150 11 159 78 81 15 85 126 130 8,3 133 ID 07 0:06:00 0:42:00 103 102 11 IT 08 0:04:00 0:48:00 99 101 10 113 77 81 16 87 114 116 9,7 123 ID 08 0:01:00 0:52:00 106 104 5,7 IT 09 0:04:00 0:53:00 124 125 13 165 77 80 15 85 122 125 7,9 129 ID 09 0:01:00 0:57:00 110 106 9,2 IT 10 0:04:00 0:58:00 148 150 14 172 78 81 15 83 131 134 8,8 139 ID 10 0:01:00 1:02:00 122 125 9,2 IT 11 0:04:00 1:03:00 173 175 16 192 77 80 18 85 137 141 11 148 ID 11 0:01:00 1:07:00 131 130 8,8 IT 12 0:04:00 1:08:00 195 200 25 212 77 80 15 84 148 153 13 160 ID 12 0:01:00 1:12:00 135 130 14 IT 13 0:04:00 1:13:00 212 222 30 232 78 81 16 85 159 164 15 172 ID 13 0:01:00 1:17:00 146 143 17 IT 14 0:04:00 1:18:00 245 249 23 261 79 83 16 87 169 176 17 182 ID 14 0:01:00 1:22:00 157 160 16 IT 15 0:04:00 1:23:00 268 274 40 288 79 83 16 87 179 186 17 192 ID 15 0:01:00 1:27:00 167 166 17 IT 16 0:01:37 1:28:00 277 297 66 315 52 72 33 78 175 181 14 190 5. Ending of locomotor activity and ending of data recording 6. Download, synchronization and union of all the data obtained by each device, through the individual registration timescale of each device used during the session. 7. The values are calculated for each TMM of Oxygen-Charged Capillary Hemoglobin (O2HHb), Oxygen-Discharged Capillary Hemoglobin (HHb), Muscle Hemoglobin Blood Flow (0ThB), Muscular Blood Flow of Oxygen-Charged Capillary Hemoglobin (O2HHb) and Muscular Blood Flow of Oxygen-Discharged Hemoglobin (0HHb), from the recorded data of Muscle Oxygen Saturation (SmO2%) and Capillary Hemoglobin (ThB). 8. Data obtained erroneously and / or by device registration error during activity are filtered and excluded. Data that are not within the following parameters and all data obtained from the calculation of any of them are excluded: a. SMO2% [Between 1% SmO2 and 99% SmO2] b. ThB [Between 9.5 g / dL and 14,9 g / dL] c. HR [Between 40bpm and 230bpm] 9. The data that present a greater difference than that established in the following parameters between the determined value and the contiguous values in the temporary register are filtered and excluded, and all the data obtained from the calculation of any of the they: a. b. c. Difference of SMO2% [> ±10% SmO2%] Difference of ThB [> ±0.3 g / dL] Difference of HR [> ±7ppm] 2021307653   16 Sep 2026 10. In Figure 3-9, the data obtained during the activity in dispersion data where the SmO2% values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 11. In Figure 10-16, the data obtained during the activity in dispersion data where the ThB values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 12. In Figure 17-23, the data obtained during the activity in dispersion data where the 0ThB values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 13. In Figure 24-30, the data obtained during the activity in dispersion data where the O2HHb values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 14. In Figure 31-37, the data obtained during the activity in dispersion data where the HHb values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 15. In Figure 38-44, the data obtained during the activity in dispersion data where the 0O2HHb values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. 16. In Figure 38-44, the data obtained during the activity in dispersion data where the 0HHb values obtained and / or calculated are established on the axis (y) and the locomotor performance data values on the axis (x) external power developed during locomotive activity can be observed. - Analysis and Evaluation of the recorded data of the Locomotor Performance 1. Calculation of the Minimum Activation Threshold (UAmin), Aerobic Threshold (UAe) and Anaerobic Threshold (UANA). 1.1. The values obtained of Power or Cadence of Pedalling equivalent to “0” are filtered and excluded. 1.2. From the values represented in Figures 3-58, the General Trend Line of the Values is obtained for each graph. 2021307653   16 Sep 2026 1.3. In Table 2, the Equation of the Trend Line |y|SmO2% calculated from the values of SmO2% of each TMM can be observed. Table 2. Equation of the Trend Line of |y|SmO2% of each TMM TM Equation of the Trend Line |y|SmO2 RF L y| =                   -2E-11X6 + 3E-08x5 - 1E-05x4 + 0,0031x3 - 0,4032x2 + 27,173x - 657,15 RF R y| =                     -9E-12x6 + 1E-08x5 - 6E-06x4 + 0,0014x3 - 0,202x2 + 14,059x - 315,89 Represented in Figure 3 VL L VL R y| =                   -1E-11x6 + 2E-08x5 - 7E-06x4 + 0,0018x3 - 0,2428x2 + 16,733x - 385,62 y| =                   -1E-11x6 + 1E-08x5 - 7E-06x4 + 0,0018x3 - 0,2431x2 + 16,924x - 392,28 Represented in Figure 4 ST L y| =                     -1E-11x6 + 1E-08x5 - 6E-06x4 + 0,0014x3 - 0,191x2 + 13,395x - 306,51 ST R y| =                   -1E-11x6 + 1 E-08x5 - 7E-06x4 + 0,0017x3 - 0,2249x2 + 15,067x - 319,87 Represented in Figure 5 GM L GM R y| =                   -5E-12x6 + 6E-09x5 - 3E-06x4 + 0,0009x3 - 0,1306x2 + 9,7767x - 203,18 y| =                   -5E-12x6 + 7E-09x5 - 4E-06x4 + 0,0009x3 - 0,1303x2 + 9,1126x - 157,57 Represented in Figure 6 VI L y| =                     -1E-11x6 + 2E-08x5 - 8E-06x4 + 0,002x3 - 0,2713x2 + 19,337x - 493,21 VI R y| =                   -2E-11x6 + 2E-08x5 - 1E-05x4 + 0,0024x3 - 0,2972x2 + 18,768x - 407,38 Represented in Figure 7 GA L GA R y| =                   2E-11x6 - 2E-08x5 + 1E-05x4 - 0,0027x3 + 0,3333x2 - 20,338x + 545,65 y| =                    2E-11x6 - 3E-08x5 + 1E-05x4 - 0,0027x3 + 0,3227x2 - 19,531x + 537,28 Represented in Figure 8 TA L TA R y| =                   -3E-11x6 + 3E-08x5 - 1E-05x4 + 0,0033x3 - 0,4137x2 + 26,652x - 628,77 y| =                      -1E-11x6 + 2E-08x5 - 8E-06x4 + 0,002x3 - 0,281x2 + 19,933x - 502,86 Represented in Figure 9 [(x) represents the analyzed power value; (|y|) represents the value of SmO2%] 1.4. In Table 3, the Equation of the Trend Line |K|ThB calculated from the values of ThB of each TMM can be observed. Table 3. Equation of the Trend Line of |y|ThB of each TMM TM Equation of the Trend Line |y|ThB RF L |y| =                      -5E-14x6 + 7E-11x5 - 4E-08x4 + 1E-05x3 - 0,0016x2 + 0,1291x + 8,6505 RF R |y| =                      -1E-13x6 + 2E-10x5 - 9E-08x4 + 2E-05x3 - 0,0029x2 + 0,1952x + 7,2974 Represented in Figure 10 VL L |y| =                       4E-13x6 - 5E-10x5 + 2E-07x4 - 5E-05x3 + 0,0063x2 - 0,4036x + 22,558 VL R |y| =                       -3E-13x6 + 3E-10x5 - 2E-07x4 + 4E-05x3 - 0,005x2 + 0,3382x + 3,0815 Represented in Figure 11 ST L |y|=                       -2E-13x6 + 3E-10x5 - 1E-07x4 + 4E-05x3 - 0,0051x2 + 0,3543x + 2,395 ST R |y|=                         4E-13x6 - 5E-10x5 + 3E-07x4 - 6E-05x3 + 0,0083x2 - 0,5663x + 27,62 Represented in Figure 12 GM L |y| =                      -6E-13x6 + 7E-10x5 - 3E-07x4 + 8E-05x3 - 0,0108x2 + 0,7317x - 7,9018 GM R |y| =                      -6E-13x6 + 7E-10x5 - 3E-07x4 + 8E-05x3 - 0,0103x2 + 0,6872x - 6,6108 Represented in Figure 13 VI L |y| =                       1E-13x6 - 1E-10x5 + 7E-08x4 - 2E-05x3 + 0,0021x2 - 0,1426x + 16,574 2021307653   16 Sep 2026 VI R |y| =                        2E-13x6 - 2E-10x5 + 9E-08x4 - 2E-05x3 + 0,003x2 - 0,2031x + 18,268 Represented in Figure 14 GA L |y| =                      -6E-13x6 + 7E-10x5 - 3E-07x4 + 8E-05x3 - 0,0104x2 + 0,6759x - 5,4769 GA R |y| =                      -5E-13x6 + 6E-10x5 - 3E-07x4 + 6E-05x3 - 0,0085x2 + 0,5747x - 3,3749 Represented in Figure 15 TA L TA R |y| =                          2E-13x6 - 3E-10x5 + 1E-07x4 - 3E-05x3 + 0,004x2 - 0,2698x + 20,29 |y| =                       4E-13x6 - 4E-10x5 + 2E-07x4 - 5E-05x3 + 0,0059x2 - 0,3943x + 23,108 Represented in Figure 16 [(x) represents the analyzed power value; (|y|) represents the value of ThB] 1.5. In Table 4, the Equation of the Trend Line |y|0ThB calculated from the values of 0ThB of each TMM can be observed. Table 4. Equation of the Trend Line of |y|0ThB of each TMM TM Ecuacion de la L^nea de Tendencia de |y|$ThB RF L RF R |y| = |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0731x2 + 4,8586x - 105,1 -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0757x2 + 4,9991x - 108,03 Represented in Figure 17 VL L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0755x2 + 5,006x - 109,18 VL R |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0744x2 + 4,9425x - 108,01 Represented in Figure 18 ST L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0738x2 + 4,9112x - 107,45 ST R |y| = -5E-12x6 + 5E-09x5 - 3E-06x4 + 0,0006x3 - 0,0787x2 + 5,1666x - 111,89 Represented in Figure 19 GM L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0005x3 - 0,0699x2 + 4,6867x - 103,1 GM R |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0005x3 - 0,0682x2 + 4,5589x - 99,743 Represented in Figure 20 VI L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0779x2 + 5,1214x - 110,35 VI R |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0784x2 + 5,1666x - 111,66 Represented in Figure 21 GA L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0758x2 + 5,0374x - 110,73 GA R |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0005x3 - 0,0717x2 + 4,8132x - 105,99 Represented in Figure 22 TA L |y| = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0776x2 + 5,1066x - 109,44 TA R |y| = -5E-12x6 + 5E-09x5 - 3E-06x4 + 0,0006x3 - 0,0782x2 + 5,1403x - 110,85 Represented in Figure 23 [(x) represents the analyzed power value; (|y|) represents the value of &ThB] 1.6. In Table 5, the Equation of the Trend Line |y|O2HHb calculated from the values of O2HHb of each TMM can be observed. 2021307653   16 Sep 2026 Table 5. Equation of the Trend Line of |Y|O2HHb of each TMM TM__________________________Ecuacion de la L^nea de Tendencia de |Y|O2HHb RF L RF R Y Y = = -3E-12x6 + 3E-09x5 - 2E-06x4 + 0,0004x3 - 0,0531x2 + 3,614x - 88,785 -3E-12x6 + 4E-09x5 - 2E-06x4 + 0,0005x3 - 0,0609x2 + 4,0896x - 99,856 Represented in Figure 24 VL L Y = -3E-12x6 + 4E-09x5 - 2E-06x4 + 0,0004x3 - 0,0581x2 + 3,8815x - 94,091 VL R Y = -4E-12x6 + 4E-09x5 - 2E-06x4 + 0,0005x3 - 0,0643x2 + 4,3291x - 106,51 Represented in Figure 25 ST L Y = -3E-12x6 + 4E-09x5 - 2E-06x4 + 0,0004x3 - 0,057x2 + 3,9203x - 98,558 ST R Y = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0006x3 - 0,0727x2 + 4,7863x - 114,86 Represented in Figure 26 GM L Y = -2E-12x6 + 3E-09x5 - 1E-06x4 + 0,0003x3 - 0,0403x2 + 2,7221x - 63,193 GM R Y = -2E-12x6 + 2E-09x5 - 8E-07x4 + 0,0002x3 - 0,0248x2 + 1,6246x - 31,521 Represented in Figure 27 VI L Y = -3E-12x6 + 3E-09x5 - 2E-06x4 + 0,0004x3 - 0,0532x2 + 3,6317x - 91,927 VI R Y = -6E-12x6 + 7E-09x5 - 3E-06x4 + 0,0007x3 - 0,0882x2 + 5,4779x - 126,9 Represented in Figure 28 GA L Y = -5E-12x6 + 6E-09x5 - 3E-06x4 + 0,0007x3 - 0,0971x2 + 6,5766x - 169,02 GA R Y = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0005x3 - 0,0722x2 + 4,8761x - 121,62 Represented in Figure 29 TA L Y = -4E-12x6 + 5E-09x5 - 2E-06x4 + 0,0005x3 - 0,0671x2 + 4,3533x - 105,03 TA R Y = -4E-12x6 + 4E-09x5 - 2E-06x4 + 0,0005x3 - 0,0597x2 + 3,9817x - 98,479 Represented in Figure 30 [(x) represents the analyzed power value; (|Y|) represents the value of O2HHb] 1.7. In Table 6, the Equation of the Trend Line |Y|HHb calculated from the values of HHb of each TMM can be observed. Table 6. Equation of the Trend Line of |Y|HHb of each TMM TM__________________________Ecuacion de la L^nea de Tendencia de |Y| HHb RF L Y| = 3E-12x6 - 3E-09x5 + 1E-06x4 - 0,0004x3 + 0,047x2 - 3,1681x + 88,604 RF R Y| = 4E-12x6 - 4E-09x5 + 2E-06x4 - 0,0005x3 + 0,0606x2 - 3,9358x + 105,27 Represented in Figure 31 VL L Y| = 3E-12x6 - 4E-09x5 + 2E-06x4 - 0,0004x3 + 0,0531x2 - 3,4848x + 94,389 VL R Y| = 4E-12x6 - 4E-09x5 + 2E-06x4 - 0,0005x3 + 0,0598x2 - 3,9644x + 107,4 Represented in Figure 32 ST L Y| = 3E-12x6 - 4E-09x5 + 2E-06x4 - 0,0004x3 + 0,0554x2 - 3,6991x + 102,2 ST R Y| = 5E-12x6 - 5E-09x5 + 2E-06x4 - 0,0006x3 + 0,071x2 - 4,5624x + 118,74 Represented in Figure 33 GM L Y| = 2E-12x6 - 3E-09x5 + 1E-06x4 - 0,0003x3 + 0,036x2 - 2,3767x + 64,476 GM R Y| = 2E-12x6 - 2E-09x5 + 1E-06x4 - 0,0002x3 + 0,0262x2 - 1,5959x + 39,38 Represented in Figure 34 VI L Y| = 3E-12x6 - 3E-09x5 + 1E-06x4 - 0,0003x3 + 0,0444x2 - 3,0416x + 88,905 VI R Y| = 3E-12x6 - 3E-09x5 + 1E-06x4 - 0,0003x3 + 0,0409x2 - 2,562x + 68,472 Represented in Figure 35 2021307653   16 Sep 2026 GA L      |Y| = 4E-12x6 - 5E-09x5 + 2E-06x4 - 0,0006x3 + 0,0829x2 - 5,7024x + 159,68 GA R      |Y| =                 4E-12x6 - 5E-09x5 + 2E-06x4 - 0,0005x3 + 0,067x2 - 4,4753x + 121,62 Represented in Figure 36 TA L TA R |Y| =                 4E-12x6 - 5E-09x5 + 2E-06x4 - 0,0005x3 + 0,0606x2 - 3,8733x + 104,39 |Y| =                 5E-12x6 - 6E-09x5 + 3E-06x4 - 0,0007x3 + 0,0885x2 - 5,8788x + 160,53 Represented in Figure 37 [(x) represents the analyzed power value; (|Y|) represents the value of HHb] 1.8. In Table 7, the Equation of the Trend Line |Y|0O2HHb calculated from the values of 0O2HHb of each TMM can be observed. Table 7. Equation of the Trend Line of |Y|0O2HHb of each TMM TM________________________Ecuacion de la L^nea de Tendencia de |Y|¢O2HHb RF L RF R Y Y = = -7E-12x6 + 8E-09x5 - 4E-06x4 + 0,0009x3 - 0,1144x2 + 7,5826x - 184,2 -7E-12x6 + 8E-09x5 - 4E-06x4 + 0,0009x3 - 0,1242x2 + 8,2442x - 201,37 Represented in Figure 38 VL L Y = -6E-12x6 + 7E-09x5 - 3E-06x4 + 0,0008x3 - 0,1051x2 + 7,1225x - 175,33 VL R Y = -5E-12x6 + 7E-09x5 - 3E-06x4 + 0,0008x3 - 0,1047x2 + 7,14x - 176,47 Represented in Figure 39 ST L Y = -6E-12x6 + 7E-09x5 - 3E-06x4 + 0,0008x3 - 0,1026x2 + 6,98x - 173,68 ST R Y = -6E-12x6 + 7E-09x5 - 3E-06x4 + 0,0008x3 - 0,1069x2 + 6,972x - 162,39 Represented in Figure 40 GM L Y = -6E-12x6 + 7E-09x5 - 3E-06x4 + 0,0008x3 - 0,1023x2 + 6,8896x - 166,47 GM R Y = -9E-12x6 + 1 E-08x5 - 5E-06x4 + 0,0011x3 - 0,1328x2 + 8,5201x - 197,46 Represented in Figure 41 VI L Y = -8E-12x6 + 9E-09x5 - 4E-06x4 + 0,0011x3 - 0,1435x2 + 9,7141x - 249,13 VI R Y = -1E-11x6 + 1 E-08x5 - 5E-06x4 + 0,0012x3 - 0,1488x2 + 9,5092x - 226,58 Represented in Figure 42 GA L Y = -7E-12x6 + 8E-09x5 - 4E-06x4 + 0,0011x3 - 0,1459x2 + 10,178x - 266,64 GA R Y = -6E-12x6 + 8E-09x5 - 4E-06x4 + 0,0009x3 - 0,1248x2 + 8,551x - 215,44 Represented in Figure 43 TA L Y = -9E-12x6 + 1 E-08x5 - 5E-06x4 + 0,0011x3 - 0,1373x2 + 8,8469x - 213,73 TA R Y = -8E-12x6 + 9E-09x5 - 4E-06x4 + 0,001x3 - 0,1229x2 + 8,1145x - 200,43 Represented in Figure 44 [(x) represents the analyzed power value; (|Y|) represents the value of QO2HHb] 1.9. In Table 8, the Equation of the Trend Line |Y|0HHb calculated from the values of 0HHb of each TMM can be observed. Table 8. Equation of the Trend Line of |Y|0HHb of each TMM TM Ecuacion de la L^nea de Tendencia de |Y|$HHb RF L |Y| =                   5E-12x6 - 6E-09x5 + 3E-06x4 - 0,0008x3 + 0,1026x2 - 6,9946x + 195,71 RF R |Y| =                   1E-11x6 - 1E-08x5 + 5E-06x4 - 0,0013x3 + 0,1693x2 - 11,132x + 297,01 Represented in Figure 45 VL L |Y| =                   1E-11x6 - 1E-08x5 + 6E-06x4 - 0,0015x3 + 0,1952x2 - 12,865x + 342,15 2021307653   16 Sep 2026 VL R |y| = 1E-11x6 - 1E-08x5 + 7E-06x4 - 0,0016x3 + 0,201x2 - 13,201x + 349,47 Represented in Figure 46 ST L |y| = 1E-11x6 - 1E-08x5 + 6E-06x4 - 0,0015x3 + 0,1898x2 - 12,574x + 337,53 ST R |y| = 1E-11x6 - 1E-08x5 + 7E-06x4 - 0,0016x3 + 0,2103x2 - 13,737x + 359,59 Represented in Figure 47 GM L |y| = 9E-12x6 - 1E-08x5 + 5E-06x4 - 0,0011x3 + 0,1484x2 - 9,8392x + 262,16 GM R |y| = 1E-11x6 - 1E-08x5 + 5E-06x4 - 0,0013x3 + 0,1661x2 - 10,856x + 282,1 Represented in Figure 48 VI L |y| = 1E-11x6 - 1E-08x5 + 6E-06x4 - 0,0014x3 + 0,1864x2 - 12,48x + 342,46 VI R |y| = 2E-11x6 - 2E-08x5 + 8E-06x4 - 0,0019x3 + 0,2317x2 - 14,531x + 369,98 Represented in Figure 49 GA L |y| = 9E-12x6 - 1E-08x5 + 5E-06x4 - 0,0012x3 + 0,1601x2 - 10,892x + 301,26 GA R |y| = 9E-12x6 - 1E-08x5 + 5E-06x4 - 0,0012x3 + 0,1601x2 - 10,892x + 301,26 Represented in Figure 50 TA L |y| = 1E-11x6 - 2E-08x5 + 8E-06x4 - 0,0018x3 + 0,2256x2 - 14,502x + 380,63 TA R |y| = 1E-11x6 - 1E-08x5 + 7E-06x4 - 0,0016x3 + 0,2007x2 - 13,228x + 355,97 Represented in Figure 51 [(x) represents the analyzed power value; (|y|) represents the value of QHHb] 1.10. In Table 9, Table 10 and Table 11, the calculated values of |y|SmO2% of each TMM, at each intensity can be observed. Table 9. Trend Line Values |y|SmO2% between UAmnand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |ZonaOp| Lim Inf |ZonaOp| 136 72 53 76 72 76 77 90 91 53 45 88 89 46 55 82 66 138 71 52 76 72 76 77 90 91 53 44 88 89 46 55 82 65 140 71 52 76 72 76 77 90 91 53 44 88 89 46 55 82 65 142 71 51 76 71 76 77 90 91 52 44 88 89 46 55 82 65 144 71 51 75 71 75 76 90 91 52 43 88 89 46 55 82 65 146 71 51 75 71 75 76 90 91 52 43 88 89 46 54 82 64 148 71 50 75 71 75 76 90 91 51 43 88 89 46 54 82 64 150 71 50 75 70 75 76 90 91 51 42 88 89 46 54 82 64 152 71 50 75 70 75 76 90 91 51 42 88 89 46 54 82 64 154 71 50 75 70 75 76 91 91 50 42 88 89 46 54 82 64 156 71 49 75 70 75 76 91 91 50 41 88 89 46 54 82 64 158 71 49 75 70 74 76 91 91 50 41 88 88 46 54 81 64 160 71 49 74 69 74 76 91 91 49 41 88 88 46 53 81 63 162 71 49 74 69 74 75 91 91 49 40 88 88 46 53 81 63 164 71 48 74 69 74 75 91 91 49 40 88 88 46 53 81 63 166 71 48 74 69 74 75 91 91 48 40 87 88 46 53 81 63 168 71 48 74 69 73 75 91 92 48 39 87 88 46 53 81 63 170 71 48 74 68 73 75 91 92 48 39 87 88 46 53 81 63 172 70 48 74 68 73 75 91 92 48 39 87 88 46 53 81 62 174 70 48 73 68 72 75 91 92 47 38 87 87 46 53 81 62 176 70 47 73 68 72 74 91 92 47 38 87 87 46 53 80 62 178 70 47 73 68 72 74 91 92 47 37 86 87 46 53 80 62 180 70 47 73 67 72 74 91 92 46 37 86 87 46 53 80 62 182 70 47 73 67 71 74 91 92 46 36 86 87 46 53 80 61 184 70 47 72 67 71 73 91 92 46 36 86 87 46 53 80 61 186 70 47 72 67 71 73 91 92 45 36 86 87 45 53 80 61 188 69 47 72 66 70 73 92 92 45 35 86 87 45 52 79 60 190 69 46 71 66 70 72 92 92 45 35 86 87 45 52 79 60 192 69 46 71 66 69 72 92 92 44 34 86 87 45 52 79 60 2021307653   16 Sep 2026 194 69 46 71 65 69 72 92 92 44 34 85 87 45 52 78 59 196 69 46 70 65 68 71 92 93 43 33 85 87 44 52 78 59 198 68 46 70 65 68 71 92 93 43 32 85 87 44 52 78 58 200 68 46 70 64 67 70 92 93 43 32 85 87 44 52 78 58 Min 68 46 70 64 67 70 90 91 43 32 85 87 44 52 78 58 Max 72 53 76 72 76 77 92 93 53 45 88 89 46 55 82 66 CT 0,9 2,0 1,8 2,2 2,5 1,9 0,5 0,6 3,1 3,8 1,1 0,8 0,5 0,9 1,4 2,1 _ Y 70 48 73 68 73 75 91 92 48 39 87 88 45 53 81 62 Y 71 48 74 69 73 75 91 92 48 39 87 88 46 53 81 63 a' i I      '                 t         / a a     t ■ «     *                t        tat      i      a a     • a •           f           ra                         f                       a •           a     * [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 10. Trend Line Values |Y|SmO2% between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |ZonaOp| Lim Inf |ZonaOp| 202 68 45 69 64 67 70 92 93 42 31 85 87 44 52 77 57 204 67 45 69 64 66 69 92 93 42 31 85 88 43 51 77 57 206 67 45 68 63 66 69 92 93 41 30 85 88 43 51 76 56 208 66 45 68 63 65 68 92 93 41 29 85 88 43 51 76 56 210 66 45 67 62 65 68 92 93 40 29 85 88 42 51 76 55 212 65 44 67 62 64 67 92 93 40 28 85 88 42 51 75 55 214 65 44 66 61 64 67 91 92 40 28 85 88 42 50 75 54 216 65 44 66 61 63 66 91 92 39 27 85 88 41 50 74 53 218 64 43 65 60 62 65 91 92 39 26 85 89 41 50 74 53 220 64 43 65 60 62 65 91 92 38 26 85 89 40 50 73 52 222 63 43 64 59 61 64 91 92 38 25 85 89 40 49 73 51 224 62 42 64 59 61 63 91 92 37 25 85 89 39 49 72 51 226 62 42 63 58 60 63 91 92 37 24 85 89 39 49 72 50 228 61 42 62 58 59 62 91 92 36 24 85 89 39 48 71 49 230 61 41 62 57 59 61 90 92 36 23 85 89 38 48 71 49 232 60 41 61 57 58 60 90 92 35 22 85 89 38 48 70 48 234 60 41 61 56 57 60 90 91 35 22 85 89 37 47 70 47 236 59 40 60 55 56 59 90 91 34 21 85 89 37 47 69 46 238 59 40 59 55 56 58 90 91 34 21 84 89 37 47 68 46 240 58 39 59 54 55 57 89 91 33 20 84 89 36 46 68 45 242 57 39 58 54 54 56 89 91 33 20 84 89 36 46 67 44 244 57 38 58 53 54 56 89 90 33 20 84 89 35 46 66 43 246 56 38 57 53 53 55 89 90 32 19 83 89 35 45 65 42 248 56 37 56 52 52 54 88 90 32 19 83 89 35 45 65 42 250 55 37 56 51 52 53 88 90 31 19 82 89 35 45 64 41 Min 55 37 56 51 52 53 88 90 31 19 82 87 35 45 64 41 Max 68 45 69 64 67 70 92 93 42 31 85 89 44 52 77 57 CT 3,9 2,6 4,2 3,9 4,8 5,2 1,1 0,9 3,4 4,0 0,8 0,6 2,9 2,2 4,0 5,1 _ Y 62 42 63 58 60 62 90 92 37 24 85 89 39 49 71 50 Y [(Min) Minim 62 um va 42 lue; ( 63 Max) 58 Maxir 60 um v 63 alue; 91 (u) st 92 andar 37 d dev 24 iation 85 value 89 ; (Y) 39 vera 49 je val 72 ue; (Y) m 50 edian value] Table 11. Trend Line Values |Y|SmO2% >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 55 36 55 51 51 53 88 90 31 18 82 88 34 44 63 40 254 54 36 55 50 50 52 88 89 31 18 81 88 34 44 63 39 256 54 35 54 50 50 51 87 89 30 18 81 88 34 44 62 39 258 53 35 54 49 49 50 87 89 30 18 80 88 34 43 61 38 260 53 34 53 48 48 50 87 89 30 18 80 87 33 43 61 37 262 52 33 53 48 48 49 86 88 29 17 79 87 33 43 60 37 264 52 33 52 47 47 48 86 88 29 17 78 86 33 42 59 36 266 51 32 52 47 46 47 86 88 29 17 77 86 33 42 59 36 268 51 32 51 46 46 47 85 88 29 17 76 85 33 42 58 35 270 50 31 51 46 45 46 85 87 29 17 75 85 33 42 57 35 2021307653   16 Sep 2026 272 50 30 50 45 44 45 85 87 28 17 74 84 33 41 57 34 274 49 30 50 45 44 45 84 87 28 17 73 84 33 41 56 34 276 49 29 50 44 43 44 84 87 28 17 72 83 32 41 56 33 278 48 28 49 44 42 44 83 87 28 17 71 83 32 40 55 33 280 48 28 49 43 41 43 83 86 28 17 69 82 32 40 54 32 282 47 27 49 43 41 43 83 86 28 17 68 82 32 40 54 32 284 47 26 48 42 40 42 82 86 28 17 67 81 32 40 53 31 286 46 25 48 42 39 42 82 86 28 17 65 81 31 40 53 31 288 45 25 48 42 38 41 82 86 28 17 64 80 31 39 52 30 290 45 24 47 41 38 41 81 85 28 17 62 80 30 39 52 30 292 44 23 47 41 37 40 81 85 28 17 61 80 30 39 51 29 294 43 22 47 40 36 40 80 85 28 17 60 79 29 39 51 29 296 42 21 46 40 35 39 80 85 28 17 58 79 28 38 50 28 298 41 21 46 39 34 39 80 85 28 16 57 79 27 38 50 28 300 40 20 46 38 33 38 79 84 28 16 55 79 26 38 49 27 Min 40 20 46 38 33 38 79 84 28 16 55 79 26 38 49 27 Max 55 36 55 51 51 53 88 90 31 18 82 88 34 44 63 40 CT 4,3 5,1 2,8 3,7 5,3 4,4 2,7 1,6 1,0 0,5 8,5 3,3 2,1 2,0 4,3 3,8 _ Y 48 29 50 44 43 45 84 87 29 17 71 83 32 41 56 33 Y 49 29 50 44 43 44 84 87 28 17 72 83 32 41 56 33 a' i I      '                 t         / a a     t ■ «     *                t        tat      i      a a     • a •           f           ra                         f                       a •           a     * [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.11. In Table 12, Table 13 and Table 14, the calculated values of |K|ThB of each TMM, at each intensity can be observed. Table 12. Trend Line Values |K|ThB between UAmnand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM Rer VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 136 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,1 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 138 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 140 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 142 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 144 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 146 12,8 12,6 12,1 12,1 12,2 12,1 12,1 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 148 12,8 12,6 12,1 12,1 12,2 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 150 12,8 12,6 12,1 12,1 12,2 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,5 12,3 12,0 152 12,8 12,6 12,1 12,1 12,1 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,0 154 12,8 12,6 12,1 12,1 12,1 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,0 156 12,8 12,7 12,1 12,1 12,1 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,0 158 12,8 12,7 12,1 12,1 12,1 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,0 160 12,8 12,7 12,1 12,1 12,1 12,1 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 162 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 164 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 166 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 168 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 170 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,2 12,9 12,4 12,4 12,1 172 12,8 12,7 12,1 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 174 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 176 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 178 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 180 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 182 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 184 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 186 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 188 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 190 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,6 12,6 11,9 12,3 12,9 12,4 12,4 12,1 192 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,1 194 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,1 196 12,8 12,7 12,0 12,1 12,1 12,0 12,2 12,2 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 198 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 200 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 2021307653   16 Sep 2026 Min Max a _ Y Y 12,8 12,8 0,0 12,8 12,8 12,6 12,7 0,0 12,7 12,7 12,0 12,1 0,0 12,1 12,1 12,1 12,1 0,0 12,1 12,1 12,1 12,2 0,0 12,1 12,1 12,0 12,1 0,1 12,0 12,0 12,1 12,2 0,0 12,2 12,2 12,1 12,2 0,0 12,2 12,2 12,6 12,7 0,0 12,6 12,6 12,6 12,6 0,0 12,6 12,6 11,9 11,9 0,0 11,9 11,9 12,2 12,3 0,0 12,2 12,2 12,9 12,9 0,0 12,9 12,9 12,4 12,5 0,0 12,4 12,4 12,3 12,4 0,0 12,4 12,4 12,0 12,1 0,0 12,0 12,1 a        / a a a a a •               a       tat      i     a a • t •          a       a^ ra                      a                    at          a a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 13. Trend Line Values |Y|ThB between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 204 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 206 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 208 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 210 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,4 12,0 212 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,3 12,9 12,4 12,3 12,0 214 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,1 12,7 12,6 11,9 12,2 12,9 12,4 12,3 12,0 216 12,8 12,7 12,0 12,1 12,1 12,0 12,1 12,0 12,7 12,6 11,9 12,2 12,9 12,4 12,3 12,0 218 12,8 12,7 12,0 12,1 12,1 12,0 12,0 12,0 12,7 12,6 11,9 12,2 12,9 12,4 12,3 12,0 220 12,8 12,7 12,0 12,1 12,1 12,0 12,0 12,0 12,7 12,6 11,9 12,2 12,9 12,4 12,3 12,0 222 12,8 12,7 12,0 12,1 12,1 12,0 12,0 12,0 12,7 12,6 11,8 12,2 12,9 12,4 12,3 12,0 224 12,8 12,7 12,0 12,1 12,1 12,0 12,0 12,0 12,7 12,6 11,8 12,2 12,9 12,5 12,3 11,9 226 12,8 12,7 12,0 12,0 12,1 12,0 12,0 12,0 12,7 12,6 11,8 12,2 12,9 12,5 12,3 11,9 228 12,8 12,7 12,0 12,0 12,1 12,0 12,0 12,0 12,7 12,6 11,8 12,2 12,9 12,5 12,3 11,9 230 12,8 12,7 12,0 12,0 12,1 12,0 12,0 11,9 12,7 12,7 11,8 12,2 12,9 12,5 12,3 11,9 232 12,8 12,7 12,0 12,0 12,1 12,0 12,0 11,9 12,7 12,7 11,8 12,2 12,9 12,5 12,3 11,9 234 12,8 12,7 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,8 12,2 12,9 12,5 12,3 11,9 236 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,8 12,2 12,9 12,5 12,3 11,9 238 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,8 12,1 12,9 12,5 12,3 11,9 240 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,8 12,1 13,0 12,5 12,3 11,9 242 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 244 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 246 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 248 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,9 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 250 12,8 12,8 12,0 12,0 12,1 12,0 11,9 11,8 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 Min 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 Max 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 a 0,0 0,0 0,0 0,0 0,0 0,0 0,1 0,1 0,0 0,0 0,1 0,1 0,0 0,0 0,0 0,1 _ Y 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 Y 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 atm^a a aat t               a       taa     a a a    •               a       tat      a     a a    • t •          a         ra                      a       a^ia         at          >    a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 14. Trend Line Values |Y|ThB >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 12,8 12,8 12,0 12,0 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,9 254 12,8 12,8 12,0 12,0 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,1 13,0 12,5 12,3 11,8 256 12,8 12,8 12,0 12,0 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,0 13,0 12,5 12,3 11,8 258 12,8 12,8 12,0 12,0 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,0 13,0 12,5 12,3 11,8 260 12,8 12,8 12,0 12,0 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,8 262 12,8 12,8 12,0 12,1 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,8 264 12,7 12,8 12,0 12,1 12,1 12,0 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,8 266 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,9 268 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,9 270 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,7 12,0 12,9 12,5 12,3 11,9 272 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,7 11,9 12,9 12,5 12,3 11,9 274 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,3 11,9 276 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,3 11,9 278 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,3 11,9 280 12,7 12,8 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,3 11,9 2021307653   16 Sep 2026 282 12,8 12,9 12,0 12,1 12,1 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,3 11,9 284 12,8 12,9 12,0 12,1 12,2 12,1 11,8 11,8 12,7 12,7 11,6 11,9 12,9 12,5 12,4 11,9 286 12,8 12,9 12,0 12,1 12,2 12,1 11,8 11,8 12,7 12,7 11,6 11,8 12,9 12,5 12,4 11,9 288 12,8 12,9 12,0 12,1 12,2 12,1 11,8 11,8 12,7 12,7 11,6 11,8 12,9 12,5 12,4 11,9 290 12,8 12,9 12,0 12,1 12,2 12,1 11,7 11,8 12,7 12,7 11,6 11,8 12,9 12,5 12,4 11,9 292 12,8 12,9 12,0 12,1 12,2 12,1 11,7 11,8 12,7 12,7 11,6 11,8 13,0 12,5 12,4 11,9 294 12,8 12,9 12,0 12,1 12,2 12,1 11,7 11,8 12,7 12,7 11,6 11,8 13,0 12,5 12,4 11,9 296 12,8 12,9 12,0 12,1 12,2 12,1 11,7 11,8 12,7 12,7 11,6 11,7 13,0 12,5 12,4 11,9 298 12,8 12,9 12,0 12,1 12,2 12,1 11,7 11,8 12,7 12,7 11,6 11,7 13,0 12,5 12,4 11,9 300 12,8 12,9 12,0 12,2 12,2 12,1 11,7 11,7 12,8 12,7 11,5 11,7 13,0 12,5 12,4 11,9 Min 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 Max 13 13 12 12 12 12 12 12 13 13 12 12 13 13 12 12 CT 0,0 0,1 0,0 0,0 0,1 0,0 0,0 0,0 0,0 0,0 0,0 0,1 0,0 0,0 0,1 0,0 _ Y 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 Y 13 13 12 12 12 12 12 12 13 13 12 12 13 12 12 12 na a' i I I' '               t       ja a    K » a    '               t       tat      i     a a    • a •          t         ri                      t       / Cti         a •          i    a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.12. In Table 15, Table 16 and Table 17, the calculated values of |Y|0ThB of each TMM, at each intensity can be observed. Table 15. Trend Line Values |Y|0ThB between UAmnand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM Rer VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 136 26,6 26,2 25,2 25,1 25,3 25,1 25,1 25,3 26,0 26,0 24,7 25,3 26,8 25,8 25,6 25,0 138 26,8 26,4 25,3 25,3 25,4 25,2 25,2 25,4 26,2 26,2 24,8 25,5 26,9 25,9 25,8 25,1 140 26,9 26,5 25,4 25,4 25,6 25,3 25,3 25,6 26,4 26,3 24,9 25,6 27,1 26,1 25,9 25,3 142 27,1 26,7 25,6 25,6 25,7 25,5 25,5 25,7 26,5 26,5 25,1 25,8 27,3 26,2 26,1 25,4 144 27,3 26,9 25,7 25,7 25,9 25,6 25,6 25,9 26,7 26,6 25,3 25,9 27,4 26,4 26,3 25,6 146 27,4 27,0 25,9 25,9 26,0 25,8 25,8 26,1 26,9 26,8 25,4 26,1 27,6 26,6 26,4 25,8 148 27,6 27,2 26,0 26,0 26,2 26,0 26,0 26,3 27,1 27,0 25,6 26,3 27,8 26,8 26,6 25,9 150 27,8 27,4 26,2 26,2 26,4 26,1 26,1 26,4 27,3 27,2 25,8 26,5 28,0 26,9 26,8 26,1 152 28,0 27,6 26,4 26,4 26,5 26,3 26,3 26,6 27,5 27,4 26,0 26,7 28,2 27,1 27,0 26,3 154 28,2 27,8 26,6 26,6 26,7 26,5 26,5 26,8 27,7 27,6 26,1 26,9 28,4 27,3 27,2 26,5 156 28,4 28,0 26,8 26,8 26,9 26,7 26,7 27,0 27,9 27,8 26,3 27,1 28,6 27,5 27,4 26,7 158 28,6 28,2 26,9 26,9 27,1 26,9 26,9 27,2 28,1 28,0 26,5 27,3 28,8 27,7 27,6 26,9 160 28,8 28,5 27,1 27,1 27,3 27,1 27,1 27,4 28,3 28,2 26,7 27,5 29,0 28,0 27,8 27,1 162 29,0 28,7 27,3 27,3 27,5 27,3 27,3 27,6 28,5 28,4 26,9 27,7 29,3 28,2 28,0 27,3 164 29,3 28,9 27,5 27,5 27,7 27,5 27,5 27,8 28,8 28,7 27,2 27,9 29,5 28,4 28,2 27,5 166 29,5 29,1 27,7 27,7 27,9 27,7 27,7 28,0 29,0 28,9 27,4 28,1 29,7 28,6 28,4 27,7 168 29,7 29,4 28,0 28,0 28,1 27,9 27,9 28,2 29,2 29,1 27,6 28,3 29,9 28,8 28,6 27,9 170 29,9 29,6 28,2 28,2 28,3 28,1 28,1 28,4 29,5 29,3 27,8 28,6 30,2 29,1 28,9 28,1 172 30,1 29,8 28,4 28,4 28,5 28,3 28,3 28,6 29,7 29,6 28,0 28,8 30,4 29,3 29,1 28,3 174 30,4 30,0 28,6 28,6 28,7 28,5 28,5 28,8 29,9 29,8 28,2 29,0 30,6 29,5 29,3 28,5 176 30,6 30,3 28,8 28,8 28,9 28,7 28,7 29,0 30,2 30,0 28,4 29,2 30,9 29,7 29,5 28,7 178 30,8 30,5 29,0 29,0 29,1 28,9 28,9 29,2 30,4 30,3 28,7 29,4 31,1 30,0 29,7 28,9 180 31,0 30,7 29,2 29,2 29,3 29,2 29,2 29,4 30,6 30,5 28,9 29,7 31,3 30,2 30,0 29,1 182 31,3 31,0 29,4 29,4 29,5 29,4 29,4 29,6 30,9 30,7 29,1 29,9 31,6 30,4 30,2 29,3 184 31,5 31,2 29,6 29,6 29,7 29,6 29,6 29,8 31,1 31,0 29,3 30,1 31,8 30,6 30,4 29,6 186 31,7 31,4 29,8 29,9 29,9 29,8 29,8 30,0 31,3 31,2 29,5 30,3 32,0 30,8 30,6 29,8 188 31,9 31,6 30,0 30,1 30,1 30,0 30,0 30,2 31,6 31,4 29,7 30,5 32,2 31,1 30,8 30,0 190 32,1 31,9 30,2 30,3 30,3 30,2 30,2 30,4 31,8 31,6 29,9 30,8 32,5 31,3 31,0 30,2 192 32,3 32,1 30,4 30,5 30,5 30,4 30,4 30,6 32,0 31,9 30,1 31,0 32,7 31,5 31,2 30,4 194 32,6 32,3 30,6 30,7 30,7 30,6 30,6 30,8 32,2 32,1 30,3 31,2 32,9 31,7 31,4 30,5 196 32,8 32,5 30,8 30,9 30,9 30,8 30,8 31,0 32,5 32,3 30,5 31,4 33,1 31,9 31,6 30,7 198 33,0 32,7 31,0 31,1 31,1 31,0 31,0 31,2 32,7 32,5 30,7 31,6 33,3 32,1 31,8 30,9 200 33,2 33,0 31,2 31,3 31,3 31,2 31,2 31,3 32,9 32,7 30,9 31,8 33,5 32,3 32,0 31,1 Min 26,6 26,2 25,2 25,1 25,3 25,1 25,1 25,3 26,0 26,0 24,7 25,3 26,8 25,8 25,6 25,0 Max 33,2 33,0 31,2 31,3 31,3 31,2 31,2 31,3 32,9 32,7 30,9 31,8 33,5 32,3 32,0 31,1 CT 2,0 2,1 1,9 1,9 1,9 1,9 1,9 1,9 2,1 2,1 1,9 2,0 2,1 2,0 2,0 1,9 _ Y 29,8 29,4 28,0 28,0 28,2 28,0 28,0 28,2 29,3 29,2 27,6 28,4 30,0 28,9 28,7 27,9 Y 29,7 29,4 28,0 28,0 28,1 27,9 27,9 28,2 29,2 29,1 27,6 28,3 29,9 28,8 28,6 27,9 2021307653   16 Sep 2026 a' i I       '                   t          / a a t ■ «      *                   t         t a a       i       a a • a •             f            ra                             f         r^Za           a •             a * [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 16. Trend Line Values |Y|0ThB between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 33,4 33,2 31,4 31,5 31,5 31,3 31,3 31,5 33,1 32,9 31,1 32,0 33,7 32,5 32,2 31,3 204 33,6 33,4 31,6 31,6 31,7 31,5 31,5 31,7 33,3 33,1 31,2 32,2 33,9 32,7 32,4 31,5 206 33,8 33,6 31,7 31,8 31,9 31,7 31,7 31,9 33,5 33,3 31,4 32,4 34,1 32,9 32,6 31,6 208 34,0 33,8 31,9 32,0 32,0 31,9 31,9 32,0 33,7 33,5 31,6 32,5 34,3 33,1 32,8 31,8 210 34,1 34,0 32,1 32,2 32,2 32,0 32,0 32,2 33,9 33,7 31,8 32,7 34,5 33,3 33,0 32,0 212 34,3 34,2 32,3 32,4 32,4 32,2 32,2 32,3 34,1 33,9 31,9 32,9 34,7 33,4 33,1 32,2 214 34,5 34,4 32,4 32,5 32,6 32,4 32,4 32,5 34,3 34,1 32,1 33,1 34,9 33,6 33,3 32,3 216 34,7 34,5 32,6 32,7 32,7 32,5 32,5 32,7 34,5 34,3 32,2 33,2 35,1 33,8 33,5 32,5 218 34,9 34,7 32,8 32,9 32,9 32,7 32,7 32,8 34,6 34,5 32,4 33,4 35,3 34,0 33,7 32,6 220 35,0 34,9 32,9 33,1 33,1 32,9 32,9 32,9 34,8 34,7 32,5 33,5 35,5 34,1 33,8 32,8 222 35,2 35,1 33,1 33,2 33,2 33,0 33,0 33,1 35,0 34,8 32,7 33,7 35,6 34,3 34,0 33,0 224 35,4 35,3 33,2 33,4 33,4 33,2 33,2 33,2 35,2 35,0 32,8 33,8 35,8 34,5 34,1 33,1 226 35,6 35,5 33,4 33,5 33,6 33,3 33,3 33,4 35,3 35,2 33,0 34,0 36,0 34,6 34,3 33,3 228 35,7 35,6 33,5 33,7 33,7 33,5 33,5 33,5 35,5 35,4 33,1 34,1 36,2 34,8 34,5 33,4 230 35,9 35,8 33,7 33,9 33,9 33,6 33,6 33,6 35,7 35,5 33,2 34,3 36,3 35,0 34,6 33,5 232 36,1 36,0 33,9 34,0 34,0 33,8 33,8 33,8 35,8 35,7 33,4 34,4 36,5 35,1 34,8 33,7 234 36,2 36,2 34,0 34,2 34,2 33,9 33,9 33,9 36,0 35,9 33,5 34,5 36,7 35,3 34,9 33,8 236 36,4 36,3 34,2 34,3 34,4 34,1 34,1 34,0 36,2 36,0 33,6 34,7 36,8 35,4 35,1 34,0 238 36,5 36,5 34,3 34,5 34,5 34,3 34,3 34,2 36,3 36,2 33,7 34,8 37,0 35,6 35,2 34,1 240 36,7 36,7 34,5 34,6 34,7 34,4 34,4 34,3 36,5 36,4 33,9 34,9 37,2 35,8 35,4 34,2 242 36,9 36,8 34,6 34,8 34,8 34,6 34,6 34,4 36,7 36,5 34,0 35,0 37,3 35,9 35,5 34,4 244 37,0 37,0 34,8 34,9 35,0 34,7 34,7 34,5 36,8 36,7 34,1 35,2 37,5 36,1 35,7 34,5 246 37,2 37,2 34,9 35,1 35,1 34,9 34,9 34,7 37,0 36,8 34,2 35,3 37,7 36,2 35,8 34,6 248 37,3 37,4 35,1 35,3 35,3 35,0 35,0 34,8 37,2 37,0 34,3 35,4 37,8 36,4 35,9 34,8 250 37,5 37,5 35,2 35,4 35,5 35,2 35,2 34,9 37,3 37,2 34,5 35,5 38,0 36,5 36,1 34,9 Min 33 33 31 31 32 31 31 32 33 33 31 32 34 33 32 31 Max 38 38 35 35 35 35 35 35 37 37 34 36 38 37 36 35 CT 1,3 1,3 1,2 1,2 1,2 1,2 1,2 1,0 1,3 1,3 1,0 1,1 1,3 1,2 1,2 1,1 _ Y 36 35 33 33 34 33 33 33 35 35 33 34 36 35 34 33 Y 36 35 33 34 34 33 33 33 35 35 33 34 36 35 34 33 r a m a a a a a • •                      r           « a a       t ■ «       a                      f           t a a         a        a a       • a •               f                                                   f          r^Za             a •               a       a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 17. Trend Line Values |Y|0ThB >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 33,4 33,2 31,4 31,5 31,5 31,3 31,3 31,5 33,1 32,9 31,1 32,0 33,7 32,5 32,2 31,3 204 33,6 33,4 31,6 31,6 31,7 31,5 31,5 31,7 33,3 33,1 31,2 32,2 33,9 32,7 32,4 31,5 206 33,8 33,6 31,7 31,8 31,9 31,7 31,7 31,9 33,5 33,3 31,4 32,4 34,1 32,9 32,6 31,6 208 34,0 33,8 31,9 32,0 32,0 31,9 31,9 32,0 33,7 33,5 31,6 32,5 34,3 33,1 32,8 31,8 210 34,1 34,0 32,1 32,2 32,2 32,0 32,0 32,2 33,9 33,7 31,8 32,7 34,5 33,3 33,0 32,0 212 34,3 34,2 32,3 32,4 32,4 32,2 32,2 32,3 34,1 33,9 31,9 32,9 34,7 33,4 33,1 32,2 214 34,5 34,4 32,4 32,5 32,6 32,4 32,4 32,5 34,3 34,1 32,1 33,1 34,9 33,6 33,3 32,3 216 34,7 34,5 32,6 32,7 32,7 32,5 32,5 32,7 34,5 34,3 32,2 33,2 35,1 33,8 33,5 32,5 218 34,9 34,7 32,8 32,9 32,9 32,7 32,7 32,8 34,6 34,5 32,4 33,4 35,3 34,0 33,7 32,6 220 35,0 34,9 32,9 33,1 33,1 32,9 32,9 32,9 34,8 34,7 32,5 33,5 35,5 34,1 33,8 32,8 222 35,2 35,1 33,1 33,2 33,2 33,0 33,0 33,1 35,0 34,8 32,7 33,7 35,6 34,3 34,0 33,0 224 35,4 35,3 33,2 33,4 33,4 33,2 33,2 33,2 35,2 35,0 32,8 33,8 35,8 34,5 34,1 33,1 226 35,6 35,5 33,4 33,5 33,6 33,3 33,3 33,4 35,3 35,2 33,0 34,0 36,0 34,6 34,3 33,3 228 35,7 35,6 33,5 33,7 33,7 33,5 33,5 33,5 35,5 35,4 33,1 34,1 36,2 34,8 34,5 33,4 230 35,9 35,8 33,7 33,9 33,9 33,6 33,6 33,6 35,7 35,5 33,2 34,3 36,3 35,0 34,6 33,5 232 36,1 36,0 33,9 34,0 34,0 33,8 33,8 33,8 35,8 35,7 33,4 34,4 36,5 35,1 34,8 33,7 234 36,2 36,2 34,0 34,2 34,2 33,9 33,9 33,9 36,0 35,9 33,5 34,5 36,7 35,3 34,9 33,8 236 36,4 36,3 34,2 34,3 34,4 34,1 34,1 34,0 36,2 36,0 33,6 34,7 36,8 35,4 35,1 34,0 238 36,5 36,5 34,3 34,5 34,5 34,3 34,3 34,2 36,3 36,2 33,7 34,8 37,0 35,6 35,2 34,1 240 36,7 36,7 34,5 34,6 34,7 34,4 34,4 34,3 36,5 36,4 33,9 34,9 37,2 35,8 35,4 34,2 2021307653   16 Sep 2026 242 36,9 36,8 34,6 34,8 34,8 34,6 34,6 34,4 36,7 36,5 34,0 35,0 37,3 35,9 35,5 34,4 244 37,0 37,0 34,8 34,9 35,0 34,7 34,7 34,5 36,8 36,7 34,1 35,2 37,5 36,1 35,7 34,5 246 37,2 37,2 34,9 35,1 35,1 34,9 34,9 34,7 37,0 36,8 34,2 35,3 37,7 36,2 35,8 34,6 248 37,3 37,4 35,1 35,3 35,3 35,0 35,0 34,8 37,2 37,0 34,3 35,4 37,8 36,4 35,9 34,8 250 37,5 37,5 35,2 35,4 35,5 35,2 35,2 34,9 37,3 37,2 34,5 35,5 38,0 36,5 36,1 34,9 Min 33 33 31 31 32 31 31 32 33 33 31 32 34 33 32 31 Max 38 38 35 35 35 35 35 35 37 37 34 36 38 37 36 35 CT 1,3 1,3 1,2 1,2 1,2 1,2 1,2 1,0 1,3 1,3 1,0 1,1 1,3 1,2 1,2 1,1 _ Y 36 35 33 33 34 33 33 33 35 35 33 34 36 35 34 33 Y 36 35 33 34 34 33 33 33 35 35 33 34 36 35 34 33 na a' i I I' '                   t         ja a      K » a     '                   t         a a a       i       a a      a a a             t            ri                             t         / Cti            a a             i      a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.13. In Table 18, Table 19 and Table 20, the calculated values of |Y|O2HHb of each TMM, at each intensity can be observed. Table 18. Trend Line Values |Y|O2HHb between UAmnand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 136 9,2 6,5 9,1 8,6 9,1 9,1 10,9 11,1 6,6 5,4 10,0 10,5 5,9 6,8 10,1 8,2 138 9,2 6,5 9,1 8,6 9,1 9,1 10,9 11,1 6,6 5,4 10,0 10,5 5,9 6,8 10,1 8,1 140 9,1 6,4 9,1 8,5 9,1 9,1 10,9 11,1 6,5 5,4 10,0 10,5 5,8 6,8 10,1 8,1 142 9,1 6,4 9,1 8,5 9,1 9,1 10,9 11,1 6,5 5,4 10,0 10,5 5,8 6,7 10,0 8,1 144 9,1 6,3 9,1 8,5 9,1 9,1 11,0 11,1 6,5 5,3 10,1 10,5 5,8 6,7 10,0 8,1 146 9,1 6,3 9,0 8,5 9,1 9,1 11,0 11,1 6,4 5,3 10,1 10,6 5,8 6,7 10,0 8,1 148 9,1 6,3 9,0 8,5 9,0 9,1 11,0 11,1 6,4 5,3 10,1 10,6 5,8 6,7 10,0 8,0 150 9,1 6,3 9,0 8,4 9,0 9,1 11,0 11,1 6,4 5,3 10,2 10,6 5,8 6,7 10,0 8,0 152 9,1 6,2 9,0 8,4 9,0 9,1 11,0 11,1 6,3 5,3 10,2 10,7 5,9 6,7 10,0 8,0 154 9,1 6,2 9,0 8,4 9,0 9,1 11,0 11,1 6,3 5,2 10,3 10,7 5,9 6,7 10,0 8,0 156 9,1 6,2 9,0 8,4 9,0 9,1 11,0 11,1 6,3 5,2 10,3 10,7 5,9 6,7 10,0 8,0 158 9,1 6,2 9,0 8,4 9,0 9,1 11,1 11,2 6,2 5,2 10,4 10,8 5,9 6,7 10,0 8,0 160 9,1 6,2 9,0 8,4 9,0 9,1 11,1 11,2 6,2 5,2 10,4 10,8 5,9 6,7 10,0 8,0 162 9,1 6,2 9,0 8,4 9,0 9,1 11,1 11,2 6,2 5,2 10,5 10,8 5,9 6,7 10,0 7,9 164 9,1 6,2 9,0 8,4 8,9 9,1 11,1 11,2 6,2 5,1 10,5 10,9 5,9 6,7 10,0 7,9 166 9,0 6,2 9,0 8,4 8,9 9,1 11,1 11,2 6,1 5,1 10,6 10,9 5,9 6,7 10,0 7,9 168 9,0 6,1 9,0 8,3 8,9 9,1 11,1 11,2 6,1 5,1 10,6 10,9 5,9 6,7 10,0 7,9 170 9,0 6,1 9,0 8,3 8,9 9,1 11,1 11,2 6,1 5,1 10,6 11,0 6,0 6,7 10,0 7,9 172 9,0 6,1 9,0 8,3 8,9 9,1 11,1 11,2 6,1 5,0 10,7 11,0 6,0 6,7 10,0 7,8 174 9,0 6,1 8,9 8,3 8,9 9,1 11,2 11,2 6,0 5,0 10,7 11,0 6,0 6,7 10,0 7,8 176 9,0 6,1 8,9 8,3 8,8 9,1 11,2 11,2 6,0 5,0 10,8 11,1 6,0 6,7 10,0 7,8 178 9,0 6,1 8,9 8,3 8,8 9,1 11,2 11,2 6,0 4,9 10,8 11,1 6,0 6,7 10,0 7,8 180 9,0 6,1 8,9 8,3 8,8 9,1 11,2 11,2 5,9 4,9 10,8 11,1 6,0 6,7 9,9 7,7 182 9,0 6,1 8,9 8,2 8,8 9,1 11,2 11,2 5,9 4,8 10,8 11,1 6,0 6,7 9,9 7,7 184 9,0 6,1 8,8 8,2 8,7 9,0 11,2 11,2 5,8 4,7 10,9 11,2 6,0 6,7 9,9 7,7 186 8,9 6,1 8,8 8,2 8,7 9,0 11,2 11,2 5,8 4,7 10,9 11,2 5,9 6,6 9,9 7,6 188 8,9 6,1 8,8 8,2 8,7 9,0 11,2 11,2 5,8 4,6 10,9 11,2 5,9 6,6 9,8 7,6 190 8,9 6,1 8,7 8,1 8,6 8,9 11,2 11,2 5,7 4,5 10,9 11,2 5,9 6,6 9,8 7,5 192 8,9 6,1 8,7 8,1 8,6 8,9 11,2 11,2 5,7 4,5 10,9 11,2 5,9 6,6 9,8 7,5 194 8,8 6,0 8,6 8,1 8,5 8,8 11,2 11,2 5,6 4,4 10,9 11,2 5,9 6,6 9,7 7,4 196 8,8 6,0 8,6 8,0 8,5 8,8 11,2 11,2 5,6 4,3 10,9 11,2 5,8 6,5 9,7 7,4 198 8,7 6,0 8,5 8,0 8,4 8,7 11,2 11,2 5,5 4,2 10,8 11,2 5,8 6,5 9,6 7,3 200 8,7 6,0 8,5 7,9 8,3 8,7 11,1 11,2 5,5 4,1 10,8 11,2 5,8 6,5 9,6 7,2 Min 8,7 6,0 8,5 7,9 8,3 8,7 10,9 11,1 5,5 4,1 10,0 10,5 5,8 6,5 9,6 7,2 Max 9,2 6,5 9,1 8,6 9,1 9,1 11,2 11,2 6,6 5,4 10,9 11,2 6,0 6,8 10,1 8,2 CT 0,1 0,1 0,2 0,2 0,2 0,1 0,1 0,1 0,3 0,4 0,3 0,3 0,1 0,1 0,1 0,3 Y 9,0 6,2 8,9 8,3 8,9 9,0 11,1 11,2 6,1 5,0 10,5 10,9 5,9 6,7 9,9 7,8 Y 9,0 6,1 9,0 8,3 8,9 9,1 11,1 11,2 6,1 5,1 10,6 10,9 5,9 6,7 10,0 7,9 ram^a a aaa a                t         / a a     a a a     •                t        a a a       a      a a     • a •           t        a^                            t                       a •           it [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 2021307653   16 Sep 2026 Table 19. Trend Line Values |Y|O2HHb between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 8,7 5,9 8,4 7,9 8,3 8,6 11,1 11,2 5,4 4,0 10,8 11,2 5,7 6,5 9,5 7,2 204 8,6 5,9 8,4 7,8 8,2 8,5 11,1 11,2 5,3 3,9 10,8 11,2 5,7 6,4 9,5 7,1 206 8,6 5,9 8,3 7,7 8,1 8,5 11,1 11,1 5,3 3,8 10,7 11,1 5,6 6,4 9,4 7,0 208 8,5 5,8 8,2 7,7 8,1 8,4 11,1 11,1 5,2 3,7 10,7 11,1 5,6 6,4 9,4 6,9 210 8,5 5,8 8,2 7,6 8,0 8,3 11,0 11,1 5,2 3,6 10,6 11,1 5,5 6,3 9,3 6,9 212 8,4 5,7 8,1 7,5 7,9 8,2 11,0 11,1 5,1 3,5 10,6 11,1 5,5 6,3 9,2 6,8 214 8,3 5,7 8,0 7,5 7,8 8,1 11,0 11,1 5,0 3,4 10,5 11,0 5,4 6,2 9,1 6,7 216 8,3 5,6 7,9 7,4 7,7 8,0 11,0 11,1 5,0 3,3 10,4 11,0 5,4 6,2 9,1 6,6 218 8,2 5,6 7,9 7,3 7,6 7,9 10,9 11,0 4,9 3,2 10,4 11,0 5,3 6,1 9,0 6,5 220 8,1 5,5 7,8 7,2 7,6 7,8 10,9 11,0 4,8 3,1 10,3 10,9 5,2 6,1 8,9 6,4 222 8,1 5,5 7,7 7,2 7,5 7,7 10,9 11,0 4,8 3,0 10,2 10,9 5,2 6,1 8,8 6,3 224 8,0 5,4 7,6 7,1 7,4 7,6 10,8 11,0 4,7 3,0 10,1 10,8 5,1 6,0 8,7 6,2 226 7,9 5,4 7,5 7,0 7,3 7,5 10,8 10,9 4,6 2,9 10,1 10,8 5,1 6,0 8,6 6,1 228 7,9 5,3 7,4 6,9 7,2 7,4 10,8 10,9 4,6 2,8 10,0 10,7 5,0 5,9 8,5 6,0 230 7,8 5,2 7,3 6,8 7,1 7,3 10,7 10,9 4,5 2,7 9,9 10,7 4,9 5,9 8,4 5,9 232 7,7 5,2 7,3 6,8 7,0 7,1 10,7 10,9 4,4 2,6 9,8 10,6 4,9 5,8 8,3 5,8 234 7,6 5,1 7,2 6,7 6,9 7,0 10,7 10,9 4,4 2,5 9,7 10,6 4,8 5,8 8,2 5,7 236 7,6 5,0 7,1 6,6 6,8 6,9 10,6 10,8 4,3 2,5 9,6 10,5 4,8 5,7 8,1 5,5 238 7,5 5,0 7,0 6,5 6,7 6,8 10,6 10,8 4,2 2,4 9,6 10,5 4,7 5,7 8,0 5,4 240 7,4 4,9 6,9 6,4 6,6 6,7 10,6 10,8 4,2 2,4 9,5 10,5 4,6 5,7 7,9 5,3 242 7,3 4,8 6,9 6,3 6,5 6,6 10,5 10,8 4,1 2,3 9,4 10,4 4,6 5,6 7,8 5,2 244 7,3 4,8 6,8 6,3 6,4 6,5 10,5 10,7 4,1 2,3 9,3 10,4 4,5 5,6 7,7 5,1 246 7,2 4,7 6,7 6,2 6,3 6,4 10,5 10,7 4,0 2,2 9,2 10,3 4,5 5,5 7,6 5,0 248 7,1 4,6 6,6 6,1 6,2 6,3 10,4 10,7 4,0 2,2 9,2 10,3 4,4 5,5 7,5 4,9 250 7,0 4,5 6,6 6,0 6,1 6,2 10,4 10,7 3,9 2,2 9,1 10,3 4,4 5,5 7,4 4,8 Min 7,0 4,5 6,6 6,0 6,1 6,2 10,4 10,7 3,9 2,2 9,1 10,3 4,4 5,5 7,4 4,8 Max 8,7 5,9 8,4 7,9 8,3 8,6 11,1 11,2 5,4 4,0 10,8 11,2 5,7 6,5 9,5 7,2 CT 0,5 0,4 0,6 0,6 0,7 0,8 0,2 0,2 0,5 0,6 0,6 0,3 0,4 0,3 0,7 0,7 _ Y 7,9 5,3 7,5 7,0 7,2 7,4 10,8 10,9 4,6 3,0 10,0 10,8 5,1 6,0 8,6 6,1 Y 7,9 5,4 7,5 7,0 7,3 7,5 10,8 10,9 4,6 2,9 10,1 10,8 5,1 6,0 8,6 6,1 a        / a a a a a •               a       tat      i     a a • t •          a       a^ ra                      a                    at          i a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 20. Trend Line Values |Y|O2HHb >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 7,0 4,5 6,5 6,0 6,0 6,1 10,4 10,6 3,9 2,2 9,0 10,2 4,4 5,5 7,3 4,7 254 6,9 4,4 6,4 5,9 5,9 6,0 10,4 10,6 3,8 2,2 8,9 10,2 4,3 5,4 7,3 4,6 256 6,8 4,4 6,4 5,8 5,8 5,9 10,3 10,6 3,8 2,2 8,9 10,2 4,3 5,4 7,2 4,6 258 6,8 4,3 6,3 5,8 5,7 5,8 10,3 10,6 3,8 2,2 8,8 10,2 4,3 5,4 7,1 4,5 260 6,7 4,2 6,3 5,7 5,6 5,8 10,3 10,6 3,7 2,2 8,8 10,1 4,3 5,4 7,0 4,4 262 6,6 4,2 6,2 5,7 5,6 5,7 10,2 10,5 3,7 2,2 8,7 10,1 4,2 5,3 7,0 4,4 264 6,6 4,1 6,2 5,6 5,5 5,6 10,2 10,5 3,7 2,3 8,7 10,1 4,2 5,3 6,9 4,3 266 6,5 4,0 6,2 5,6 5,4 5,6 10,2 10,5 3,7 2,3 8,6 10,1 4,2 5,3 6,9 4,3 268 6,4 4,0 6,1 5,5 5,4 5,5 10,1 10,5 3,7 2,3 8,6 10,1 4,2 5,3 6,8 4,2 270 6,4 3,9 6,1 5,5 5,3 5,5 10,1 10,4 3,7 2,4 8,5 10,1 4,2 5,3 6,8 4,2 272 6,3 3,9 6,1 5,5 5,3 5,4 10,1 10,4 3,7 2,4 8,5 10,1 4,2 5,3 6,7 4,2 274 6,3 3,8 6,0 5,4 5,2 5,4 10,0 10,4 3,6 2,4 8,5 10,1 4,2 5,2 6,7 4,1 276 6,2 3,8 6,0 5,4 5,1 5,4 10,0 10,3 3,6 2,5 8,4 10,1 4,2 5,2 6,7 4,1 278 6,1 3,7 6,0 5,4 5,1 5,3 9,9 10,3 3,6 2,5 8,4 10,1 4,2 5,2 6,6 4,1 280 6,1 3,6 6,0 5,3 5,1 5,3 9,9 10,3 3,6 2,5 8,4 10,1 4,2 5,2 6,6 4,1 282 6,0 3,6 6,0 5,3 5,0 5,3 9,8 10,2 3,6 2,5 8,3 10,1 4,2 5,1 6,6 4,0 284 5,9 3,5 5,9 5,3 5,0 5,3 9,8 10,2 3,6 2,5 8,3 10,1 4,1 5,1 6,5 4,0 286 5,9 3,4 5,9 5,2 4,9 5,3 9,7 10,1 3,6 2,4 8,2 10,0 4,1 5,0 6,5 4,0 288 5,8 3,4 5,9 5,2 4,9 5,2 9,6 10,1 3,6 2,4 8,2 10,0 4,1 5,0 6,5 4,0 290 5,7 3,3 5,8 5,2 4,9 5,2 9,5 10,0 3,6 2,3 8,1 10,0 4,0 4,9 6,5 3,9 292 5,6 3,2 5,8 5,1 4,8 5,2 9,4 9,9 3,6 2,2 8,0 10,0 4,0 4,8 6,4 3,9 294 5,5 3,1 5,8 5,1 4,8 5,2 9,3 9,8 3,6 2,0 7,9 9,9 3,9 4,7 6,4 3,9 296 5,4 3,0 5,7 5,0 4,7 5,1 9,2 9,7 3,6 1,8 7,8 9,9 3,8 4,6 6,3 3,8 2021307653   16 Sep 2026 298 5,3 2,9 5,7 4,9 4,7 5,1 9,0 9,6 3,5 1,6 7,7 9,8 3,7 4,5 6,3 3,7 300 5,2 2,8 5,6 4,9 4,6 5,0 8,9 9,5 3,5 1,3 7,6 9,7 3,6 4,3 6,2 3,7 Min 5,2 2,8 5,6 4,9 4,6 5,0 8,9 9,5 3,5 1,3 7,6 9,7 3,6 4,3 6,2 3,7 Max 7,0 4,5 6,5 6,0 6,0 6,1 10,4 10,6 3,9 2,5 9,0 10,2 4,4 5,5 7,3 4,7 CT 0,5 0,5 0,2 0,3 0,4 0,3 0,4 0,3 0,1 0,3 0,4 0,1 0,2 0,3 0,3 0,3 Y 6,2 3,7 6,0 5,4 5,2 5,5 9,9 10,2 3,7 2,2 8,4 10,0 4,1 5,1 6,7 4,1 Y 6,2 3,8 6,0 5,4 5,1 5,4 10,0 10,3 3,6 2,3 8,4 10,1 4,2 5,2 6,7 4,1 na a' i I I' '                   t         ja a      K » a     '                   t         a a a       i       a a      a a a             t            ri                             t         / Cti            a a             i      a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.14. In Table 21, Table 22 and Table 23, the calculated values of |Y|0O2HHb of each TMM, at each intensity can be observed. Table 21. Trend Line Values |Y|0O2HHb between UAmnand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM Rer VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 136 19,2 13,7 19,1 18,2 19,2 19,3 22,8 22,9 13,7 11,5 21,1 22,0 12,3 14,2 21,2 17,2 138 19,3 13,7 19,2 18,2 19,3 19,4 23,0 23,1 13,7 11,5 21,2 22,2 12,4 14,3 21,3 17,2 140 19,4 13,7 19,3 18,2 19,4 19,5 23,1 23,3 13,7 11,5 21,4 22,3 12,4 14,3 21,4 17,3 142 19,5 13,7 19,4 18,3 19,5 19,6 23,3 23,4 13,7 11,4 21,5 22,5 12,5 14,4 21,5 17,3 144 19,6 13,7 19,4 18,3 19,5 19,7 23,4 23,6 13,7 11,4 21,7 22,7 12,6 14,4 21,6 17,4 146 19,7 13,7 19,5 18,4 19,6 19,8 23,6 23,8 13,8 11,4 21,9 22,9 12,6 14,5 21,7 17,5 148 19,8 13,7 19,6 18,4 19,7 19,9 23,8 24,0 13,8 11,4 22,1 23,0 12,7 14,6 21,8 17,5 150 19,9 13,7 19,7 18,5 19,8 20,0 24,0 24,2 13,8 11,4 22,3 23,2 12,8 14,7 21,9 17,6 152 20,0 13,8 19,8 18,6 19,9 20,1 24,1 24,4 13,8 11,4 22,5 23,4 12,9 14,7 22,1 17,6 154 20,1 13,8 19,9 18,6 20,0 20,2 24,3 24,6 13,9 11,4 22,7 23,6 13,0 14,8 22,2 17,7 156 20,2 13,9 20,0 18,7 20,1 20,3 24,5 24,8 13,9 11,4 22,9 23,9 13,1 14,9 22,3 17,8 158 20,4 13,9 20,1 18,8 20,2 20,5 24,7 25,0 13,9 11,4 23,1 24,1 13,2 15,0 22,5 17,8 160 20,5 14,0 20,2 18,9 20,3 20,6 24,9 25,2 14,0 11,5 23,4 24,3 13,3 15,1 22,6 17,9 162 20,6 14,0 20,3 19,0 20,3 20,7 25,1 25,4 14,0 11,5 23,6 24,5 13,4 15,2 22,7 18,0 164 20,7 14,1 20,4 19,0 20,4 20,8 25,3 25,6 14,1 11,5 23,8 24,7 13,5 15,3 22,8 18,0 166 20,8 14,1 20,6 19,1 20,5 20,9 25,5 25,9 14,1 11,5 24,1 25,0 13,6 15,4 23,0 18,1 168 20,9 14,2 20,7 19,2 20,6 21,0 25,7 26,1 14,1 11,5 24,3 25,2 13,7 15,5 23,1 18,2 170 21,1 14,3 20,8 19,3 20,7 21,1 25,9 26,3 14,2 11,4 24,6 25,4 13,8 15,6 23,2 18,2 172 21,2 14,3 20,9 19,4 20,8 21,2 26,1 26,5 14,2 11,4 24,8 25,7 13,9 15,7 23,3 18,3 174 21,3 14,4 20,9 19,5 20,8 21,3 26,3 26,7 14,2 11,4 25,0 25,9 14,0 15,8 23,5 18,3 176 21,4 14,5 21,0 19,5 20,9 21,4 26,5 26,9 14,3 11,4 25,3 26,1 14,1 15,8 23,6 18,4 178 21,5 14,5 21,1 19,6 20,9 21,5 26,7 27,1 14,3 11,4 25,5 26,4 14,2 15,9 23,7 18,4 180 21,6 14,6 21,2 19,7 21,0 21,5 26,9 27,3 14,3 11,3 25,7 26,6 14,2 16,0 23,8 18,4 182 21,6 14,7 21,3 19,7 21,0 21,6 27,1 27,5 14,3 11,3 25,9 26,8 14,3 16,1 23,9 18,5 184 21,7 14,7 21,3 19,8 21,1 21,7 27,3 27,7 14,3 11,2 26,1 27,0 14,4 16,2 24,0 18,5 186 21,8 14,8 21,4 19,9 21,1 21,7 27,5 27,9 14,3 11,1 26,3 27,2 14,4 16,2 24,0 18,5 188 21,9 14,8 21,5 19,9 21,1 21,7 27,7 28,0 14,3 11,1 26,5 27,4 14,5 16,3 24,1 18,5 190 21,9 14,9 21,5 19,9 21,2 21,8 27,8 28,2 14,3 11,0 26,7 27,6 14,5 16,3 24,2 18,5 192 22,0 14,9 21,5 20,0 21,2 21,8 28,0 28,4 14,3 10,9 26,9 27,8 14,5 16,4 24,2 18,5 194 22,0 14,9 21,6 20,0 21,2 21,8 28,2 28,5 14,2 10,8 27,1 28,0 14,6 16,4 24,3 18,5 196 22,1 15,0 21,6 20,0 21,2 21,8 28,3 28,7 14,2 10,7 27,2 28,2 14,6 16,5 24,3 18,4 198 22,1 15,0 21,6 20,0 21,1 21,8 28,5 28,8 14,1 10,6 27,4 28,4 14,6 16,5 24,4 18,4 200 22,1 15,0 21,6 20,1 21,1 21,8 28,6 28,9 14,1 10,5 27,5 28,6 14,6 16,5 24,4 18,3 Min 19,2 13,7 19,1 18,2 19,2 19,3 22,8 22,9 13,7 10,5 21,1 22,0 12,3 14,2 21,2 17,2 Max 22,1 15,0 21,6 20,1 21,2 21,8 28,6 28,9 14,3 11,5 27,5 28,6 14,6 16,5 24,4 18,5 CT 1,0 0,5 0,8 0,7 0,7 0,9 1,8 1,9 0,2 0,3 2,1 2,1 0,8 0,8 1,1 0,4 _ Y 20,8 14,3 20,6 19,2 20,4 20,8 25,7 26,0 14,0 11,3 24,3 25,2 13,6 15,4 23,0 18,0 Y 20,9 14,2 20,7 19,2 20,6 21,0 25,7 26,1 14,1 11,4 24,3 25,2 13,7 15,5 23,1 18,2 ram^a a aaa a                t         / a a     a a a     •                t        a a a       a      a a     • a •           t        a^                            t                       a •           it [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 2021307653   16 Sep 2026 Table 22. Trend Line Values |Y|0O2HHb between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 22,1 15,0 21,6 20,1 21,1 21,8 28,8 29,1 14,0 10,3 27,6 28,7 14,6 16,6 24,4 18,3 204 22,2 15,0 21,6 20,0 21,0 21,7 28,9 29,2 14,0 10,2 27,7 28,9 14,6 16,6 24,4 18,2 206 22,2 15,0 21,6 20,0 21,0 21,7 29,1 29,3 13,9 10,1 27,8 29,0 14,5 16,6 24,4 18,1 208 22,2 15,0 21,6 20,0 20,9 21,6 29,2 29,4 13,8 9,9 27,9 29,2 14,5 16,6 24,4 18,1 210 22,2 15,0 21,5 20,0 20,9 21,5 29,3 29,5 13,7 9,8 28,0 29,3 14,5 16,6 24,4 18,0 212 22,1 15,0 21,5 19,9 20,8 21,5 29,4 29,6 13,6 9,6 28,1 29,4 14,4 16,6 24,4 17,9 214 22,1 15,0 21,4 19,9 20,7 21,4 29,6 29,7 13,5 9,4 28,1 29,5 14,4 16,6 24,3 17,8 216 22,1 14,9 21,4 19,9 20,6 21,3 29,7 29,8 13,4 9,3 28,2 29,6 14,4 16,6 24,3 17,6 218 22,1 14,9 21,3 19,8 20,5 21,2 29,8 29,9 13,3 9,1 28,2 29,7 14,3 16,6 24,2 17,5 220 22,0 14,9 21,2 19,7 20,4 21,1 29,9 30,0 13,2 8,9 28,2 29,8 14,2 16,6 24,1 17,3 222 22,0 14,8 21,2 19,7 20,3 20,9 30,0 30,1 13,1 8,8 28,2 29,9 14,2 16,6 24,1 17,2 224 21,9 14,8 21,1 19,6 20,2 20,8 30,0 30,2 13,0 8,6 28,2 30,0 14,1 16,6 24,0 17,0 226 21,9 14,7 21,0 19,5 20,1 20,7 30,1 30,3 12,9 8,4 28,2 30,1 14,0 16,6 23,9 16,9 228 21,8 14,7 20,9 19,4 19,9 20,5 30,2 30,4 12,7 8,3 28,2 30,2 14,0 16,5 23,8 16,7 230 21,8 14,6 20,8 19,3 19,8 20,4 30,3 30,4 12,6 8,1 28,1 30,2 13,9 16,5 23,7 16,5 232 21,7 14,5 20,7 19,2 19,6 20,2 30,4 30,5 12,5 7,9 28,1 30,3 13,8 16,5 23,5 16,3 234 21,7 14,5 20,6 19,1 19,5 20,1 30,4 30,6 12,4 7,8 28,0 30,3 13,8 16,5 23,4 16,2 236 21,6 14,4 20,5 19,0 19,3 19,9 30,5 30,7 12,3 7,6 28,0 30,4 13,7 16,5 23,3 16,0 238 21,5 14,3 20,4 18,9 19,2 19,8 30,5 30,8 12,2 7,5 27,9 30,4 13,6 16,5 23,2 15,8 240 21,4 14,2 20,2 18,8 19,0 19,6 30,6 30,9 12,0 7,4 27,8 30,5 13,6 16,4 23,0 15,6 242 21,4 14,1 20,1 18,7 18,9 19,4 30,6 30,9 11,9 7,3 27,7 30,5 13,5 16,4 22,9 15,4 244 21,3 14,1 20,0 18,6 18,7 19,3 30,7 31,0 11,8 7,1 27,6 30,6 13,5 16,4 22,8 15,2 246 21,2 14,0 19,9 18,4 18,6 19,1 30,7 31,1 11,7 7,0 27,5 30,6 13,4 16,4 22,6 15,0 248 21,1 13,9 19,8 18,3 18,4 18,9 30,8 31,2 11,7 6,9 27,4 30,6 13,4 16,4 22,5 14,9 250 21,0 13,8 19,7 18,2 18,2 18,8 30,8 31,3 11,6 6,9 27,3 30,7 13,3 16,4 22,3 14,7 Min 21,0 13,8 19,7 18,2 18,2 18,8 28,8 29,1 11,6 6,9 27,3 28,7 13,3 16,4 22,3 14,7 Max 22,2 15,0 21,6 20,1 21,1 21,8 30,8 31,3 14,0 10,3 28,2 30,7 14,6 16,6 24,4 18,3 CT 0,4 0,4 0,6 0,6 0,9 1,0 0,6 0,7 0,8 1,1 0,3 0,6 0,4 0,1 0,7 1,2 _ Y 21,8 14,6 20,9 19,4 19,9 20,5 30,0 30,2 12,8 8,5 27,9 29,9 14,0 16,5 23,7 16,7 Y 21,9 14,7 21,0 19,5 20,1 20,7 30,1 30,3 12,9 8,4 28,0 30,1 14,0 16,6 23,9 16,9 a        / a a a a a •               a       tat      i     a a • t •          a       a^ ra                      a                    at          i a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 23. Trend Line Values |Y|0O2HHb >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 20,9 13,7 19,5 18,1 18,1 18,6 30,9 31,4 11,5 6,8 27,2 30,7 13,3 16,4 22,2 14,5 254 20,8 13,6 19,4 18,0 17,9 18,4 30,9 31,5 11,4 6,7 27,0 30,7 13,2 16,4 22,1 14,3 256 20,7 13,4 19,3 17,8 17,7 18,3 30,9 31,6 11,4 6,7 26,9 30,7 13,2 16,4 21,9 14,2 258 20,6 13,3 19,2 17,7 17,6 18,1 30,9 31,7 11,3 6,7 26,8 30,8 13,2 16,4 21,8 14,0 260 20,5 13,2 19,1 17,6 17,4 17,9 30,9 31,8 11,3 6,7 26,7 30,8 13,2 16,3 21,7 13,8 262 20,4 13,1 19,0 17,5 17,2 17,8 31,0 31,8 11,2 6,6 26,5 30,8 13,1 16,3 21,5 13,7 264 20,3 12,9 18,9 17,3 17,1 17,6 31,0 31,9 11,2 6,7 26,4 30,8 13,1 16,3 21,4 13,5 266 20,2 12,8 18,8 17,2 16,9 17,4 31,0 32,0 11,2 6,7 26,3 30,9 13,1 16,3 21,3 13,4 268 20,0 12,6 18,7 17,1 16,7 17,3 30,9 32,1 11,2 6,7 26,2 30,9 13,1 16,3 21,2 13,2 270 19,9 12,5 18,7 17,0 16,5 17,1 30,9 32,1 11,2 6,7 26,0 30,9 13,0 16,3 21,0 13,1 272 19,7 12,3 18,6 16,9 16,4 17,0 30,9 32,2 11,2 6,8 25,9 30,9 13,0 16,2 20,9 12,9 274 19,6 12,1 18,5 16,7 16,2 16,8 30,8 32,2 11,2 6,8 25,8 30,9 13,0 16,2 20,8 12,8 276 19,4 11,9 18,4 16,6 16,0 16,7 30,8 32,2 11,2 6,9 25,6 31,0 12,9 16,1 20,6 12,7 278 19,2 11,6 18,4 16,5 15,8 16,5 30,7 32,2 11,2 6,9 25,5 31,0 12,9 16,0 20,5 12,5 280 18,9 11,4 18,3 16,4 15,7 16,3 30,6 32,2 11,3 7,0 25,4 31,0 12,8 15,9 20,3 12,4 282 18,7 11,1 18,3 16,2 15,5 16,2 30,5 32,1 11,3 7,0 25,3 31,0 12,7 15,8 20,2 12,2 284 18,4 10,8 18,2 16,1 15,3 16,0 30,4 32,0 11,3 7,0 25,1 31,0 12,7 15,7 20,0 12,1 286 18,1 10,4 18,1 16,0 15,1 15,8 30,2 31,8 11,3 7,1 25,0 30,9 12,5 15,5 19,9 11,9 288 17,7 10,1 18,1 15,8 14,8 15,6 30,0 31,7 11,3 7,1 24,9 30,9 12,4 15,3 19,7 11,7 290 17,3 9,6 18,0 15,7 14,6 15,4 29,8 31,4 11,4 7,1 24,7 30,8 12,2 15,1 19,5 11,6 292 16,9 9,2 18,0 15,5 14,4 15,2 29,5 31,2 11,4 7,0 24,6 30,8 12,0 14,8 19,3 11,4 294 16,4 8,7 17,9 15,3 14,1 15,0 29,3 30,8 11,3 7,0 24,4 30,7 11,7 14,5 19,1 11,2 296 15,9 8,1 17,8 15,1 13,8 14,7 28,9 30,4 11,3 6,9 24,2 30,6 11,4 14,1 18,9 10,9 2021307653   16 Sep 2026 298 15,3 7,5 17,7 14,9 13,5 14,5 28,5 29,9 11,2 6,7 24,1 30,5 11,1 13,7 18,7 10,7 300 14,7 6,8 17,6 14,7 13,2 14,2 28,1 29,3 11,2 6,5 23,9 30,3 10,6 13,2 18,4 10,4 Min 14,7 6,8 17,6 14,7 13,2 14,2 28,1 29,3 11,2 6,5 23,9 30,3 10,6 13,2 18,4 10,4 Max 20,9 13,7 19,5 18,1 18,1 18,6 31,0 32,2 11,5 7,1 27,2 31,0 13,3 16,4 22,2 14,5 CT 1,8 2,0 0,6 1,0 1,4 1,3 0,8 0,7 0,1 0,2 1,0 0,2 0,7 0,9 1,1 1,2 Y 18,8 11,3 18,5 16,5 15,9 16,6 30,3 31,6 11,3 6,8 25,6 30,8 12,6 15,7 20,5 12,6 Y 19,4 11,9 18,4 16,6 16,0 16,7 30,8 31,8 11,3 6,8 25,6 30,8 12,9 16,1 20,6 12,7 na a' i I I' '                   t         ja a      K » a     '                   t         a a a       i       a a      a a a             t            ri                             t         / Cti            a a             i      a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.15. In Table 24, Table 25 and Table 26, the calculated values of |Y|HHb of each TMM, at each intensity can be observed. Table 24. Trend Line Values |Y|HHb between UAminand UAe. Watts RF L RF R VL L VL R ST L ST R GM L GM Rer VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 136 3,6 6,1 3,0 3,5 3,5 2,9 1,2 1,1 5,9 6,9 1,9 1,7 7,0 5,8 4,5 2,4 138 3,7 6,2 3,0 3,5 3,5 2,9 1,2 1,1 6,0 7,0 1,9 1,7 7,0 5,8 4,6 2,5 140 3,7 6,2 3,0 3,5 3,5 2,9 1,2 1,1 6,0 7,0 1,8 1,7 7,0 5,8 4,6 2,5 142 3,7 6,2 3,0 3,6 3,6 2,9 1,2 1,1 6,0 7,1 1,8 1,7 7,1 5,8 4,6 2,5 144 3,7 6,3 3,0 3,6 3,6 2,9 1,2 1,1 6,1 7,1 1,8 1,6 7,1 5,8 4,7 2,5 146 3,7 6,3 3,0 3,6 3,6 2,9 1,2 1,1 6,1 7,2 1,8 1,6 7,1 5,8 4,7 2,5 148 3,7 6,3 3,0 3,6 3,6 2,9 1,2 1,1 6,2 7,2 1,7 1,6 7,0 5,8 4,7 2,5 150 3,7 6,3 3,0 3,6 3,6 2,9 1,2 1,0 6,2 7,2 1,7 1,6 7,0 5,8 4,7 2,5 152 3,7 6,4 3,0 3,6 3,6 2,9 1,1 1,0 6,2 7,3 1,7 1,5 7,0 5,8 4,7 2,5 154 3,7 6,4 3,0 3,6 3,6 2,9 1,1 1,0 6,3 7,3 1,6 1,5 7,0 5,8 4,8 2,5 156 3,7 6,4 3,0 3,6 3,6 2,9 1,1 1,0 6,3 7,4 1,6 1,5 7,0 5,8 4,8 2,5 158 3,7 6,4 3,0 3,7 3,7 2,9 1,1 1,0 6,3 7,4 1,6 1,4 7,0 5,8 4,8 2,5 160 3,8 6,4 3,0 3,7 3,7 2,9 1,1 1,0 6,4 7,5 1,5 1,4 7,0 5,8 4,8 2,5 162 3,8 6,4 3,1 3,7 3,7 2,9 1,1 1,0 6,4 7,5 1,5 1,4 7,0 5,7 4,8 2,5 164 3,8 6,5 3,1 3,7 3,7 2,9 1,1 1,0 6,4 7,5 1,4 1,3 7,0 5,7 4,8 2,5 166 3,8 6,5 3,1 3,7 3,7 2,9 1,0 1,0 6,5 7,6 1,4 1,3 7,0 5,7 4,9 2,5 168 3,8 6,5 3,1 3,7 3,7 2,9 1,0 0,9 6,5 7,6 1,3 1,3 7,0 5,7 4,9 2,5 170 3,8 6,5 3,1 3,7 3,7 2,9 1,0 0,9 6,5 7,7 1,3 1,3 7,0 5,7 4,9 2,5 172 3,8 6,5 3,1 3,7 3,7 2,9 1,0 0,9 6,6 7,7 1,3 1,2 7,0 5,7 4,9 2,5 174 3,8 6,5 3,1 3,7 3,7 2,9 1,0 0,9 6,6 7,8 1,2 1,2 7,0 5,7 5,0 2,5 176 3,8 6,5 3,1 3,8 3,8 2,9 1,0 0,9 6,7 7,8 1,2 1,2 7,0 5,7 5,0 2,6 178 3,8 6,5 3,2 3,8 3,8 2,9 1,0 0,9 6,7 7,9 1,2 1,1 7,0 5,7 5,0 2,6 180 3,8 6,6 3,2 3,8 3,8 3,0 1,0 0,9 6,8 7,9 1,1 1,1 7,0 5,7 5,0 2,6 182 3,9 6,6 3,2 3,8 3,8 3,0 1,0 0,9 6,8 8,0 1,1 1,1 7,0 5,7 5,1 2,6 184 3,9 6,6 3,2 3,9 3,9 3,0 1,0 0,9 6,8 8,1 1,1 1,1 7,0 5,7 5,1 2,6 186 3,9 6,6 3,3 3,9 3,9 3,0 1,0 0,9 6,9 8,1 1,1 1,1 7,0 5,7 5,1 2,6 188 3,9 6,6 3,3 3,9 3,9 3,1 1,0 0,9 6,9 8,2 1,1 1,1 7,1 5,7 5,2 2,7 190 4,0 6,7 3,4 4,0 4,0 3,1 1,0 0,9 7,0 8,2 1,1 1,1 7,1 5,7 5,2 2,7 192 4,0 6,7 3,4 4,0 4,0 3,2 1,0 0,9 7,0 8,3 1,1 1,1 7,1 5,7 5,3 2,7 194 4,0 6,7 3,4 4,0 4,0 3,2 1,0 0,9 7,1 8,4 1,1 1,1 7,1 5,7 5,3 2,8 196 4,1 6,8 3,5 4,1 4,1 3,3 1,0 0,9 7,2 8,5 1,1 1,1 7,2 5,8 5,4 2,8 198 4,1 6,8 3,5 4,1 4,1 3,4 1,0 1,0 7,2 8,5 1,1 1,1 7,2 5,8 5,4 2,8 200 4,1 6,8 3,6 4,2 4,2 3,4 1,0 1,0 7,3 8,6 1,1 1,1 7,2 5,8 5,5 2,9 Min 3,6 6,1 3,0 3,5 3,5 2,9 1,0 0,9 5,9 6,9 1,1 1,1 7,0 5,7 4,5 2,4 Max 4,1 6,8 3,6 4,2 4,2 3,4 1,2 1,1 7,3 8,6 1,9 1,7 7,2 5,8 5,5 2,9 CT 0,1 0,2 0,2 0,2 0,2 0,1 0,1 0,1 0,4 0,5 0,3 0,2 0,1 0,1 0,3 0,1 _ Y 3,8 6,5 3,2 3,8 3,8 3,0 1,1 1,0 6,5 7,7 1,4 1,3 7,0 5,7 4,9 2,6 Y 3,8 6,5 3,1 3,7 3,7 2,9 1,0 1,0 6,5 7,6 1,3 1,3 7,0 5,7 4,9 2,5 ram^a a aaa a                t         / a a     a a a     •                t        a a a       a      a a     • a •           t        a^                            t                       a •           it [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 2021307653   16 Sep 2026 Table 25. Trend Line Values |Y|HHb between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 4,2 6,9 3,7 4,3 4,3 3,5 1,0 1,0 7,3 8,7 1,1 1,1 7,3 5,9 5,5 2,9 204 4,2 6,9 3,7 4,3 4,3 3,6 1,0 1,0 7,4 8,8 1,1 1,1 7,3 5,9 5,6 2,9 206 4,3 7,0 3,8 4,4 4,4 3,7 1,0 1,0 7,5 8,8 1,2 1,1 7,4 5,9 5,6 3,0 208 4,3 7,0 3,9 4,4 4,4 3,7 1,0 1,0 7,5 8,9 1,2 1,2 7,4 6,0 5,7 3,0 210 4,4 7,1 3,9 4,5 4,5 3,8 1,1 1,0 7,6 9,0 1,2 1,2 7,5 6,0 5,8 3,1 212 4,4 7,1 4,0 4,6 4,6 3,9 1,1 1,0 7,6 9,1 1,3 1,2 7,5 6,1 5,8 3,2 214 4,5 7,2 4,1 4,6 4,6 4,0 1,1 1,1 7,7 9,2 1,3 1,3 7,6 6,1 5,9 3,2 216 4,5 7,2 4,1 4,7 4,7 4,1 1,1 1,1 7,8 9,2 1,4 1,3 7,6 6,2 6,0 3,3 218 4,6 7,3 4,2 4,8 4,8 4,2 1,1 1,1 7,8 9,3 1,5 1,3 7,7 6,3 6,1 3,3 220 4,7 7,3 4,3 4,9 4,9 4,3 1,2 1,1 7,9 9,4 1,5 1,4 7,8 6,3 6,1 3,4 222 4,7 7,4 4,4 4,9 4,9 4,4 1,2 1,1 8,0 9,5 1,6 1,4 7,8 6,4 6,2 3,5 224 4,8 7,4 4,5 5,0 5,0 4,5 1,2 1,1 8,0 9,5 1,6 1,4 7,9 6,4 6,3 3,5 226 4,9 7,5 4,5 5,1 5,1 4,6 1,2 1,1 8,1 9,6 1,7 1,5 7,9 6,5 6,4 3,6 228 4,9 7,6 4,6 5,2 5,2 4,7 1,2 1,1 8,2 9,7 1,8 1,5 8,0 6,6 6,5 3,7 230 5,0 7,6 4,7 5,3 5,3 4,8 1,3 1,2 8,2 9,8 1,9 1,5 8,0 6,6 6,5 3,7 232 5,1 7,7 4,8 5,3 5,3 4,9 1,3 1,2 8,3 9,8 1,9 1,6 8,1 6,7 6,6 3,8 234 5,1 7,7 4,8 5,4 5,4 5,0 1,3 1,2 8,4 9,9 2,0 1,6 8,1 6,7 6,7 3,9 236 5,2 7,8 4,9 5,5 5,5 5,1 1,3 1,2 8,4 10,0 2,1 1,6 8,2 6,8 6,8 3,9 238 5,3 7,9 5,0 5,6 5,6 5,2 1,3 1,2 8,5 10,0 2,2 1,7 8,2 6,8 6,9 4,0 240 5,4 7,9 5,1 5,6 5,6 5,3 1,4 1,2 8,5 10,1 2,3 1,7 8,3 6,9 6,9 4,1 242 5,4 8,0 5,1 5,7 5,7 5,4 1,4 1,2 8,6 10,1 2,3 1,7 8,3 6,9 7,0 4,1 244 5,5 8,0 5,2 5,8 5,8 5,5 1,4 1,2 8,6 10,2 2,4 1,8 8,4 7,0 7,1 4,2 246 5,6 8,1 5,3 5,9 5,9 5,6 1,4 1,2 8,7 10,2 2,5 1,8 8,4 7,0 7,2 4,3 248 5,6 8,1 5,3 5,9 5,9 5,7 1,4 1,2 8,7 10,3 2,6 1,8 8,4 7,1 7,2 4,4 250 5,7 8,2 5,4 6,0 6,0 5,8 1,5 1,2 8,8 10,3 2,6 1,8 8,5 7,1 7,3 4,4 Min 4,2 6,9 3,7 4,3 4,3 3,5 1,0 1,0 7,3 8,7 1,1 1,1 7,3 5,9 5,5 2,9 Max 5,7 8,2 5,4 6,0 6,0 5,8 1,5 1,2 8,8 10,3 2,6 1,8 8,5 7,1 7,3 4,4 CT 0,5 0,4 0,5 0,5 0,5 0,7 0,1 0,1 0,4 0,5 0,5 0,2 0,4 0,4 0,6 0,5 _ Y 4,9 7,5 4,5 5,1 5,1 4,6 1,2 1,1 8,1 9,6 1,8 1,5 7,9 6,5 6,4 3,6 Y 4,9 7,5 4,5 5,1 5,1 4,6 1,2 1,1 8,1 9,6 1,7 1,5 7,9 6,5 6,4 3,6 a        / a a a a a •               a       tat      i     a a • t •          a       a^ ra                      a                    at          i a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 26. Trend Line Values |Y|HHb >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 5,8 8,2 5,4 6,0 6,0 5,8 1,5 1,2 8,8 10,3 2,7 1,8 8,5 7,1 7,4 4,5 254 5,8 8,3 5,5 6,1 6,1 5,9 1,5 1,2 8,8 10,4 2,8 1,8 8,5 7,1 7,5 4,6 256 5,9 8,3 5,5 6,2 6,2 6,0 1,5 1,2 8,9 10,4 2,8 1,8 8,6 7,2 7,5 4,6 258 6,0 8,4 5,6 6,2 6,2 6,0 1,5 1,2 8,9 10,4 2,9 1,9 8,6 7,2 7,6 4,7 260 6,0 8,5 5,6 6,3 6,3 6,1 1,5 1,2 8,9 10,4 2,9 1,9 8,6 7,2 7,7 4,7 262 6,1 8,5 5,7 6,3 6,3 6,2 1,6 1,2 8,9 10,4 3,0 1,9 8,6 7,2 7,7 4,8 264 6,1 8,6 5,7 6,4 6,4 6,2 1,6 1,2 9,0 10,4 3,1 1,9 8,6 7,2 7,8 4,8 266 6,2 8,6 5,8 6,4 6,4 6,3 1,6 1,2 9,0 10,5 3,1 1,8 8,6 7,2 7,8 4,9 268 6,3 8,7 5,8 6,4 6,4 6,3 1,6 1,2 9,0 10,5 3,1 1,8 8,6 7,2 7,9 4,9 270 6,3 8,7 5,8 6,5 6,5 6,4 1,7 1,3 9,0 10,5 3,2 1,8 8,7 7,2 7,9 5,0 272 6,4 8,8 5,9 6,5 6,5 6,4 1,7 1,3 9,0 10,5 3,2 1,8 8,7 7,2 8,0 5,0 274 6,5 8,9 5,9 6,6 6,6 6,5 1,7 1,3 9,0 10,5 3,2 1,8 8,7 7,2 8,0 5,1 276 6,5 8,9 5,9 6,6 6,6 6,5 1,7 1,3 9,1 10,4 3,3 1,8 8,7 7,2 8,1 5,1 278 6,6 9,0 6,0 6,7 6,7 6,6 1,8 1,4 9,1 10,4 3,3 1,8 8,7 7,2 8,1 5,2 280 6,7 9,1 6,0 6,7 6,7 6,7 1,8 1,4 9,1 10,4 3,3 1,8 8,8 7,2 8,2 5,2 282 6,7 9,2 6,1 6,8 6,8 6,7 1,9 1,5 9,1 10,4 3,4 1,8 8,8 7,3 8,2 5,3 284 6,8 9,3 6,1 6,8 6,8 6,8 2,0 1,6 9,1 10,5 3,4 1,8 8,8 7,3 8,3 5,3 286 6,9 9,4 6,2 6,9 6,9 6,9 2,0 1,7 9,1 10,5 3,4 1,8 8,9 7,3 8,4 5,4 288 7,0 9,6 6,2 6,9 6,9 7,0 2,1 1,8 9,2 10,5 3,4 1,8 9,0 7,4 8,4 5,5 290 7,1 9,7 6,3 7,0 7,0 7,1 2,2 1,9 9,2 10,5 3,5 1,8 9,0 7,4 8,5 5,6 292 7,2 9,9 6,4 7,1 7,1 7,2 2,3 2,0 9,2 10,5 3,5 1,9 9,1 7,5 8,6 5,7 294 7,3 10,1 6,5 7,2 7,2 7,4 2,5 2,2 9,3 10,6 3,5 1,9 9,3 7,6 8,7 5,8 296 7,5 10,3 6,6 7,3 7,3 7,5 2,6 2,4 9,4 10,7 3,6 2,0 9,4 7,7 8,9 5,9 2021307653   16 Sep 2026 298 7,6 10,6 6,7 7,5 7,5 7,7 2,8 2,6 9,4 10,7 3,7 2,1 9,6 7,9 9,0 6,1 300 7,8 10,9 6,9 7,6 7,6 7,9 3,0 2,8 9,5 10,8 3,7 2,2 9,8 8,1 9,2 6,2 Min 5,8 8,2 5,4 6,0 6,0 5,8 1,5 1,2 8,8 10,3 2,7 1,8 8,5 7,1 7,4 4,5 Max 7,8 10,9 6,9 7,6 7,6 7,9 3,0 2,8 9,5 10,8 3,7 2,2 9,8 8,1 9,2 6,2 CT 0,6 0,7 0,4 0,4 0,4 0,6 0,4 0,5 0,2 0,1 0,3 0,1 0,3 0,2 0,5 0,5 Y 6,6 9,1 6,0 6,7 6,7 6,7 1,9 1,6 9,1 10,5 3,2 1,9 8,8 7,3 8,1 5,2 Y 6,5 8,9 5,9 6,6 6,6 6,5 1,7 1,3 9,1 10,5 3,3 1,8 8,7 7,2 8,1 5,1 na a' i I I' '                   t         ja a      K » a     '                   t         a a a       i       a a      a a a             t            ri                             t         / Cti            a a             i      a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.16. In Table 27, Table 28 and Table 29, the calculated values of |Y|0HHb of each TMM, at each intensity can be observed. Table 27. Trend Line Values |Y|0HHb between UAmnand UAe. ro Watts RF L RF R VL L VL R ST L ST R GM L GM Rer VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zon< Op| 136 7,7 13,0 6,6 7,6 6,7 6,4 2,9 2,8 12,8 15,1 3,9 3,7 15,1 12,1 9,4 4,9 138 7,7 13,1 6,7 7,7 6,7 6,4 2,9 2,8 12,9 15,2 3,9 3,7 15,2 12,2 9,5 5,0 140 7,8 13,3 6,7 7,8 6,8 6,5 2,9 2,8 13,1 15,3 3,9 3,7 15,3 12,3 9,6 5,0 142 7,9 13,4 6,8 7,8 6,8 6,5 2,9 2,8 13,2 15,5 3,9 3,7 15,4 12,4 9,6 5,0 144 8,0 13,6 6,8 7,9 6,8 6,5 2,8 2,7 13,4 15,6 3,8 3,6 15,4 12,5 9,7 5,0 146 8,0 13,7 6,8 8,0 6,9 6,6 2,8 2,7 13,5 15,7 3,8 3,6 15,5 12,5 9,8 5,1 148 8,1 13,9 6,8 8,0 6,9 6,6 2,8 2,7 13,6 15,9 3,7 3,6 15,5 12,6 9,9 5,1 150 8,2 14,0 6,8 8,1 6,9 6,6 2,7 2,6 13,8 16,0 3,7 3,5 15,6 12,7 9,9 5,1 152 8,2 14,1 6,9 8,1 7,0 6,6 2,7 2,6 13,9 16,1 3,6 3,4 15,6 12,7 10,0 5,1 154 8,3 14,2 6,9 8,1 7,0 6,6 2,6 2,5 14,0 16,2 3,5 3,4 15,6 12,8 10,0 5,1 156 8,4 14,3 6,9 8,2 7,0 6,6 2,6 2,5 14,1 16,4 3,5 3,3 15,7 12,8 10,1 5,1 158 8,4 14,4 6,9 8,2 7,0 6,6 2,5 2,4 14,2 16,5 3,4 3,2 15,7 12,9 10,2 5,1 160 8,5 14,5 6,9 8,2 7,1 6,6 2,5 2,3 14,4 16,6 3,3 3,2 15,8 12,9 10,2 5,1 162 8,6 14,6 6,9 8,3 7,1 6,6 2,4 2,3 14,5 16,8 3,3 3,1 15,8 13,0 10,3 5,1 164 8,6 14,7 6,9 8,3 7,1 6,6 2,4 2,2 14,6 16,9 3,2 3,0 15,8 13,0 10,4 5,1 166 8,7 14,8 7,0 8,4 7,2 6,6 2,3 2,1 14,8 17,1 3,1 3,0 15,9 13,1 10,4 5,1 168 8,8 15,0 7,0 8,4 7,2 6,6 2,3 2,1 14,9 17,3 3,1 2,9 15,9 13,1 10,5 5,1 170 8,8 15,1 7,0 8,5 7,3 6,6 2,2 2,0 15,0 17,4 3,0 2,8 16,0 13,2 10,6 5,1 172 8,9 15,2 7,1 8,5 7,3 6,7 2,2 1,9 15,2 17,6 3,0 2,8 16,1 13,2 10,7 5,1 174 9,0 15,3 7,1 8,6 7,4 6,7 2,1 1,9 15,4 17,8 2,9 2,7 16,1 13,3 10,8 5,2 176 9,1 15,4 7,2 8,7 7,5 6,8 2,1 1,8 15,5 18,0 2,9 2,7 16,2 13,4 10,9 5,2 178 9,2 15,5 7,3 8,8 7,6 6,8 2,1 1,8 15,7 18,3 2,8 2,6 16,3 13,5 11,1 5,3 180 9,3 15,7 7,3 8,9 7,7 6,9 2,0 1,8 15,9 18,5 2,8 2,6 16,4 13,6 11,2 5,3 182 9,4 15,8 7,4 9,0 7,8 7,0 2,0 1,7 16,1 18,8 2,8 2,6 16,6 13,7 11,4 5,4 184 9,5 15,9 7,5 9,1 7,9 7,1 2,0 1,7 16,3 19,0 2,8 2,5 16,7 13,8 11,5 5,5 186 9,6 16,1 7,6 9,2 8,1 7,2 2,0 1,7 16,5 19,3 2,8 2,5 16,8 13,9 11,7 5,6 188 9,7 16,3 7,8 9,4 8,2 7,4 2,0 1,7 16,7 19,6 2,8 2,5 17,0 14,0 11,9 5,7 190 9,8 16,4 7,9 9,5 8,4 7,5 2,0 1,7 16,9 19,9 2,8 2,5 17,2 14,2 12,1 5,8 192 10,0 16,6 8,1 9,7 8,6 7,7 2,0 1,7 17,2 20,3 2,8 2,5 17,4 14,3 12,3 6,0 194 10,1 16,8 8,3 9,9 8,8 7,9 2,0 1,7 17,4 20,6 2,9 2,6 17,6 14,5 12,5 6,1 196 10,3 17,0 8,4 10,1 9,0 8,1 2,0 1,7 17,7 21,0 2,9 2,6 17,8 14,6 12,8 6,3 198 10,4 17,2 8,6 10,3 9,2 8,3 2,1 1,7 18,0 21,3 3,0 2,6 18,0 14,8 13,1 6,4 200 10,6 17,4 8,8 10,5 9,4 8,5 2,1 1,8 18,2 21,7 3,0 2,7 18,2 15,0 13,3 6,6 Min 7,7 13,0 6,6 7,6 6,7 6,4 2,0 1,7 12,8 15,1 2,8 2,5 15,1 12,1 9,4 4,9 Max 10,6 17,4 8,8 10,5 9,4 8,5 2,9 2,8 18,2 21,7 3,9 3,7 18,2 15,0 13,3 6,6 CT 0,8 1,2 0,6 0,8 0,8 0,6 0,3 0,4 1,6 1,9 0,4 0,4 0,8 0,8 1,1 0,5 _ Y 8,9 15,0 7,3 8,7 7,5 6,9 2,4 2,1 15,1 17,7 3,2 3,0 16,2 13,3 10,8 5,3 Y 8,8 15,0 7,0 8,4 7,2 6,6 2,3 2,1 14,9 17,3 3,1 2,9 15,9 13,1 10,5 5,1 ram^a a aaa a                t         / a a     a a a     •                t        a a a       a      a a     • a •           t        a^                            t                       a •           it [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 2021307653   16 Sep 2026 Table 28. Trend Line Values |Y|0HHb between UAe and Uana. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 202 10,8 17,6 9,1 10,7 9,7 8,7 2,2 1,8 18,5 22,1 3,1 2,7 18,5 15,2 13,6 6,8 204 11,0 17,8 9,3 11,0 10,0 9,0 2,2 1,9 18,8 22,5 3,2 2,8 18,7 15,4 13,9 7,0 206 11,1 18,1 9,6 11,2 10,2 9,3 2,3 1,9 19,1 22,9 3,3 2,9 19,0 15,6 14,2 7,2 208 11,3 18,3 9,8 11,5 10,5 9,6 2,4 2,0 19,4 23,3 3,4 3,0 19,3 15,8 14,5 7,4 210 11,6 18,6 10,1 11,8 10,8 9,9 2,5 2,1 19,8 23,7 3,6 3,1 19,6 16,1 14,8 7,6 212 11,8 18,8 10,4 12,1 11,1 10,2 2,5 2,2 20,1 24,2 3,7 3,2 19,9 16,3 15,1 7,8 214 12,0 19,1 10,7 12,3 11,5 10,5 2,6 2,3 20,4 24,6 3,9 3,3 20,2 16,6 15,4 8,1 216 12,2 19,4 11,0 12,6 11,8 10,9 2,7 2,4 20,8 25,0 4,0 3,4 20,5 16,8 15,7 8,3 218 12,5 19,6 11,3 13,0 12,1 11,2 2,8 2,5 21,1 25,4 4,2 3,5 20,8 17,1 16,0 8,6 220 12,7 19,9 11,6 13,3 12,5 11,6 2,9 2,6 21,5 25,9 4,3 3,6 21,1 17,3 16,4 8,8 222 12,9 20,2 11,9 13,6 12,9 11,9 3,0 2,7 21,8 26,3 4,5 3,8 21,4 17,6 16,7 9,1 224 13,2 20,5 12,2 13,9 13,2 12,3 3,2 2,8 22,2 26,7 4,7 3,9 21,7 17,8 17,1 9,3 226 13,5 20,8 12,5 14,2 13,6 12,7 3,3 2,9 22,5 27,1 4,9 4,0 22,1 18,1 17,4 9,6 228 13,7 21,1 12,9 14,6 14,0 13,1 3,4 3,0 22,9 27,5 5,1 4,2 22,4 18,3 17,8 9,9 230 14,0 21,4 13,2 14,9 14,3 13,5 3,5 3,1 23,2 27,9 5,3 4,3 22,7 18,6 18,2 10,2 232 14,3 21,7 13,5 15,2 14,7 13,9 3,6 3,3 23,6 28,3 5,5 4,4 23,0 18,9 18,5 10,5 234 14,5 22,0 13,9 15,5 15,1 14,3 3,8 3,4 23,9 28,7 5,8 4,5 23,3 19,1 18,9 10,7 236 14,8 22,3 14,2 15,8 15,5 14,6 3,9 3,5 24,2 29,0 6,0 4,7 23,6 19,4 19,2 11,0 238 15,1 22,6 14,5 16,2 15,8 15,0 4,0 3,6 24,6 29,3 6,2 4,8 23,9 19,6 19,6 11,3 240 15,4 22,9 14,8 16,5 16,2 15,4 4,1 3,7 24,9 29,6 6,4 4,9 24,2 19,8 20,0 11,6 242 15,7 23,1 15,1 16,8 16,6 15,8 4,2 3,8 25,2 29,9 6,6 5,0 24,4 20,1 20,4 12,0 244 16,0 23,4 15,4 17,1 16,9 16,2 4,3 3,9 25,5 30,2 6,9 5,1 24,7 20,3 20,8 12,3 246 16,2 23,7 15,7 17,4 17,3 16,5 4,4 4,0 25,8 30,5 7,1 5,2 24,9 20,5 21,2 12,6 248 16,5 24,0 16,0 17,6 17,6 16,9 4,5 4,1 26,0 30,7 7,3 5,3 25,2 20,7 21,5 13,0 250 16,8 24,3 16,3 17,9 17,9 17,2 4,6 4,1 26,3 30,9 7,5 5,4 25,4 20,9 21,9 13,3 Min 10,8 17,6 9,1 10,7 9,7 8,7 2,2 1,8 18,5 22,1 3,1 2,7 18,5 15,2 13,6 6,8 Max 16,8 24,3 16,3 17,9 17,9 17,2 4,6 4,1 26,3 30,9 7,5 5,4 25,4 20,9 21,9 13,3 CT 1,9 2,1 2,3 2,3 2,6 2,7 0,8 0,8 2,4 2,8 1,4 0,9 2,2 1,8 2,6 2,0 _ Y 13,6 20,8 12,6 14,3 13,7 12,8 3,3 2,9 22,5 26,9 5,1 4,0 22,0 18,1 17,5 9,8 Y 13,5 20,8 12,5 14,2 13,6 12,7 3,3 2,9 22,5 27,1 4,9 4,0 22,1 18,1 17,4 9,6 a        / a a a a a •               a       tat      i     a a • t •          a       a^ ra                      a                    at          i a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] Table 29. Trend Line Values |Y|0HHb >UAna. Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R Lim Sup |Zona Op| Lim Inf |Zona Op| 252 17,1 24,6 16,5 18,2 18,3 17,6 4,7 4,2 26,5 31,1 7,8 5,5 25,6 21,0 22,2 13,5 254 17,4 24,8 16,8 18,4 18,6 17,9 4,8 4,3 26,7 31,3 8,0 5,5 25,8 21,2 22,5 13,8 256 17,7 25,1 17,0 18,7 18,9 18,2 4,9 4,3 27,0 31,4 8,2 5,6 25,9 21,4 22,8 14,1 258 18,0 25,4 17,2 18,9 19,2 18,5 5,0 4,4 27,1 31,5 8,4 5,6 26,1 21,5 23,1 14,3 260 18,2 25,6 17,4 19,1 19,5 18,8 5,1 4,4 27,3 31,6 8,6 5,7 26,2 21,6 23,3 14,5 262 18,5 25,9 17,6 19,3 19,7 19,1 5,1 4,4 27,5 31,7 8,8 5,7 26,3 21,8 23,6 14,8 264 18,8 26,2 17,8 19,5 20,0 19,3 5,2 4,5 27,6 31,8 9,0 5,7 26,5 21,9 23,8 15,0 266 19,1 26,4 17,9 19,7 20,3 19,6 5,3 4,5 27,7 31,8 9,2 5,7 26,6 22,0 24,1 15,2 268 19,3 26,7 18,1 19,9 20,5 19,8 5,3 4,5 27,8 31,9 9,4 5,7 26,7 22,1 24,3 15,4 270 19,6 27,0 18,2 20,0 20,7 20,0 5,4 4,5 27,9 31,9 9,6 5,7 26,7 22,2 24,5 15,5 272 19,9 27,2 18,3 20,2 20,9 20,2 5,5 4,5 28,0 31,9 9,8 5,7 26,8 22,3 24,7 15,7 274 20,1 27,5 18,4 20,3 21,2 20,4 5,5 4,5 28,1 31,9 10,0 5,7 26,9 22,4 24,9 15,9 276 20,4 27,8 18,5 20,5 21,4 20,6 5,6 4,5 28,1 31,9 10,1 5,7 27,0 22,5 25,1 16,0 278 20,6 28,1 18,6 20,6 21,6 20,8 5,7 4,5 28,1 31,9 10,3 5,7 27,0 22,6 25,2 16,2 280 20,9 28,4 18,7 20,8 21,8 20,9 5,8 4,5 28,2 32,0 10,5 5,7 27,1 22,7 25,5 16,4 282 21,2 28,7 18,8 21,0 22,0 21,1 5,9 4,6 28,2 32,0 10,7 5,7 27,2 22,8 25,7 16,6 284 21,4 29,1 18,9 21,1 22,2 21,3 6,0 4,6 28,2 32,1 10,9 5,7 27,3 22,9 25,9 16,8 286 21,7 29,5 19,0 21,3 22,4 21,4 6,1 4,6 28,2 32,2 11,1 5,7 27,5 23,1 26,2 17,0 288 22,0 29,9 19,0 21,5 22,6 21,6 6,2 4,7 28,2 32,3 11,3 5,7 27,7 23,2 26,4 17,2 290 22,3 30,3 19,1 21,7 22,8 21,8 6,4 4,8 28,2 32,5 11,6 5,7 27,9 23,4 26,7 17,4 292 22,5 30,8 19,3 22,0 23,1 22,0 6,6 4,9 28,2 32,8 11,8 5,8 28,1 23,7 26,9 17,6 294 22,8 31,3 19,4 22,3 23,4 22,2 6,8 5,0 28,2 33,1 12,1 5,9 28,4 24,0 27,2 17,9 296 23,2 31,9 19,6 22,6 23,7 22,5 7,1 5,2 28,3 33,5 12,4 6,1 28,8 24,3 27,6 18,2 2021307653   16 Sep 2026 298 23,5 32,5 19,7 23,0 24,0 22,8 7,4 5,5 28,4 34,0 12,7 6,2 29,2 24,7 28,0 18,5 300 23,8 33,2 20,0 23,4 24,4 23,1 7,7 5,7 28,5 34,6 13,1 6,5 29,8 25,2 28,4 18,8 Min 17,1 24,6 16,5 18,2 18,3 17,6 4,7 4,2 26,5 31,1 7,8 5,5 25,6 21,0 22,2 13,5 Max 23,8 33,2 20,0 23,4 24,4 23,1 7,7 5,7 28,5 34,6 13,1 6,5 29,8 25,2 28,4 18,8 CT 2,0 2,5 0,9 1,4 1,7 1,6 0,8 0,4 0,5 0,8 1,5 0,2 1,1 1,1 1,8 1,5 Y 20,4 28,2 18,4 20,6 21,3 20,5 5,8 4,6 27,9 32,2 10,2 5,8 27,2 22,7 25,1 16,1 Y 20,4 27,8 18,5 20,5 21,4 20,6 5,6 4,5 28,1 31,9 10,1 5,7 27,0 22,5 25,1 16,0 na a' i I I' '               t       ja a    K » a    '               t       tat      i     a a    • a •          t         ri                      t       / Cti         a •          i    a [(Min) Minimum value; (Max) Maximum value; (u) standard deviation value; (Y) average value; (Y) median value] 1.17. In Figure 52-100, the graphical representation of the calculated values corresponding to the slope of the trend line (p) of |Y|SmO2%, |Y|O2HHb, |Y|0O2HHb, |K|HHb, |Y|0HHb, |Y|ThB and |Y|0ThB, of each TMM can be observed. 1.18. In Table 30, the intensity ranges which produce the 1st, 2nd and 3rd General Change in the Slopes of the Trend Lines of (p)|Y|SmO2%, (p)|Y|O2HHb, (p)|Y|$O2HHb, (p)|Y|HHb, (p)|Y|0HHb, (p)|Y|ThB and (p)|Y|0ThB, of each TMM can be observed. The 1st General Change (p) is equals the Minimum Activation Threshold (UAmin), the 2nd General Change (p) is equals the Aerobic Threshold (UAe) and the 3rd General Change (p) is equals the Threshold Anaerobic (Uana), of each TMM. Table 30. General changes in trend and physiological thresholds of each TMM. 1st Change (p) 2nd Change (p) 3rd Change (p) UAmin Individual UAe Individual UAna Individual Rango|X| (Watts) Rango|X| (Watts) Rango|X| (Watts) TMM |X| (Watts) |X| (Watts) |X| (Watts) RF L 134 - 138 198 - 206 246 - 266 136 202 256 RF R 132 - 142 198 - 208 244 - 266 137 203 255 VL L 130 - 138 134 192 - 206 199 254 - 270 262 VL R 130 - 140 196 - 206 254 - 268 135 201 261 ST L 132 - 144 138 196 - 206 201 254 - 268 261 ST R 130 - 138 192 - 204 254 - 276 134 198 265 GM L 132 - 138 192 - 208 244 - 262 135 200 253 GM R 130 - 140 194 - 206 238 - 262 135 200 250 VI L 132 - 150 190 - 206 244 - 270 141 198 257 VI R 126 - 140 184 - 206 250 - 258 2021307653   16 Sep 2026 133 195 254 GA L 126 - 138 194 - 214 258 - 274 132 204 266 GA R 126 - 138 132 190 - 212 201 256 - 260 258 TA L 130 - 138 192 - 206 252 - 258 134 199 255 TA R 132 - 144 194 - 210 246 - 270 138 202 258 1.19. In Table 31, the median values of all the general changes of (p) of the set of TMsm, that are equivalent to UAmin, UAe and UANA of the global locomotor system can be observed. Table 31. General Change in Trend and Global Physiological Thresholds 1st General Change (p) 2nd General      3rd General Change (p)      Change (p) UAmin UAe               UAna Ra.ngo |*|   130 - 138 (Watts) |X| (Watts)      136 192 - 206       252 - 268 201             258 2. Analysis and Evaluation of Locomotor Performance Factors A3. Factor Funcional por Inhibition Muscular de la Capacidad Oxidativa - In Table 9-11 and Table 18-23, the calculated value of |Z|SmO2%, |F|O2HHb and |F|0O2HHb, of each TMM, in each INTTL greater than or equal to UAmin can be observed. - In Table 32-37, the results of the CSV of |Z|SmO2%, |F|0O2HHb and |F|O2HHb, of each TMM and his TMCM, in each INTTL greater than or equal to UAmin can be observed. -   In Table 38, can be observed NSCSV equivalent to the value of CSV. -   In Table 39, Table 40 and Table 41, the values of Coef-(p) of (p)|Z|SmO2%, (p)|F|O2HHb and (p)|y|0O2HHb, between each TMM and his TMCMcan be observed. - In Table 42, the equivalence of Coef-(p) with the NSCoef-(p) of the general trend between each TMM and his TMCM can be observed. Table 32. CSV of each TMM and hiss TMCM of |Z|SmO2% in each INTTL >UAmnand <UAe Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 136 0,22 0,04 0,01 0,01 0,12 0,01 0,13 138 0,22 0,04 0,01 0,01 0,12 0,01 0,13 co o 250 248 246 244 240 238 236 234 232 230 228 226 224 222 220 218 216 214 212 210 208 206 204 202 Watts o N) co 1    0,28 I 0,28 I 0,27 o NJ o NJ o NJ o NJ o NJ I 0,27 o NO I 0,27 o NO I 0,27 o NJ I 0,27 o NJ o NJ o NJ o NJ o NJ I 0,28 I 0,28 I 0,28 I 0,28 RF L RF R 90'0    | 1    0,06 I 0,06 I 0,06 I 0,06 I 0,06 I 0,06 I 0,05 90'0    | I 0,05 I 0,05 I 0,05 I 0,05 I 0,05 I 0,05 I 0,05 I 0,05 90'0    | I 0,05 I 0,05 90'0    | I 0,05 90'0    | I 0,06 I 0,06 VL L VL R o o NJ 1 0,02 I 0,02 I 0,02 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 STL ST R L0‘0    1 1    0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 I 0,01 GM L GM R 9£‘0    | I 0,36 I 0,35 I 0,35 I 0,34 I 0,34 I 0,33 I 0,33 I 0,32 I 0,31 I 0,31 I 0,30 I 0,29 I 0,29 I 0,28 I 0,27 I 0,26 I 0,26 o NO CH I 0,24 I 0,24 I 0,23 I 0,22 I 0,22 I 0,21 VI L VI R 90'0    | I 0,05 I 0,05 I 0,05 I 0,04 I 0,04 I 0,04 I 0,04 I 0,04 I 0,04 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,03 I 0,02 I 0,02 I 0,02 I 0,02 I 0,02 I 0,02 I 0,02 GAL GA R p co o co o co o co o co o co I 0,17 I 0,17 I 0,17 I 0,17 I 0,16 I 0,16 I 0,16 I 0,15 I 0,15 I 0,15 I 0,14 I 0,14 I 0,14 I 0,13 I 0,13 I 0,13 I 0,12 I 0,12 I 0,12 TA L TA R Table 33. CSV of each TMM and hiss TMCM of |y|SmO2% in each INTTL >UAe and <UAna 2021307653   16 Sep 2026 2021307653   16 Sep 2026 Table 34. CSV of each TMM and hiss TMCM of |F|O2HHb in each INTTL >UAmnand <UAe Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 136 0,239 0,040 0,000 0,009 0,136 0,035 0,103 138 0,243 0,041 0,000 0,009 0,136 0,035 0,103 140 0,247 0,042 0,001 0,009 0,136 0,034 0,102 142 0,250 0,044 0,001 0,009 0,136 0,033 0,101 144 0,253 0,045 0,002 0,008 0,136 0,033 0,100 146 0,256 0,046 0,003 0,008 0,135 0,032 0,099 148 0,258 0,047 0,004 0,008 0,134 0,031 0,098 150 0,261 0,047 0,005 0,008 0,133 0,030 0,097 152 0,263 0,048 0,006 0,007 0,132 0,029 0,095 154 0,264 0,049 0,007 0,007 0,131 0,028 0,094 156 0,266 0,049 0,008 0,006 0,130 0,027 0,092 158 0,267 0,050 0,009 0,006 0,130 0,026 0,091 160 0,268 0,050 0,011 0,006 0,129 0,025 0,089 162 0,268 0,051 0,012 0,005 0,129 0,024 0,088 164 0,269 0,051 0,013 0,005 0,128 0,024 0,087 166 0,269 0,051 0,014 0,005 0,129 0,023 0,086 168 0,269 0,051 0,016 0,004 0,129 0,022 0,084 170 0,269 0,051 0,017 0,004 0,130 0,022 0,083 172 0,269 0,051 0,018 0,004 0,131 0,021 0,082 174 0,269 0,051 0,019 0,003 0,132 0,020 0,081 176 0,269 0,051 0,020 0,003 0,134 0,020 0,081 178 0,269 0,051 0,021 0,003 0,137 0,020 0,080 180 0,268 0,051 0,022 0,003 0,139 0,019 0,080 182 0,268 0,051 0,023 0,003 0,143 0,019 0,079 184 0,267 0,051 0,024 0,002 0,147 0,019 0,079 186 0,267 0,050 0,025 0,002 0,151 0,019 0,079 188 0,267 0,050 0,025 0,002 0,156 0,020 0,079 190 0,266 0,050 0,026 0,002 0,161 0,020 0,080 192 0,266 0,050 0,026 0,002 0,167 0,020 0,080 194 0,266 0,050 0,027 0,002 0,173 0,021 0,081 196 0,265 0,049 0,027 0,002 0,180 0,022 0,082 198 0,265 0,049 0,027 0,002 0,188 0,023 0,083 200 0,265 0,049 0,027 0,003 0,196 0,024 0,084 Table 35. CSV of each TMM and hiss TMCM of |F|O2HHb in each INTTL >UAe and <UAna Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 202 0,27 0,05 0,03 0,00 0,20 0,02 0,09 204 0,27 0,05 0,03 0,00 0,21 0,03 0,09 206 0,27 0,05 0,03 0,00 0,22 0,03 0,09 208 0,27 0,05 0,03 0,00 0,23 0,03 0,09 210 0,27 0,05 0,03 0,00 0,24 0,03 0,09 212 0,27 0,05 0,03 0,00 0,25 0,03 0,10 214 0,27 0,05 0,03 0,01 0,26 0,03 0,10 216 0,27 0,05 0,02 0,01 0,28 0,04 0,10 218 0,27 0,05 0,02 0,01 0,29 0,04 0,10 220 0,27 0,05 0,02 0,01 0,30 0,04 0,11 222 0,27 0,05 0,02 0,01 0,31 0,04 0,11 224 0,27 0,05 0,02 0,01 0,32 0,05 0,11 226 0,27 0,05 0,02 0,01 0,33 0,05 0,12 228 0,28 0,05 0,02 0,01 0,34 0,05 0,12 230 0,28 0,05 0,02 0,01 0,35 0,05 0,12 232 0,28 0,05 0,02 0,01 0,36 0,06 0,13 234 0,28 0,05 0,02 0,01 0,37 0,06 0,13 236 0,28 0,05 0,02 0,01 0,38 0,06 0,13 238 0,29 0,05 0,02 0,01 0,39 0,07 0,14 240 0,29 0,05 0,01 0,01 0,39 0,07 0,14 242 0,29 0,06 0,01 0,01 0,40 0,07 0,14 244 0,29 0,06 0,01 0,01 0,40 0,08 0,15 246 0,30 0,06 0,01 0,02 0,40 0,08 0,15 2021307653   16 Sep 2026 248  I    0,30    I    0,06    I    0,01    I    0,02    I    0,40    I    0,08    I    0,15 250  |    0,30    |    0,06    |    001    |    0,02    |    0,40    |    0,09    |    00 5 Table 36. CSV of each TMM and hiss TMCM of |F|0O2HHb in each INTTL >UAminand <UAe Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 136 0,237 0,038 0,004 0,003 0,123 0,033 0,102 138 0,241 0,039 0,004 0,003 0,125 0,032 0,102 140 0,245 0,040 0,004 0,004 0,126 0,032 0,101 142 0,248 0,041 0,005 0,004 0,128 0,032 0,100 144 0,251 0,042 0,005 0,005 0,129 0,031 0,099 146 0,254 0,043 0,006 0,005 0,131 0,031 0,098 148 0,257 0,044 0,006 0,006 0,132 0,030 0,097 150 0,259 0,045 0,007 0,006 0,133 0,030 0,096 152 0,261 0,046 0,008 0,007 0,135 0,029 0,095 154 0,263 0,047 0,008 0,007 0,136 0,029 0,093 156 0,265 0,048 0,009 0,008 0,138 0,028 0,092 158 0,266 0,048 0,010 0,008 0,139 0,028 0,091 160 0,268 0,049 0,011 0,009 0,141 0,027 0,090 162 0,269 0,050 0,011 0,009 0,142 0,027 0,089 164 0,269 0,050 0,012 0,009 0,144 0,026 0,087 166 0,270 0,051 0,013 0,010 0,146 0,026 0,086 168 0,271 0,051 0,014 0,010 0,148 0,025 0,086 170 0,271 0,052 0,014 0,010 0,150 0,025 0,085 172 0,271 0,052 0,015 0,010 0,153 0,025 0,084 174 0,272 0,052 0,016 0,010 0,155 0,024 0,084 176 0,272 0,053 0,017 0,010 0,158 0,024 0,083 178 0,272 0,053 0,017 0,010 0,161 0,024 0,083 180 0,272 0,053 0,018 0,010 0,164 0,024 0,083 182 0,272 0,053 0,018 0,010 0,168 0,024 0,083 184 0,272 0,053 0,019 0,010 0,171 0,024 0,083 186 0,272 0,053 0,019 0,010 0,175 0,024 0,083 188 0,272 0,053 0,020 0,009 0,179 0,024 0,083 190 0,271 0,053 0,020 0,009 0,184 0,024 0,084 192 0,271 0,053 0,021 0,009 0,188 0,024 0,085 194 0,271 0,053 0,021 0,008 0,193 0,025 0,085 196 0,271 0,053 0,021 0,008 0,198 0,025 0,086 198 0,271 0,053 0,022 0,008 0,203 0,026 0,088 200 0,271 0,053 0,022 0,007 0,209 0,026 0,089 Table 37. CSV of each TMM and hiss TMCM of |F|0O2HHb in each INTTL >UAe and <UAna Watts RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 202 0,27 0,05 0,02 0,01 0,21 0,03 0,09 204 0,27 0,05 0,02 0,01 0,22 0,03 0,09 206 0,27 0,05 0,02 0,01 0,23 0,03 0,09 208 0,27 0,05 0,02 0,01 0,23 0,03 0,10 210 0,27 0,05 0,02 0,01 0,24 0,03 0,10 212 0,27 0,05 0,02 0,00 0,25 0,03 0,10 214 0,27 0,05 0,02 0,00 0,25 0,03 0,10 216 0,27 0,05 0,02 0,00 0,26 0,04 0,10 218 0,27 0,05 0,02 0,00 0,27 0,04 0,11 220 0,27 0,05 0,02 0,00 0,27 0,04 0,11 222 0,28 0,05 0,02 0,00 0,28 0,04 0,11 224 0,28 0,05 0,02 0,00 0,29 0,04 0,11 226 0,28 0,05 0,02 0,00 0,29 0,05 0,12 228 0,28 0,05 0,02 0,00 0,30 0,05 0,12 230 0,28 0,05 0,02 0,00 0,31 0,05 0,12 232 0,28 0,05 0,02 0,00 0,32 0,05 0,12 234 0,28 0,05 0,02 0,00 0,32 0,06 0,13 236 0,28 0,05 0,02 0,00 0,33 0,06 0,13 238 0,28 0,05 0,02 0,01 0,33 0,06 0,13 2021307653   16 Sep 2026 240 0,29 0,05 0,02 0,01 0,34 0,07 0,13 242 0,29 0,05 0,02 0,01 0,35 0,07 0,14 244 0,29 0,05 0,02 0,01 0,35 0,07 0,14 246 0,29 0,05 0,02 0,01 0,35 0,08 0,14 248 0,29 0,05 0,02 0,01 0,36 0,08 0,14 250 0,30 0,05 0,02 0,01 0,36 0,08 0,15 Table 38. NSCSV equivalent to the values of CSV Symmetry Level (NSCSV ) CSV SmO2% O2HHb - HHb 0O2HHb - 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01 < 0,05 > 0,001 < 0,005 > 0,01 < 0,05 Minimal > 0,05 < 0,20 > 0,005 < 0,02 > 0,05 < 0,2 Asymmetry > 0,20 > 0,02 > 0,2 - There is a Functional Factor Limitation due to Muscular Inhibition of Oxidative Capacity in the Left Rectus Femoris (RF L) because it meets the established criteria of Factor (A3) that can be determined: 1) In Table 9 and Table 10, the minimum value of |Z|SmO2% of RFL, is greater than 50% SmO2%, in the 100% of INTTL greater than or equal to UAe and less than UAna, can be observed 2) In Table 34-37, the CSV of |F|SmO2%, |F|O2HHb and |F|0O2HHb of RFL with respect to RF R is asymmetric, in all INTTL greater than or equal to UAe and less than UAna can be observed. 3) In Table 39, Table 40 and Table 41, the general trend (p)|Z|SmO2%, (p)|F|O2HHb and (p)|F|0O2HHb is symmetric in the >70% of the TMsm with respect their TMsCm, in the R-INTTL (UAmin - UAe) and (UAe - UAna) can be observed. Table 39. Values of SmO2% of the R-INTTL (UAmn- UAe)and (UAe - UAna), Coef-(p) and the equivalent symmetry level (NsCoef-(p)) TM UAmin UAe (p) Coef-(p) Symmetry UAe UAna (p) Coef-(p) Symmetry » / 0ws « / 0WS » / 0ws » / 0ws RF L 72 68 -0,06 -0,018 Min 68 55 -0,26 -0,014 Min RF R 53 46 -0,11 45 37 -0,18 VL L 76 70 -0,10 -0,002 Perf 69 56 -0,28 0,000 Perf VL R 72 64 -0,12 64 51 -0,26 ST L 76 67 -0,13 -0,003 Perf 67 52 -0,32 -0,001 Perf ST R 77 70 -0,10 70 53 -0,35 GM L 90 92 0,02 0,000 Perf 92 88 -0,07 -0,002 Perf GM R 91 93 0,02 93 90 -0,06 VI L 54 43 -0,17 -0,004 Perf 42 31 -0,23 -0,003 Perf 2021307653   16 Sep 2026 VI R 45     32   -0,20                        31     19   -0,26 GA L GA R 88     85   -0,04    nnnn             85     82   -0,06    n „nc 89     87   -0,02   -0'002   Perf       87     89    0,02    -0'195   Mm TA L TA R 46    44   -0,03    nnnn            44    35   -0,19    n nnc 56     52   -0,06   -0,009   Opt       52     45   -0,14   -0,006   Opt Min: NS Minimum; Opt: NS Optimal; Perf: NS Perfect; (Asi) NS Asymmetric Table 40. Values of O2HHb of the R-INTTL (UAmin - UAe) and (UAe - UAna), Coef-(p) and the equivalent symmetry level (NSCoef-(p)) TM UAmin UAe (P) Coef-(p) Symmetry UAe UAna (P) Coef-(p) Symmetry O2HHb O2HHb O2HHb O2HHb RF L 9,2 8,7 -0,01 -0,0002 Perf 8,66 7,03 -0,03 -0,0004 Perf RF R 6,6 6,0 -0,01 5,93 4,55 -0,03 VL L 9,1 8,5 -0,01 -0,0001 Perf 8,42 6,57 -0,04 0,0000 Perf VL R 8,6 7,9 -0,01 7,86 6,04 -0,04 ST L 9,2 8,3 -0,01 -0,0012 Min 8,28 6,07 -0,05 -0,0002 Perf ST R 9,2 8,7 -0,01 8,60 6,18 -0,05 GM L 10,9 11,1 0,00 0,0005 Opt 11,12 10,41 -0,01 -0,0007 Opt GM R 11,1 11,2 0,00 11,17 10,67 -0,01 VI L 6,6 5,5 -0,02 -0,0002 Min 5,40 3,91 -0,03 -0,0008 Opt VI R 5,5 4,1 -0,02 4,04 2,19 -0,04 GA L 10,0 10,8 0,01 0,0002 Min 10,79 9,08 -0,04 -0,0050 Asi GA R 10,5 11,2 0,01 11,18 10,26 -0,02 TA L 5,9 5,8 0,00 -0,0014 Min 5,72 4,41 -0,03 -0,0010 Opt TA R 6,8 6,5 0,00 6,46 5,49 -0,02 Min: NS Minimum; Opt: NS Optimal; Perf: NS Perfect; (Asi) NS Asymmetric Table 41. Values of 0O2HHb of the R-INTTL (UAmin - UAe) and (UAe - UAna), Coef-(p) and the equivalent symmetry level (NSCoef-(p)) TM UAmin UAe (p) Coef-(p) Symmetry UAe UAna (p) Coef-(p) Symmetry _Q I I o e _Q I I o e _Q I I o e _Q I I o e RF L 19,2 22,1 0,05 0,010 Opt 22,15 21,03 -0,02 0,00 Opt RF R 13,7 15,0 0,02 15,02 13,77 -0,03 VL L 19,1 21,6 0,04 0,001 Perf 21,62 19,66 -0,04 0,00 Opt VL R 18,1 20,1 0,03 20,05 18,20 -0,04 ST L 19,2 21,1 0,03 0,001 Pef 21,09 18,22 -0,06 0,00 Perf ST R 19,3 21,8 0,04 21,76 18,76 -0,06 GM L 22,7 28,6 0,09 0,000 Perf 28,79 30,82 0,04 0,00 Perf GM R 22,8 28,9 0,09 29,07 31,31 0,05 VI L 13,7 14,1 0,01 -0,043 Asi 14,03 11,57 -0,05 0,00 Perf VI R 11,6 10,5 -0,02 10,34 6,87 -0,07 GA L 20,9 27,5 0,10 0,000 Perf 27,63 27,28 -0,01 0,07 Opt GA R 21,9 28,6 0,10 28,72 30,65 0,04 TA L 12,3 14,6 0,04 0,000 Perf 14,58 13,32 -0,03 -0,02 Perf TA R 14,2 16,5 0,04 16,57 16,39 0,00 2021307653   16 Sep 2026 Min: NS Minimum; Opt: NS Optimal; Perf: NS Perfect; (Asi) NS Asymmetric Table 42. NSCoef-(p) equivalent to the values Coef-(p) Symmetry Level (NS Coef-(p)) Coef- (p) SmO2% O2HHb - HHb 0O2HHb- 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01   < 0,05 > 0,001  < 0,005 > 0,01  < 0,05 Minimal > 0,05   < 0,15 > 0,005  < 0,015 > 0,05  < 0,15 Asymmetry > 0,15 > 0,015 > 0,15 A.4. Neuromuscular Factor of Oxidative Capacity (Intermuscular Coordination). - In Table 9-29, the calculated value and minimum value |Z|SmO2%, |F|0O2HHb and |F|O2HHb, of all TMsm, in each INTTL greater than or equal to UAmin can be observed . - In Table 32-37, the CSV between the value of |Z|SmO2%, |F|O2HHb and |F|0O2HHb, of each TMM and his TMCM, in each INTTL greater than or equal to UAmin and less than UAna can be observed. - In Figure 52-100, (p) calculated from |Z|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb, of all TMSM, in each INTTL greater than or equal to UAe can be observed. - In Table 32-37, the values and NSCoef-(p) of (p)|Z|SmO2%, (p)|F|0O2HHb and (p)|F|O2HHb, between each TMM and his TMCM, in the R-INTTL (UAmin - UAe)and (UAe -UAna) can be observed. - The TMSM (GM L, GM R, GA L and GA R) present a Limitation of the Neuromuscular Factor of Oxidative Capacity by meeting the criteria of Factor (A.4) that can be established: 1) In Table 9 and 10, the calculated values of |Z|SmO2%of (GM L, GM R, GA L and GA R) are >65% SmO2%, in each INTTL greater than or equal to UAmin and less than UAna can be observed. 2) In Table 32-37, the general trend of (p)|y|SmO2%, (p)|y|0O2HHb and (p)|y|O2HHb, of each TMM and his TMCM is symmetrically optimal, in more than 70% of TMSM and their TMSCM, in the R-INTTL (UAmin - UAe) and (UAe - UAna) can be observed. 3) In Table 9-11 and Table 18-23, the calculated values of |Z|SmO2%, |F|0O2HHb and |F|O2HHb of (GM L, GMR, GA L and GA R) are greater than the values of |Z|SmO2%, |F|0O2HHb and |F|O2HHb, of the other TMSM, in all INTTL greater than or equal to UAmin can be observed. 2021307653   16 Sep 2026 4) In Table 9-11, the calculated values of \y\SmO2% of the TMsm, in more than 60% of the TMSM (RF L, RF R, VL R, ST L, ST R, VI L, VI R, TA L, TA R), present values <45% SmO2%, in at least one INTTL greater than or equal to UAe can be observed. B2.1. Performance factor of analytical delivery of blood flow during exercise - In Table 9-11 and Table 18-23, the calculated values of \y\SmO2%, \y\O2HHb and |F|0O2HHb of each TMM, in each INTTL greater than or equal to UAmin can be observed. - In Table 9-11 and Table 18-23, the calculated values of SmO2%, O2HHb and 0O2HHb, of the Upper Limit of the Optimal Zone \limsup\ ZonaOp) , in each INTTL greater than or equal to UAmin can be observed. - In Table 9-11 and Table 18-23, the calculated values of SmO2%, O2HHb and 0O2HHb, of the Lower Limit of the Optimal Zone \lim inf\ ZonaOp), in each INTTL greater than or equal to UAmin can be observed. - In Table 43, the type of Analytical Muscular Blood Flow Composition of each TMM, established from the criteria of Factor (B2.1) can be observed. - In Table 43, the type of Hemoglobin Delivery Volume of each TMM, established from the criteria of Factor (B2.2) can be observed. - In Table 43, the type of Blood Flow Delivery Rate of each TMM, established from the criteria of Factor (B2.3) can be observed. Table 43. Type of Performance of each TMM of factors (B2.1), (B2.2) and (B2.3), in each R- INTTL. TM Rank intensity Flow Composition Delivery Volume Delivery rate RF L UAmin - UAe UAe - UAna >UAna Optimal Optimal Optimal RF R UAmin - UAe UAe - UAna >UAna Lesser Lesser Lesser VL L UAmin - UAe UAe - UAna >UAna Optimal Optimal Optimal VL R UAmin - UAe UAe - UAna >UAna Optimal Optimal Optimal ST L UAmin - UAe UAe - UAna >UAna Optimal Optimal Optimal ST R UAmin - UAe UAe - UAna >UAna Optimal Optimal Optimal GM L UAmin - UAe UAe - UAna Excessive Lesser Lesser 2021307653   16 Sep 2026 >UAna GM R UAmin - UAe UAe - UAna >UAna Excessive Lesser Lesser UAmin - UAe VI L UAe - UAna Lesser Lesser Lesser >UAna UAmin - UAe Lesser VI R UAe - UAna >UAna Inefficient Lesser Lesser GA L UAmin - UAe UAe - UAna Excessive Lesser Lesser >UAna Higher UAmin - UAe GA R UAe - UAna Excessive Lesser Lesser >UAna UAmin - UAe TA L UAe - UAna Lesser Lesser Lesser >UAna TA R UAmin - UAe UAe - UAna Lesser Lesser Lesser >UAna Optimal Optimal Optimal B2.2. Functional sympatholysis factor of blood flow redistribution - In Table 44-46, the maximum values of SmO2%, O2HHb and 0O2HHb of each MM, in each of the rest intervals (ID) performed can be observed. - In Table 47, the highest level of symmetry (NSCSV) calculated between the combination of >70% of the maximum values of SmO2%, O2HHb and 0O2HHb, of each ID after a work interval (IT) of average INTTL greater than or equal to UAmin can be observed. Table 44. Maximum values of SmO2%, in each ID of each TMM ID RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 01 76 78 83 79 83 87 89 94 69 71 80 87 56 59 02 83 69 82 81 82 86 90 89 66 71 86 87 68 64 03 85 62 83 79 82 86 91 89 67 74 89 91 59 65 04 81 64 84 78 83 81 90 90 67 71 89 91 79 65 05 79 61 86 82 85 83 92 92 72 69 92 92 67 62 06 85 61 85 82 86 85 93 93 74 70 92 92 63 64 07 87 81 89 88 90 87 94 95 81 81 92 93 80 74 08 87 76 89 88 90 87 94 95 82 79 93 93 72 73 09 85 84 87 85 89 89 94 95 78 73 93 92 71 79 10 88 81 87 84 88 87 94 95 75 77 93 92 70 78 11 85 66 86 83 87 86 94 94 74 75 92 92 64 71 12 83 61 84 83 85 85 94 94 78 74 92 92 61 70 13 81 69 84 81 84 83 93 94 79 75 92 92 63 65 14 80 67 86 82 83 82 92 93 84 79 92 92 61 66 15 76 57 86 83 79 77 92 92 84 78 90 90 55 60 2021307653   16 Sep 2026 Table 45. Maximum values of O2HHb, in each ID of each TMM ID RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 01 9,7 9,8 10,3 9,7 10,2 11,0 10,6 11,2 8,8 9,0 9,5 10,7 7,3 7,4 02 10,7 8,6 10,1 9,9 10,1 10,8 11,0 11,1 8,4 8,9 10,4 10,8 8,8 8,1 03 11,0 7,8 10,3 9,7 10,1 10,8 11,2 11,3 8,5 9,1 10,8 11,5 7,6 8,2 04 10,4 8,0 10,4 9,6 10,3 10,0 11,1 11,3 8,5 8,7 10,8 11,5 10,2 8,1 05 10,2 7,7 10,7 10,1 10,6 10,2 11,4 11,6 9,2 8,6 11,3 11,7 8,6 7,8 06 11,1 7,7 10,6 10,1 10,7 10,5 11,6 11,9 9,4 8,7 11,2 11,7 8,1 8,0 07 11,3 10,2 11,2 11,0 11,4 10,7 11,8 11,9 10,2 10,2 11,3 11,8 10,4 9,3 08 11,3 9,6 11,1 11,0 11,3 10,8 11,5 11,8 10,4 10,0 11,4 11,8 9,3 9,1 09 11,0 10,7 10,8 10,5 11,2 11,0 11,6 11,7 9,9 9,0 11,4 11,7 9,1 9,9 10 11,5 10,2 10,8 10,4 11,1 10,7 11,6 11,7 9,5 9,5 11,4 11,7 9,0 9,8 11 11,0 8,3 10,6 10,2 10,9 10,6 11,6 11,6 9,4 9,2 11,3 11,7 8,2 8,8 12 10,7 7,7 10,4 10,2 10,6 10,5 11,5 11,6 10,0 9,2 11,3 11,7 7,9 8,7 13 10,5 8,7 10,4 10,0 10,4 10,2 11,4 11,6 10,2 9,3 11,3 11,7 8,1 8,1 14 10,3 8,4 10,8 10,2 10,3 10,0 11,3 11,5 10,9 9,9 11,3 11,6 7,8 8,2 15 9,8 7,2 10,7 10,4 9,7 9,5 11,2 11,3 10,8 9,8 10,9 11,4 7,1 7,5 Table 46. Maximum values of 0O2HHb, in each ID of each TMM ID RF L RF R VL L VL R ST L ST R GM L GM R VI L VI R GA L GA R TA L TA R 01 18,4 16,9 20,1 19,1 19,1 21,6 20,8 22,1 17,0 16,4 18,6 21,3 13,7 13,7 02 20,4 16,5 20,6 20,2 20,4 22,1 23,4 24,3 16,9 18,4 20,5 23,1 17,8 16,5 03 21,0 15,9 21,2 19,9 20,5 20,9 23,6 23,9 17,0 18,6 22,9 24,4 14,0 14,4 04 21,6 14,8 21,7 20,3 20,8 19,9 24,3 25,0 17,4 16,5 23,1 24,9 18,9 16,4 05 21,0 15,4 21,0 20,1 20,5 20,5 24,0 24,8 17,5 16,5 23,2 24,4 15,2 15,5 06 21,8 14,6 21,4 20,6 21,0 20,9 24,6 25,6 17,8 16,7 23,8 25,4 15,7 17,3 07 22,0 17,3 22,6 21,1 21,5 20,2 25,3 26,1 18,5 19,1 24,1 25,7 19,5 17,6 08 20,9 17,7 20,8 20,4 20,9 20,9 23,3 23,7 16,6 16,7 22,5 23,2 16,1 18,3 09 21,2 19,1 21,7 21,3 21,6 21,5 24,4 24,6 17,2 16,3 23,5 24,6 16,3 17,8 10 22,2 19,6 23,1 22,2 22,9 22,2 26,1 26,5 20,2 20,2 24,7 26,0 17,3 18,5 11 22,2 16,7 24,2 22,9 22,6 22,9 27,5 27,9 20,6 20,0 26,3 27,8 15,3 16,9 12 24,3 16,9 24,8 23,1 22,6 22,8 29,5 29,6 22,5 18,9 28,0 29,8 16,9 19,8 13 23,4 18,8 26,9 24,6 23,3 23,9 31,0 31,5 25,1 20,7 29,2 31,8 16,8 18,1 14 23,7 18,1 28,5 26,3 23,2 23,7 31,6 32,1 28,0 22,9 30,0 32,2 16,9 18,9 15 22,8 17,4 28,2 28,7 22,1 22,1 31,6 32,6 27,1 24,6 28,9 31,5 16,6 18,4 - In Table 47, the CSV values of the 100% of TMSM and 71% of TMSM with higher NSCSV, in addition to the type of performance of Factor (B2.2) that the cardiovascular system performs in each IT can be observed. Table 47. CSV and Performance of Factor B2.2 in each IT CSV with 100% TMM         CSV with 71 % TMM ID SmO2 O2HHb O2HHb SmO2 O2HHb O2HHb Type of Sympatholytic Performance 02 0,12 0,11 0,13 0,06 0,06 0,08 Asymmetric 03 0,14 0,14 0,17 0,07 0,07 0,09 Asymmetric 2021307653   16 Sep 2026 04 0,12 0,12 0,16 0,08 0,08 0,12 Asymmetric 05 0,14 0,14 0,17 0,09 0,09 0,12 Asymmetric 06 0,15 0,14 0,18 0,08 0,09 0,12 Asymmetric 07 0,07 0,07 0,14 0,05 0,05 0,11 Asymmetric 10 0,09 0,09 0,13 0,06 0,06 0,09 Asymmetric 11 0,13 0,12 0,19 0,07 0,07 0,11 Asymmetric 12 0,14 0,13 0,19 0,07 0,07 0,15 Asymmetric 13 0,13 0,12 0,20 0,07 0,07 0,15 Asymmetric 14 0,13 0,12 0,20 0,07 0,06 0,14 Asymmetric 15 0,16 0,15 0,21 0,08 0,07 0,15 Asymmetric B2.3. Evolution factor of analytical cardiovascular performance - In Table 44-46, the calculated maximum value of SmO2% in each ID, of each TMM can be observed. - In Table 48, the difference calculated between the maximum values of SmO2%, between the successive ID, of each TMM can be observed. - In Table 48, the type of Evolution of Delivery of Oxygen-Loaded Blood established in each TMM analyzed, between each of the successive rest intervals based on the criteria established by Factor (B2.3) can be observed: Table 48. Difference of SmO2% of each TMM between ID ID RF L 1-2 2-3 3-4 4-5 5-6 REST INTERVAL 10-11 11-12 12-13 13-14 14-15 6-7 CO ■ 8-9 9-10 -7 DS -2 M 4 AL 2 M -6 DS -2 M 0 M 2 M -3 DL 3 AL 2 M 2 M 1 M 4 AL PF P 9 7 -2 3 0 -20 5 -8 3 15 5 -8 2 10 RF R AS AS M AL M DS AL DS AL AS AL DS M AS \ / 1   । 1 -1 -1 -2 1 -4 0 2 0 1 2 0 -2 1 VL L M M M M M DL M M M M M M M M \ / l p -2 2 1 -4 0 -6 0 3 1 2 -1 2 -1 -1 VL R M M M DL M DS M AL M M M M M M CT 1 1 0 -1 -2 -1 -4 0 1 1 1 2 1 1 4 ST L M M M M M DL M M M M M M M AL CT D 1 0 5 -2 -2 -2 0 -2 2 1 1 2 1 5 ST R M M AL M M M M M M M M M M AL -1 -1 1 -2 -1 -1 0 0 0 0 0 1 1 0 GM L M M M M M M M M M M M M M M 5 0 -1 -2 -1 -2 0 0 0 1 0 0 1 1 GM R AL M M M M M M M M M M M M M \ / l 1 3 -1 0 -5 -2 -7 -1 4 3 1 -4 -1 -5 0 VI L AL M M DL M DS M AL AL M DL M DL M \ / l P 0 -3 3 2 -1 -11 2 6 -4 2 1 -1 -4 1 VI R M DL AL M M DS M AS DL M M M DL M A 1 -6 -3 0 -3 0 0 -1 0 0 1 0 0 0 2 GA L DS DL M DL M M M M M M M M M M fZA P 0 -4 0 -1 0 -1 0 1 0 0 0 0 0 2 GA R M DL M M M M M M M M M M M M TA L -12 9 -20 13 4 -17 8 1 1 6 3 -2 2 6 2021307653   16 Sep 2026 TA R DS  AS  DS  AS  AL  DS  AS  M   M  AS  AL  M   M  AS -5     -1      0      3     -2    -10     1     -6     1      7      1      5     -1     6 DL  M   M  AL  M  DS  M  DS  M  AS  M  AL  M  AS (AS) Significant increase; (AL) Slight Increase; (DL) Slight Decrease; (DS) Significant decrease; (M) Maintenance B2.4. Muscle Blood Flow Pump Factor - Venous Return - In Table 49, the calculated values of |K|ThB, in each of the Thresholds and in the maximum intensity recorded, of each TMM can be observed. - In Table 49, the values of (p)ThB of each TMM, between in the R-INTTL (UAe - UAna)and (UAe - UAna - IntMax) can be observed. - In Table 49 and Table 11, the minimum calculated values of SmO2% of each TMM can be observed. - In Table 49, the TMM that present a Limitation in the Performance Factor of the Muscle Pumping Factor for Venous Return by meeting the criteria of the Factor (B2.4) that can be observed: o The general trend of (p)ThB of TMM is [(p)>0,0005] in one of the two R-INTTL (UAe - UAna) and / or (UAe - UAna - IntMax). o The values of SmO2% of the TMM analyzed decrease to values <50% SmO2% during R-INTTL greater than or equal to UAe Table 49. Values of ThB in each Threshold and of each TMM, (p) between each threshold and the minimum value of SmO2% UAe UAna Int Work _ . «-----»___ Rank(p) ThB Min |y|SmO2% Factor B2.4 UAe - UAna >UAna RF L 12,81 12,76 12,77 -0,0009 0,0003 40 RF R 12,72 12,77 12,94 0,0008* 0,0035* 20 Limitation in >Uae VL L 12,01 12,01 12,04 0,0000 0,0007* 46 Limitation in >Uana VL R 12,07 12,04 12,15 -0,0007 0,0022* 38 Limitation in >Uana ST L 12,10 12,06 12,23 -0,0008 0,0035* 33 Limitation in >Uana ST R 11,96 12,03 12,11 0,0014* 0,0017* 38 Limitation in >Uae GM L 12,14 11,85 11,70 -0,0057 -0,0031 79 GM R 12,13 11,85 11,75 -0,0057 -0,0020 84 VI L 12,66 12,72 12,75 0,0011* 0,0006* 28 Limitation in >Uae VI R 12,60 12,67 12,70 0,0015* 0,0006* 16 Limitation in >Uae GA L 11,93 11,71 11,55 -0,0044 -0,0033 55 GA R 12,27 12,08 11,67 -0,0040 -0,0082 79 TA L 12,91 12,95 12,98 0,0008* 0,0006* 26 Limitation in >Uae TA R 12,43 12,47 12,53 0,0009* 0,0012* 38 Limitation in >UAe 2021307653   16 Sep 2026 B3. Neurovascular system B3.1. Neuromuscular Activation Factor (Intermuscular Coordination) - In Table 50, the calculated median values of de |y|SmO2%, |y|O2HHb, |y|0O2HHb, of each TMM, in each R-INTTL can be observed. - In Table 9-11 and Table 18-23, the median calculated values of |P|SmO2%, |P|O2HHb, |y|0O2HHb, of the Upper Limit of the Optimal Zone (\limsup\ ZonaOp) and the Lower Limit of the Optimal Zone (\lim inf\ ZonaOp) can be observed. - In Table 50, the Type of Neuromuscular Activation Factor performed by each TMM, in each R-INTTL, based on the criteria established in Factor (B3.1) can be observed: Table 50. Values of |y|SmO2%, |y|O2HHb, |y|0O2HHb, of each TMM, in each R-INTTL and the performance of Factor (B3.1) Range UAmin -UAe UAe-UAna >UAna TMM £ CM o E lyl02HHb JD I I CM o Activation Level Factor B3.1 £ CM o E |r|O2HHb JD I I CM o Activation Level Factor B3.1 y SmO2% |P|O2HHb JD I I CM o Activation Level Factor B3.1 RF L 71 9,0 20,9 Opt 62 7,9 21,9 Opt 49 6,2 19,4 Opt RF R 48 6,1 14,2 A 42 5,4 14,7 A 29 3,8 11,9 A VL L 74 9,0 20,7 Opt 63 7,5 21,0 Opt 50 6,0 18,4 Opt VL R 69 8,3 19,2 Opt 58 7,0 19,5 Opt 44 5,4 16,6 Opt ST L 73 8,9 20,6 Opt 60 7,3 20,1 Opt 43 5,1 16,0 Opt ST R 75 9,1 21,0 Opt 63 7,5 20,7 Opt 44 5,4 16,7 Opt GM L 91 11,1 25,7 Exc 91 10,8 30,1 Exc 84 10,0 30,8 Exc GM R 92 11,2 26,1 Exc 92 10,9 30,3 Exc 87 10,3 31,8 Exc VI L 48 6,1 14,1 37 4,6 12,9 A 28 3,6 11,3 A VI R 39 5,1 11,4 Ex 24 2,9 8,4 Ex 17 2,3 6,8 Ex GA L 87 10,6 24,3 N 85 10,1 28,0 N 72 8,4 25,6 Men GA R 88 10,9 25,2 N 89 10,8 30,1 N 83 10,1 30,8 N TA L 46 5,9 13,7 A 39 5,1 14,0 A 32 4,2 12,9 A TA R 53 6,7 15,5 A 49 6,0 16,6 A 41 5,2 16,1 Opt Optimal Zone Limits \limSup\ 81 10,0 23,1 72 8,6 23,9 56 6,7 20,6 \lim / n / | 63 7,9 18,2 50 6,1 16,9 33 4,1 12,7 2021307653   16 Sep 2026 B.3.2. Neurovascular Structural Factor (Speed and Power of Muscle Contraction) - In Table 51, the median values and standard deviation (a) of ThB of (RF R, VIR and TA L), in each work interval (IT) can be observed. - In Table 51, the minimum value of ThB of (RF R, VI R and TA L), in each of the rest intervals (ID), the average work intensity, the average pedalling cadence and the average HR of the previous IT can be observed. -   In Table 51, the calculation of the [(Median Value) - (o)], of each IT can be observed. -  There is a Limitation in the Neurovascular Structural Factor of the (RF R, VI R and TA L) during each of the work intervals, of average intensity greater than or equal to UAmin, followed by one ID, when complying the criteria established for Factor (B3.2) that can be observed Table 51. Analysis values for Performance of Factor (B3.2) > Jz RF R VI R TA L tn LU 5 o Q. LU O z LU Q < O HR 0) CD c 2 '(D C o> c ThB ThB ThB (g / dL) CT (g / dL) CT (g / dL) CT Watts Rpm ppm T 02 |V| ThB 12,68 0,073 12,60 0,035 12,97 0,040 148 34 127 |y| - a 12,61 12,65 12,93 >UAmin <UAe D 02 ThBmin 12,57 12,44 12,85 T 03 |P| ThB 12,60 0,030 12,50 0,016 12,93 0,023 150 66 122 |y| - a 12,57 12,57 12,85 >UAmin <UAe D 03 ThBmin 12,59 12,18 12,85 T 04 |P| ThB 12,67 0,043 12,58 0,015 12,93 0,028 148 84 126 |y| - a 12,63 12,60 12,90 >UAmin <UAe D 04 ThBmin 12,58 12,07 12,83 T 05 |P| ThB 12,64 0,023 12,58 0,013 12,92 0,027 148 73 124 |Y| - a 12,61 12,62 12,89 >UAmin <UAe D 05 ThBmin 12,57 12,32 12,83 T 06 |P| ThB 12,67 0,034 12,54 0,016 12,89 0,021 149 82 127 |Y| - a 12,64 12,60 12,86 >UAmin <UAe D 06 ThBmin 12,59 12,28 12,84 T 07 |P| ThB 12,64 0,037 12,56 0,015 12,90 0,019 149 78 126 |Y| - a 12,60 12,61 12,88 >UAmin <UAe D 07 ThBmin 12,49 12,20 12,80 T 10 |P| ThB 12,64 0,031 12,61 0,017 12,92 0,025 148 78 131 2021307653   16 Sep 2026 D 10 M - a ThBmin 12,61 12,54 12,48 12,14 12,89 12,85 >UAmin <UAe T 11 |P| ThB 12,68 0,038   12,66  0,014 12,93  0,024    173    77 137 M - a 12,64 12,51 12,90 >UAmin <UAe D 11 ThBmin 12,60 12,14 12,86 T 12 |P| ThB 12,69 0,040   12,68  0,030 12,92  0,018    195    77 148 M - a 12,65 12,53 12,90 >UAe <UAna D 12 ThBmin 12,62 12,28 12,83 T 13 |P| ThB 12,74 0,053   12,68  0,016 12,92  0,026    212    78 159 M - a 12,69 12,64 12,89 >UAe <UAna D 13 ThBmin 12,63 12,31 12,85 T 14 |P| ThB 12,78 0,053    12,71   0,021 12,95  0,032    245    79 169 M - a 12,73 12,64 12,92 >UAna D 14 ThBmin 12,64 12,25 12,86 T 15 |P| ThB 12,81 0,037   12,73  0,024 12,94  0,024    268    79 179 M - a 12,77 12,66 12,92 >UAna D 15 ThBmin 12,68 12,28 12,88 B3.3. Optimal Muscle Contraction Speed - In Table 52, the median values of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb of each TMM, in each muscle contraction frequency range (R-FCM), in the R-INTTL of 140-160w can be observed. - In Table 52, the difference in the median value of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb of each TMM, of each R-FCM, with respect to the highest value of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb, of all R-FCM can be observed. - In Table 52, the difference in the median value of HHb and 0HHb of each TMM, of each R-FCM, with respect to the lowest value of HHb and 0HHb, of all R-FCM can be observed. - The following R-FCM are optimal because meeting the criteria established for Factor (B3.3) that can be established: o R- FCM Optimal: 79-80 Rpm o R-FCM Optimal: 81-82 Rpm Table 52. Median value of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb, of each R-FCM, of each TMM, in the R-INTTL of 140-160w. U- -10^-1^-00^-,^^^-1^ O O-LL-I_1^5^^^ — <<<< oror>><z>OT00>>00HH SmO2% 2021307653   16 Sep 2026 71-72 72 -1,5 50 -3,0 73 -4,0 70 -2,0 70 -7,0 77 0,0 88 -4,0 88 -6,0 51 -1,0 44 0,0 84 -5,0 85 -5,0 48 -1,0 52 -4,0 73-74 72 51 74 70 74 76 89 90 50 44 87 88 48 54 -1,5 -2,0 -3,0 -2,0 -3,0 -1,0 -3,0 -4,0 -2,0 0,0 -2,0 -2,0 -1,0 -2,0 75-76 72 52 74 70 75 75 89 90 51 44 88 88 47 54 -1,0 -1,5 -3,0 -2,0 -2,0 -1,8 -3,0 -4,0 -1,0 0,0 -1,0 -2,0 -2,0 -1,8 77-78 72 52 74 71 75 76 89 90 50 44 88 89 48 56 -1,0 -1,0 -3,0 -1,0 -2,0 -1,0 -3,0 -4,0 -2,0 0,0 -1,0 -1,0 -1,0 0,0 79-80 73 53 76 72 77 76 91 93 52 43 88 90 47 56 0,0 0,0 -1,0 0,0 0,0 -1,0 -1,0 -1,0 0,0 -1,0 -1,0 0,0 -1,8 0,0 81-82 72 52 77 72 77 77 92 94 51 43 88 90 48 56 -1,0 -1,0 0,0 0,0 0,0 0,0 0,0 0,0 -1,0 -1,0 -1,0 0,0 -1,5 0,0 83-84 72 50 74 71 76 75 90 91 49 43 88 89 48 55 -1,0 -3,5 -3,0 -1,5 -1,0 -2,5 -2,0 -3,0 -3,0 -1,0 -1,0 -1,0 -1,0 -1,0 85-86 72 49 74 70 77 74 90 91 50 43 89 89 49 55 -1,0 -4,0 -3,0 -2,0 -0,5 -3,0 -2,0 -3,0 -2,5 -1,0 0,0 -1,0 0,0 -1,3 87-88 72 48 74 70 73 73 88 90 50 43 86 88 48 54 -1,0 -5,5 -3,5 -2,0 -4,0 -4,0 -4,0 -4,5 -2,0 -1,5 -3,0 -2,0 -1,0 -2,0 89-90 71 48 73 68 72 72 88 89 49 41 84 86 47 54 -2,5 -5,0 -4,0 -4,0 -5,0 -5,0 -4,0 -5,0 -3,0 -3,0 -5,0 -4,0 -2,5 -2,0 91-92 71 49 73 68 72 72 88 89 49 42 84 86 45 53 -2,0 -4,0 -4,0 -4,0 -5,0 -5,0 -4,0 -5,0 -3,0 -2,0 -5,5 -4,0 -3,8 -3,0 93-94 71 50 72 67 71 73 88 88 50 44 82 84 47 53 -2,0 -3,0 -5,0 -5,0 -6,0 -4,0 -4,0 -6,0 -2,0 0,0 -7,0 -6,0 -2,5 -3,0 95-96 69 49 69 66 67 77 85 88 50 44 71 82 45 51 -4,0 -4,0 -8,0 -6,0 -10 0,0 -7,0    -6,0 O2HHb -2,0 0,0 -18 -8,0 -3,8 -5,0 71-72 9,2 6,0 8,8 8,5 8,5 9,2 10,7 10,8 6,4 5,0 9,9 10,2 6,2 6,5 -0,2 -0,7 -0,4 -0,3 -0,9 -0,1 -0,5 -0,6 -0,1 -0,6 -0,7 -0,8 -0,1 -0,5 73-74 9,2 6,1 9,0 8,5 9,0 9,2 10,9 11,1 6,3 5,6 10,3 10,7 6,2 6,7 -0,2 -0,6 -0,3 -0,3 -0,4 -0,1 -0,3 -0,4 -0,2 0,0 -0,3 -0,4 -0,1 -0,2 75-76 9,2 6,5 9,0 8,5 9,1 9,1 10,9 11,1 6,4 5,5 10,5 10,8 6,1 6,8 -0,1 -0,2 -0,3 -0,2 -0,3 -0,2 -0,3 -0,4 -0,1 0,0 -0,1 -0,3 -0,2 -0,2 77-78 9,2 6,6 9,0 8,6 9,2 9,1 10,9 11,2 6,3 5,6 10,5 10,9 6,2 6,9 -0,1 -0,1 -0,3 -0,1 -0,3 -0,1 -0,3 -0,3 -0,2 0,0 -0,1 -0,1 -0,1 0,0 79-80 9,4 6,7 9,2 8,7 9,4 9,2 11,1 11,4 6,5 5,4 10,5 11,1 6,1 6,9 0,0 0,0 -0,1 0,0 0,0 -0,1 -0,1 0,0 0,0 -0,2 -0,1 0,0 -0,2 0,0 81-82 9,3 6,6 9,3 8,7 9,4 9,3 11,2 11,4 6,4 5,3 10,5 11,1 6,1 6,9 -0,1 -0,1 0,0 0,0 0,0 0,0 0,0 0,0 -0,1 -0,3 -0,1 0,0 -0,2 0,0 83-84 9,2 6,3 9,0 8,5 9,3 9,0 11,0 11,3 6,2 5,4 10,5 10,9 6,2 6,8 -0,1 -0,4 -0,3 -0,2 -0,1 -0,3 -0,2 -0,2 -0,4 -0,1 -0,1 -0,1 -0,1 -0,1 85-86 9,2 6,2 8,9 8,5 9,3 8,9 11,0 11,2 6,2 5,4 10,6 10,9 6,3 6,8 -0,1 -0,5 -0,3 -0,3 -0,1 -0,4 -0,2 -0,2 -0,3 -0,1 0,0 -0,1 0,0 -0,1 87-88 9,2 6,0 8,9 8,5 8,9 8,7 10,7 11,0 6,3 5,4 10,2 10,7 6,2 6,7 -0,1 -0,7 -0,4 -0,3 -0,6 -0,5 -0,5 -0,4 -0,3 -0,2 -0,4 -0,3 -0,1 -0,2 89-90 9,0 6,1 8,8 8,2 8,7 8,7 10,7 10,9 6,2 5,2 9,9 10,4 6,0 6,7 -0,3 -0,6 -0,4 -0,5 -0,7 -0,6 -0,5 -0,5 -0,4 -0,4 -0,7 -0,6 -0,3 -0,2 91-92 9,1 6,2 8,9 8,2 8,7 8,7 10,7 10,9 6,2 5,3 9,8 10,4 5,9 6,6 -0,3 -0,5 -0,4 -0,5 -0,7 -0,6 -0,5 -0,5 -0,4 -0,3 -0,8 -0,7 -0,5 -0,3 93-94 9,1 6,3 8,7 8,1 8,6 8,8 10,7 10,7 6,3 5,0 9,6 10,1 6,0 6,6 -0,3 -0,4 -0,6 -0,6 -0,8 -0,5 -0,5 -0,7 -0,2 -0,6 -1,0 -1,0 -0,3 -0,3 95-96 8,8 6,2 8,4 8,0 8,1 8,7 10,3 10,7 6,3 5,0 8,3 9,8 5,9 6,4 -0,5 -0,5 -0,9 -0,8 -1,3 -0,6 -0,9 HHb -0,7 -0,2 -0,6 -2,3 -1,3 -0,5 -0,6 71-72 3,7 6,2 3,3 3,6 3,6 2,8 1,5 1,5 6,1 7,1 1,9 1,8 6,7 6,0 0,2 0,3 0,5 0,2 0,8 0,0 0,5 0,7 0,1 0,0 0,6 0,6 0,1 0,5 73-74 3,7 6,1 3,2 3,6 3,2 2,9 1,3 1,2 6,3 7,1 1,5 1,5 6,7 5,7 0,2 0,2 0,4 0,2 0,4 0,1 0,4 0,5 0,2 0,0 0,2 0,2 0,1 0,3 75-76 3,6 6,1 3,2 3,6 3,0 3,0 1,3 1,2 6,2 7,1 1,4 1,5 6,9 5,7 0,1 0,2 0,4 0,2 0,2 0,2 0,4 0,5 0,1 0,0 0,1 0,2 0,3 0,2 77-78 3,6 6,1 3,2 3,5 3,0 2,9 1,3 1,2 6,3 7,1 1,4 1,4 6,7 5,5 0,1 0,1 0,4 0,1 0,2 0,1 0,4 0,5 0,2 0,0 0,1 0,1 0,1 0,0 79-80 3,5 5,9 2,9 3,4 2,8 2,9 1,1 0,9 6,1 7,1 1,4 1,2 6,8 5,5 0,0 0,0 0,1 0,0 0,0 0,1 0,1 0,1 0,0 0,1 0,1 0,0 0,2 0,0 81-82 3,6 6,1 2,8 3,4 2,8 2,8 1,0 0,7 6,2 7,3 1,4 1,2 6,8 5,5 0,1 0,1 0,0 0,0 0,0 0,0 0,0 0,0 0,1 0,2 0,1 0,0 0,2 0,0 83-84 3,6 6,4 3,1 3,6 2,9 3,1 1,2 1,1 6,4 7,2 1,4 1,3 6,7 5,6 0,1 0,4 0,4 0,2 0,1 0,3 0,2 0,4 0,3 0,1 0,1 0,1 0,1 0,1 85-86 3,6 6,5 3,1 3,6 2,9 3,1 1,2 1,1 6,3 7,2 1,3 1,3 6,6 5,6 2021307653   16 Sep 2026 0,1 0,5 0,4 0,2 0,1 0,3 0,2 0,4 0,3 0,1 0,0 0,1 0,0 0,2 87-88 3,6 6,7 3,2 3,6 3,3 3,3 1,5 1,3 6,3 7,3 1,7 1,5 6,7 5,7 0,1 0,7 0,4 0,2 0,5 0,5 0,5 0,6 0,2 0,2 0,3 0,2 0,1 0,3 89-90 3,8 6,6 3,3 3,9 3,4 3,4 1,5 1,3 6,4 7,5 1,9 1,7 6,9 5,7 0,3 0,6 0,5 0,5 0,6 0,6 0,5 0,6 0,4 0,4 0,6 0,5 0,3 0,3 91-92 3,7 6,5 3,3 3,9 3,4 3,4 1,5 1,4 6,4 7,3 1,9 1,7 7,1 5,9 0,3 0,5 0,5 0,5 0,6 0,6 0,5 0,6 0,4 0,3 0,6 0,5 0,5 0,4 93-94 3,7 6,3 3,4 4,0 3,5 3,3 1,5 1,5 6,3 7,1 2,1 1,9 6,9 5,9 0,2 0,4 0,6 0,6 0,7 0,5 0,5 0,7 0,2 0,0 0,8 0,7 0,3 0,4 95-96 4,0 6,5 3,8 4,1 4,0 3,3 1,8 1,5 6,3 7,2 3,4 2,1 7,1 6,1 0,5 0,5 1,0 0,7 1,2 0,5 0,8    0,7 $O2HHb 0,2 0,1 2,1 0,9 0,5 0,7 71-72 19,2 14,6 18,7 17,7 18,0 19,8 22,6 22,9 13,4 11,7 21,0 21,6 13,0 13,6 -1,4 -0,3 -1,7 -1,8 -3,0 -0,6 -2,1 -2,5 -0,9 -0,2 -2,4 -2,8 -0,9 -1,7 73-74 19,4 14,3 18,7 17,8 19,1 19,2 23,0 23,4 13,2 11,7 21,6 22,7 12,8 14,5 -1,2 -0,5 -1,7 -1,7 -1,9 -1,2 -1,7 -2,0 -1,1 -0,2 -1,8 -1,7 -1,1 -0,8 75-76 19,5 13,8 19,0 18,1 19,3 19,1 23,0 23,4 13,5 11,7 22,0 22,7 12,9 14,4 -1,1 -1,0 -1,4 -1,4 -1,7 -1,3 -1,7 -2,0 -0,9 -0,2 -1,4 -1,7 -1,0 -0,9 77-78 19,7 13,9 19,0 18,2 19,6 19,5 23,1 23,8 13,5 11,8 22,2 23,1 13,3 14,8 -0,9 -0,9 -1,4 -1,2 -1,4 -0,9 -1,6 -1,6 -0,9 -0,1 -1,2 -1,3 -0,6 -0,6 79-80 20,6 14,8 19,9 19,1 20,7 20,0 24,2 25,2 14,3 11,9 23,1 24,2 13,5 15,3 0,0 0,0 -0,5 -0,4 -0,3 -0,4 -0,5 -0,2 -0,1 0,0 -0,3 -0,2 -0,4 0,0 81-82 20,5 14,6 20,4 19,5 21,0 20,4 24,7 25,4 14,3 11,8 23,4 24,4 13,7 15,3 -0,1 -0,2 0,0 0,0 0,0 0,0 0,0 0,0 0,0 -0,1 0,0 0,0 -0,2 0,0 83-84 20,0 13,5 19,4 18,5 20,2 19,5 24,0 24,7 13,5 11,8 23,0 23,8 13,6 14,9 -0,5 -1,3 -1,0 -1,0 -0,7 -0,9 -0,7 -0,7 -0,8 -0,1 -0,4 -0,6 -0,3 -0,4 85-86 20,2 13,6 19,5 18,6 20,3 19,6 24,0 24,5 13,5 11,8 23,0 23,9 13,9 14,8 -0,4 -1,2 -0,9 -0,9 -0,6 -0,8 -0,7 -0,9 -0,8 -0,1 -0,4 -0,5 0,0 -0,5 87-88 20,1 13,2 19,4 18,3 19,4 19,1 23,8 24,1 13,8 11,7 22,8 23,4 13,5 14,6 -0,4 -1,6 -1,0 -1,2 -1,5 -1,3 -0,9 -1,3 -0,6 -0,2 -0,6 -1,0 -0,4 -0,7 89-90 19,7 13,3 19,2 17,9 18,9 18,7 23,4 23,8 13,5 11,2 21,5 22,7 13,0 14,5 -0,9 -1,5 -1,2 -1,6 -2,0 -1,7 -1,3 -1,6 -0,8 -0,7 -2,0 -1,7 -0,9 -0,8 91-92 19,7 13,4 19,3 18,0 18,9 18,8 23,3 23,8 13,4 11,6 21,3 22,8 12,9 14,3 -0,8 -1,5 -1,1 -1,4 -2,0 -1,6 -1,4 -1,5 -0,9 -0,4 -2,1 -1,6 -1,0 -1,0 93-94 19,7 13,7 18,9 17,4 18,5 19,1 23,1 23,4 13,7 11,4 20,8 21,9 13,1 14,3 -0,9 -1,1 -1,5 -2,0 -2,4 -1,3 -1,6 -2,0 -0,6 -0,5 -2,6 -2,5 -0,8 -1,0 95-96 19,1 13,6 18,3 17,4 17,7 19,1 22,4 23,4 13,9 11,2 18,1 21,3 12,8 13,8 -1,5 -1,2 -2,1 -2,1 -3,3 -1,3 -2,3    -2,0 $HHb -0,5 -0,7 -5,3 -3,0 -1,1 -1,5 71-72 7,7 13,0 7,0 7,7 7,6 6,4 3,1 3,0 13,4 15,5 3,9 3,8 14,6 12,6 0,1 0,1 0,7 0,3 1,6 0,2 0,8 1,3 0,2 0,2 0,9 1,0 0,2 0,7 73-74 7,7 13,0 6,8 7,7 6,7 6,3 2,8 2,6 13,3 15,4 3,4 3,1 14,6 12,1 0,0 0,1 0,6 0,3 0,6 0,1 0,6 0,9 0,1 0,1 0,4 0,3 0,2 0,3 75-76 7,7 13,0 6,7 7,7 6,4 6,3 2,8 2,6 13,3 15,4 3,1 3,1 14,7 12,1 0,1 0,1 0,5 0,3 0,4 0,1 0,6 0,9 0,1 0,1 0,2 0,3 0,3 0,2 77-78 7,7 12,9 6,7 7,6 6,4 6,3 2,8 2,6 13,2 15,3 3,1 2,9 14,5 11,9 0,1 0,0 0,5 0,2 0,4 0,0 0,6 0,9 0,0 0,0 0,2 0,1 0,1 0,0 79-80 7,7 13,0 6,2 7,4 6,0 6,2 2,4 1,8 13,4 15,4 3,1 2,8 14,7 12,0 0,0 0,1 0,0 0,0 0,0 0,0 0,2 0,2 0,2 0,1 0,1 0,0 0,3 0,1 81-82 7,9 13,4 6,3 7,4 6,1 6,2 2,2 1,7 13,8 15,4 3,1 2,8 14,7 12,2 0,2 0,5 0,1 0,0 0,1 0,0 0,0 0,0 0,6 0,1 0,1 0,0 0,3 0,3 83-84 8,0 13,9 6,9 7,8 6,3 6,7 2,7 2,3 13,8 15,6 3,1 2,9 14,7 12,2 0,3 1,0 0,7 0,5 0,3 0,4 0,4 0,7 0,6 0,3 0,2 0,2 0,3 0,3 85-86 7,9 14,2 6,9 7,9 6,2 6,7 2,7 2,4 13,9 15,8 2,9 2,9 14,4 12,3 0,2 1,3 0,7 0,5 0,2 0,5 0,5 0,7 0,6 0,5 0,0 0,2 0,0 0,4 87-88 7,8 14,5 7,0 8,1 7,3 7,2 3,1 2,9 13,8 16,0 3,7 3,1 14,8 12,5 0,2 1,6 0,8 0,7 1,3 1,0 0,9 1,2 0,6 0,7 0,8 0,3 0,4 0,6 89-90 8,2 14,2 7,1 8,5 7,4 7,4 3,2 2,9 13,8 16,1 4,2 3,7 15,1 12,6 0,6 1,3 0,9 1,1 1,4 1,2 1,0 1,3 0,5 0,8 1,3 0,9 0,7 0,7 91-92 8,1 14,0 7,0 8,5 7,4 7,4 3,2 3,0 14,0 16,1 4,2 3,7 15,4 12,7 0,5 1,1 0,8 1,1 1,4 1,1 1,0 1,3 0,8 0,8 1,3 1,0 1,0 0,8 93-94 8,2 13,8 7,3 8,8 7,7 7,1 3,2 3,2 13,7 16,1 4,6 4,2 15,1 12,8 0,5 0,9 1,1 1,4 1,6 0,9 1,0 1,5 0,5 0,8 1,7 1,4 0,7 0,9 95-96 8,6 14,3 8,1 9,0 8,8 7,1 4,0 3,2 13,8 16,1 7,4 4,7 15,4 13,4 0,9 1,4 1,9 1,6 2,7 0,9 1,8 1,5 0,5 0,8 4,4 1,9 1,0 1,5 2021307653   16 Sep 2026 The following muscle performance factors do not meet the criteria established by each factor to determine that any TMM or all of them develop at least one limitation of said factors: A1. Structural Factor of Oxidative Capacity A2. Functional Factor of Oxidative Capacity by General Fatigue B1.1. Pulmonary Structural Factor B1.2. Pulmonary Functional Factor B2.1. Analytical Blood Flow Delivery Performance Factor)

Claims

1. Monitoring and evaluation method of the physical performance of a subject that includes the stages of:a. providing two or more Near-Infrared Spectroscopy sensors (NIRS), a cardiac monitoring device, an activity monitoring device and a locomotor work intensity device or monitor;b. placing or adhering the NIRS sensors on the muscle tissues (TM) to be evaluated, placing the cardiac monitoring device on the subject's chest, and placing the activity monitoring device and the locomotor work intensity device or monitor;c. starting data recording of all the devices , minimally from the start of the locomotive activity evaluated and sending it to a data processing system;d. recording, through the data processing system, the data captured, during the development of at least one Cyclical Locomotive-Physical Activity (AFC), where:- the Monitored Cyclical Physical Activity (AFCM) is continuous or interval,- the activity monitoring device records the entire time scale from the beginning to the end of the AFCM, including the multiple intervals of work and / or rest if performed,- the recording frequency of the data for each device is less than 6 seconds,- the AFCM is stable, incremental, decreasing, variable locomotor intensity or a combination of the above,- the AFCM includes a period of previous warm-up,- if the AFCM does not include at least one Rest interval (ID), the data recording will end 1 minute after the AFC ceases and that minute will be counted as an ID,- the Locomotor Work Intensity (INTTL) or the average Locomotor Work Intensity Range (R-INTTL) is greater than or equal to the Minimum Activation Threshold (UAmin);e. obtaining at least the following monitored data from all devices with their respective temporary registration:- Muscular Oxygen Saturation (SmO2% - %) and Absolute Capillary Hemoglobin (ThB - g / dL) of each of the monitored muscle tissues (TMM) that participate in AFCM, through NIRS devices,- Heart rate (HR - bpm), through the cardiac monitoring device,- Power (Watts), Running Speed (Km / h), through the locomotor work intensity device or monitor,2021307653   16 Sep 2026- time record or timescale of the AFCM, with all the time records of the start or end of AFCM, and the start and end of the different intervals developed during the AFCM, through the activity monitoring device,- cadence (rpm) or acceleration, through external locomotor performance devices and / or monitors,- analysis of metabolic gases (VO2 / CO2), lactate measurements, and data from thermographic cameras, using physiological locomotor performance devices and / or monitors;f. synchronizing, linking and joining the data obtained in a single time scale of joint data from the time record scale collected by the activity monitoring device during the AFCM and the time record of each device, through the data processing system;g. calculating, through the data processing system, at least the following values for each Monitored Muscle Tissue (TMM) that participates in the AFCM from the recorded data of SmO2% and ThB of:Oxygen-Charged Capillary Hemoglobin - g / dL (O2HHb), through the formula:% (SmO2) * g / dL (ThB) = g / dL (O2HHb)Oxygen Discharged Capillary Hemoglobin - g / dL (HHb), through the formula:g / dL (ThB) - g / dL (O2HHb) = g / dL (HHb)Muscle Blood Flow of Muscle Hemoglobin - g / dL / s (0ThB), through the formula: [g / dL (ThB) * (HR)] / 60 = g / dL / seg ($ThB)Muscular Blood Flow of Oxygen Charged Hemoglobin - g / dL / s (0O2HHb), through the formula:[g / dL (O2HHb) * (HR)] / 60 = g / dL / seg (0O2HHb)Muscular Blood Flow of Oxygen Discharged Hemoglobin - g / dL / s (0HHb), through the formula[g / dL (HHb) * (HR)] / 60 = g / dL / seg ($HHb)h. filtering and excluding, through the data processing system, the data obtained erroneously and / or due to registration error by devices during AFCM;i. filtering and excluding, through the processing system, the values that are not within the following ranges, as well as the data obtained from the calculation of any of them:-  SmO2% [Between 1% SmO2 and 99% SmO2]- ThB [Between 9.5 g / dL and 14,9 g / dL]- HR [Between 40bpm and 230bpm];j. filtering and excluding, through the processing system, the values that present a difference greater than that established in the following parameters between the temporary records of the analyzed value with respect to the previous value and the2021307653   16 Sep 2026temporally subsequent value, as well as all the data obtained from the calculation of any of them:- Difference of SmO2% [> ±10% SmO2%]- Difference of ThB [> ±0.3 g / dL]- Difference of HR [> ±7bpm].

2. Evaluation and monitoring method according to claim 1, which further comprises the steps of:k. filtering and excluding all values obtained, calculated and / or recorded during all ID or without AFC,l. filtering and excluding all values obtained, calculated and / or recorded during the first minute of each work interval (IT),m. filtering and excluding all values obtained, calculated and / or registered when the value of the INTTL or R-INTTL in the same temporary register is equivalent to “0”,n. filtering and excluding all the values obtained, calculated and / or registered when the value of Muscle Contraction Frequency (FCM) or Muscle Contraction Frequency Range (R-FCM) in the same time register is equivalent to "0",o. selecting and performing one of the following procedures:- a first procedure comprising the steps of:o calculating the statistical median value (Y) of the values SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, 0HHb of each TMM, during AFCM, in each registered Locomotor Work Intensity (INTTL) or in each Intensity Range of Locomotor Work (R-INTTL), that participates in the AFCM;o calculating and establishing the Trend Line (LinTrend) of the median values (Y -INTTL) or (Y - R-INTTL) obtained from YSmO2%, YThB, Y0ThB, YO2HHb, Y 0O2HHb, Y HHb and Y 0HHb, in each TMM;- a second procedure comprising the steps of: _o calculating the statistical average value (Y) of the values of SmO2%, ThB, 0ThB, O2HHb, 0O2HHb, HHb, $HHb, of each TMM, during AFCM, in each INTTL or R- INTTL, registered during the AFCM;o calculating and establishing the LinTrend of the average values (Y-INTTL) or (Y-R-INTTL) obtained from Y SmO2%, Y ThB, Y$ThB, YO2HHb, Y^HHb, Y HHb and Y 0HHb, in each TMM;- a third procedure comprising a step of:2021307653   16 Sep 2026o calculating and establishing the LinTrend (Value / INTTL) or (Value / R-INTTL), from all filtered values of SmO2%, ThB, $ThB, O2HHb, 0O2HHb, HHb, $HHb, in each TMM;p. calculating all values of LinTrend |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|0HHb, of each TMM, for each INTTL or R- INTTL;q. calculating the Slope (p) between each of the values of |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, | / |0O2HHb, |Y|HHb and |Y|$HHb, from each TMM;r. calculating, analyzing and determining all the trend changes of (p) in each of the LinTrend, of all the values |Y|SmO2%, |Y|ThB, |Y|$ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|0HHb, of each TMM;s. calculating, analyzing and establishing between which two values of INTTL or R- INTTL occurs the 1st, 2nd and 3rd Change in each TMM of the trend of the slope (p) of each LinTrend, through the combining at least 4 of the 7 possible (p) changes of |Y|SmO2%, |Y|ThB, |Y|0ThB, |Y|O2HHb, |Y|0O2HHb, |Y|HHb and |Y|$HHb;t. establishing the Physiological Thresholds of each TMM equivalent to the trend changes:1st Change (p)      2nd Change (p)      3rd Change (p)UAmin Individual                  UAe Individual                   UAna IndividualRank|X| (Watts)       Rank|X| (Watts)       Rank|X| (Watts)TMM       |X| (Watts)            |X| (Watts)            |X| (Watts)u. establishing the INTTL or R- INTTL of the General Physiological Thresholds from the median of the values of the individual thresholds of all TMSM:1st General         2nd General         3rd GeneralChange (p)         Change (p)         Change (p)UAmin                   UAe                    UAnaRank|X| (Watts)      Rank|X| (Watts)      Rank|X| (Watts)TMM       |X| (Watts)           |X| (Watts)           |X| (Watts)3. Monitoring and evaluation method according to claim 2, further comprising the steps of:- calculating, analyzing and determining the CSV, between at least two sets of values |Y|SmO2%,  |Y|ThB,  |Y|0ThB, |Y|O2HHb,  |Y|0O2HHb,  |Y|HHb or  |Y|$HHb,established between two determined INTTL or R- INTTL, between at least twodetermined TMSM:Standard Deviation (o) of the values of \YIA verage of the values of |Y|2021307653   16 Sep 2026- establishing the Symmetry Level (NSCSV) from the CSV value calculated from the values |y|SmO2%, |y|ThB, |y|$ThB, |y|O2HHb, |y|0O2HHb, |y|HHb or |y|$HHb, between two INTTL or two R- INTTL determined, between at least two TMSM determined:- establishing the Symmetry Level (NSCSV) from the CSV value, where:Symmetry Level (NSCSV ) CSV SmO2% O2HHb - HHb 0O2HHb - 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01 < 0,05 > 0,001 < 0,005 > 0,01 < 0,05 Minimal > 0,05 < 0,20 > 0,005 < 0,02 > 0,05 < 0,2 Asymmetry > 0,20 > 0,02 > 0,2- calculating, analyzing and determining the slope-trend (p) |y| of at least |y|SmO2%, |y|O2HHb, |y|0O2HHb, |y|HHb and / or |y|0HHb, between two INTTL or two R-INTTL, of at least two TMSM:^-^1(P)   |X|2-|X|1where (p) is the slope-trend; |Y| 1 the determined value of SmO2%, O2HHb, 0O2HHb, HHb o 0HHb, of the first LNTTL or R-INTTL and |Y|2 of the second INTTL or R-INTTL; |X| 1 is the first LNTTL or R-INTTL and |X| 2 the second INTTL or R-INTTL;- calculating, analyzing and establishing the Coef-(p) of (p)|y|SmO2%, (p)|y|O2HHb, (p)|y|0O2HHb, (p)|y|HHb and / or (p)|y|0HHb between two INTTL or two R-INTTL, of one TMM determined with respect to the trend of (p)|y|SmO2%, (p)|y|O2HHb,(p)|y|0O2HHb, (p)|y|HHb and / or (p)|y|0HHb of another TMM or a set of values trends of (p)|y|SmO2%, (p)|y|O2HHb, (p)|y|0O2HHb, (p)|y|HHb and / or (p)|y|0HHb of two or more TMSM:_ _ *-------* *-------*. . _ *---------*.Coef- (p) = [(p)|y|] - [(pi)|y|]wherein (p)|y| is the median slope-trends of the compared TMsm and (p1)|y| is the slope-trend of the analyzed TMM;- establishing the Symmetry Level (NS Coef-(p)) from the calculated value of Coef-(p) (p)|y|SmO2%, (p)|y|O2HHb, (p)|y|0O2HHb, (p)|y|HHb o (p)|y|0HHb of the analyzed TMM:2021307653   16 Sep 2026Symmetry Level (NS Coef-(p)) Coef- (p) SmO2% O2HHb - HHb 0O2HHb- 0HHb Perfect < 0,01 < 0,001 < 0,01 Optimum > 0,01   < 0,05 > 0,001  < 0,005 > 0,01  < 0,05 Minimal > 0,05   < 0,15 > 0,005  < 0,015 > 0,05  < 0,15 Asymmetry > 0,15 > 0,015 > 0,154. Monitoring and evaluation method according to claims 2 and 3, further comprising the steps of:- evaluating the value of | / |SmO2% in each INTTL or R-INTTL, INTTL greater than or equal to UAmin and less than or equal to UAna;- calculating, comparing, evaluating and establishing the Coefficient of Symmetry between Values (CSV) and the Level of Symmetry (NScsv) between | / |SmO2%, | / |O2HHb and | / |0O2HHb of each TMM and his Contralateral Muscle Tissue Monitored (TMCM), in each INTTL or R-INTTL INTTL greater than or equal to UAmin and less than or equal to UAna;- calculating, comparing and evaluating the General Trend of the Values (TGV [(p)]) | / |SmO2%, | / |0O2HHb and | / |O2HHb, of all TMsm, in the R-INTTL (UAmin - UAe) and (UAe - UAna);- calculating, comparing and establishing the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, between the combination of at least 70-75% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna);- determining that the following criteria are met to establish a limitation in a structural factor of oxidative capacity (A1):1) the value of | / |SmO2% in each INTTL or R-INTTL INTTL greater or equal than UAmin and less than or equal to UAna, is >70% SmO2%, in at least 70-75% of TMsM;2) the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb of each TMM and TMCM, have at least one optimal symmetry, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna, in at least the 70-75% of TMSM;3) the TGV of de (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is symmetric between the combination of at least 70-75% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna);4) the TGV of de (p)|y|SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is symmetric between each TMM and his TMCM, in at least 80-85% of TMSM, in the R-INTTL (UAmin - UAe) and (UAe - UAna).2021307653   16 Sep 20265. Monitoring and evaluation method according to any of claims 2 to 4, wherein in addition to comprising steps f) to u), also comprises the steps of:- evaluating the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating and evaluating the difference of SmO2% between the value of | / |SmO2% of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin;- comparing, evaluating and determining the CSV and NSCSV between the values of | / |SmO2%, | / |0O2HHb and | / |O2HHb of each TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, comparing and evaluating the TGV [(p) of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna);- calculating, comparing and establishing the lowest value of Coef-(p) and the equivalent NSCoef-(p) of (p)|y|SmO2%, (p)| / |0O2HHb and (p)|y|O2HHb, between the combination of at least 50-55% of the TMSM, in the R-INTTL (UAmin- UAe) and (UAe - UAna);- determining that the following criteria are met to establish a limitation in a functional factor of oxidative capacity by general fatigue (A2):1) the difference between the value of | / |SmO2% of each TMM and his TMCM is >5% SmO2%, in the 95% of INTTL or R-INTTL greater than or equal to UAmin, in at least the 70-75% of TMSM;2) the value of | / |SmO2% is >55% SmO2%, in the 80% of TMsm, in each INTTL or R-INTTL greater than or equal to UAmin and less than or equal to UAna;3) the values of | / |SmO2%, | / |O2HHb and | / |0O2HHb are asymmetric in at least the 50% of INTTL or R-INTTL greater than or equal to UAmin, between one TMM and his TMCM, in at least the 70 -75% of TMSM;4) the TGV of de (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is asymmetric between the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin -UAe) and (UAe - UAna).

6. Monitoring and evaluation method according to any of claims 2 to 5, further comprising the steps of:- evaluating the value of | / |SmO2% of at least one TMM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculate, comparing and evaluating the value of | / |SmO2%, | / |O2HHb and | / |0O2HHb of at least one TMM with the values of his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin;2021307653   16 Sep 2026- calculating, evaluating and determining the value of CSV and NSCSV of | / |SmO2%, | / |0O2HHb and | / |O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, comparing and evaluating the TGV [(p)] of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna);- calculating, evaluating and determining the lowest value of Coef- (p) and the equivalent NSCoef-p between the values of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, of at least the combination of the 50-55% TMSM;- determining that the following criteria are met to establish a limitation on a functional factor of oxidative capacity by muscle inhibition (A3):1) the value of | / |SmO2% is >50% SmO2% in the TMM analyzed, in the 95% of INTTL or R-INTTL greater than or equal to UAmin;2) the values of | / |SmO2%, | / |O2HHb | / |y 0O2HHb of the TMM analyzed are greater than the values of his TMCM, in the 95% of INTTL or R-INTTL greater than or equal to UAmin;3) the TGV of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is asymmetric between the TMM analyzed and his TMCM, in the R-INTTL (UAmin - UAe) and (UAe -UAna);4) the TGV of (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb is symmetricbetween the combination of at least the 50-55% of TMSM, in the R-INTTL (UAmin -UAe) and (UAe - UAna).

7. Monitoring and evaluation method according to any of claims 2 to 6, further comprising the steps of:- evaluating the value of | / |SmO2%, | / |0O2HHb and | / |O2HHb, of each TMM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, evaluating and determining the value of CSV and the equivalent NSCSV of de | / |SmO2%, | / |0O2HHb and | / |O2HHb, of at least one TMM and his TMCM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, comparing and evaluating the TGV [(p)]) of | / |SmO2%, | / |0O2HHb and | / |O2HHb of all TMsm, in the R-INTTL (UAmn- UAe) and (UAe - UAna);- calculating, evaluating and determining Coef-(p) and the equivalent NSCoef-(p) between the values (p)| / |SmO2%, (p)| / |0O2HHb and (p)| / |O2HHb, of each TMM and his TMCM, in the R-INTTL (UAmin- UAe) and (UAe - UAna);2021307653   16 Sep 2026- determining that the following criteria are met to establish a limitation on a neuromuscular factor of oxidative capacity, being intermuscular coordination, (A4):1) the value of | / |SmO2% of the TMM analyzed and of his TMCM is greater than or equal to 65% SmO2%, in each INTTL or R-INTTL greater than or equal to UAmin;2) the trend of (p)|y|SmO2%, (p)|r|0O2HHb and (p)|r|O2HHb,in the 70% of TMsm and their TMSCM are minimally symmetric, in the R-INTTL (UAmin - UAe) and (UAe -UAna);3) the values of | / |SmO2%, | / |0O2HHb and | / |O2HHb of the TMM analyzed and his TMCM are greater than the values of at least the 70-75% of the remaining TMSM, in each INTTL or R-INTTL greater than or equal to UAmin;4) the values of | / |SmO2% of at least the 50-55% of TMsm is <45% SmO2%, in any INTTL or R-INTTL greater than or equal to UAe.

8. Monitoring and evaluation method according to any of the preceding claims, where in addition to the TMSM to be evaluated, one or more TMSM that participate in the breathing process are evaluated, and where they also comprise the steps of:- calculating, analyzing and evaluating the value of | / |SmO2% of at least one TMM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, analyzing and evaluating the trend (p) of the SmO2% and 0O2HHb values of all TMSM, on the initial 5 and 10 seconds of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe;- determining that the following criteria are met to establish a limitation on a pulmonary structural factor (B1.1):1) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMsm;2) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 10 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UANA, is less than [(p) < 0000,5], in at least 70% of TMsm;3) the value of | / |SmO2% is >50% SmO2% in the TMsm that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin.2021307653   16 Sep 20269. Monitoring and evaluation method according to any of the preceding claims, where in addition to the TMSM to be evaluated, one or more TMSM that participate in the breathing process are evaluated, and where they also comprise the steps of:- calculating, analyzing and evaluating the value of |y|SmO2% of at least one TM involved in the breathing process [inspiration (inhalation) and expiration (exhalation)] during AFCM, in each INTTL or R-INTTL greater than or equal to UAmin;- calculating, analyzing and evaluating the trend (p) of the SmO2% and 0O2HHb values of all TMSM, in the initial 5 seconds, of at least one ID after an IT of INTTL or R-INTTL average greater than or equal to UAe;- determining that the following criteria are met to establish a limitation on a pulmonary functional factor of the respiratory muscles (B1.2):1) the trend of the values (p)SmO2% and (p)0O2HHb in the initial 5 seconds, in all ID after an IT of INTTL or R-INTTL average greater than or equal to UAe, is less than [(p) < 0000,5], in at least 70% of TMsm;2) the value of |y|SmO2% is <50% SmO2% in the TMsm that participate in the breathing process [inspiration (inhalation) and expiration (exhalation)], in at least one INTTL or R-INTTL greater than or equal to UAmin.

10. Monitoring and evaluation method according to any of claims 2 to 9, further comprising the steps of:- calculating the value of |y|SmO2%, |y|O2HHb, |y|0O2HHb, of each TMM, in at least one INTTL or R-INTTL greater than or equal to UAmin.- calculating the values of SmO2%, O2HHb and 0O2HHb of the Upper Limit of the Optimal Zone (\limsup\ Zona0p) and the Lower Limit of the Optimal Zone Him inf | Zona0p, in the determined INTTL or R-INTTL, from the following calculation: llimsupl Zona0? = (Median of {|y|i;|y|2;|y|3;...,}) + (a {|y|i;|y|2;|y|3;...,,}) / 2 Him inf| Zona0? = (Median of {|y|i;|y|2;|y|3;...,}) - (a {|y|i;|y|2;|y|3;..,,}) / 2wherein |y| is the value (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity; (a) is the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM at the determined intensity;- comparing and evaluating the values of |y|SmO2%, |y|O2HHb and |y|0O2HHb, of at least one TMM with the values of SmO2%, O2HHb and 0O2HHb of |lim inf\ Zona0? and of Him sup\ Zona0p, in analyzed INTTL or R-INTTL greater than or equal to UAmn;- determining the type of performance of a composition of muscular blood flow (B.2.i.i) that develops at least one TMM analyzed, in the analyzed INTTL or R-INTTL, based on the following criteria:2021307653   16 Sep 2026o excessive Muscle Oxygen Amount if:■ the value of | / |SmO2% of the TMM is <80% SmO2% in the analyzed INTTL or R-INTTL;■  the value of | / |SmO2% of the analyzed TMM is greater  thanSmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL;■  the difference between the value of | / |SmO2% of the analyzed TMM andSmO2% \limsup\ ZonaOp is >15% SmO2%, in the analyzed INTTL or R-INTTL;o greater Amount of Muscular Oxygen if:■  the value of | / |SmO2% of the analyzed TMM is greater  thanSmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL;■  the difference between the value of \ / \SmO2% of the analyzed TMM andSmO2%|limsup| Zona0p, is <15% SmO2%, in the analyzed INTTL or R-INTTL;o optimal Amount of Muscular Oxygen if:■ the value of \ / \SmO2% of the analyzed TMM is equal or less than SmO2%\limsup\ Zona0p, in the analyzed INTTL or R-INTTL;■ the value of \ / \SmO2% of the analyzed TMM is equal or greater than SmO2% Ilim inf \ Zona0p, in the analyzed INTTL or R-INTTL;o lower Amount of Muscular Oxygen if:■ the value of \ / \SmO2% of the analyzed TMM is greater than SmO2%\lim inf\ Zona0p, in the analyzed INTTL or R-INTTL;■ the value of \ / \SmO2% of the analyzed TMM is >20% SmO2%, in the analyzed INTTL or R-INTTL;o inefficient or Low Amount of Muscular Oxygen if:■ the value of \ / \SmO2% of the analyzed TMM is greater than SmO2%\lim inf \ Zona0p, in the analyzed INTTL or R-INTTL;■ the value of \ / \SmO2% of the analyzed TMM is <20% SmO2%, in the analyzed INTTL or R-INTTL;- determining the type of performance of a volume of muscle hemoglobin delivery (B.2.1.2) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria:o higher Hemoglobin Delivery Volume if:■ the value of \y\O2HHb of the analyzed TMM is greater than O2HHb \limsup\ Zona0p, in the INTTL or R-INTTL analyzed;o optimal Hemoglobin Delivery Volume if:■ the value of \y\O2HHb of the analyzed TMM analyzed is equal or less than O2HHb \lim sup\Zona0p, in the analyzed INTTL or R-INTTL;2021307653   16 Sep 2026■ the value of | / |O2HHb of the analyzed TMM is equal or greater than O2HHb Him in / | Zona0p, in the analyzed INTTL or R-INTTL;o lower Hemoglobin Delivery Volume if:■ the value of | / |O2HHb of the analyzed TMM a is less than O2HHb Him in / | Zona0p, in the analyzed INTTL or R-INTTL;- determining the type of performance of a velocity or rate of blood flow delivery (B.2.1.3) that develops at least one analyzed TMM, in the analyzed INTTL or R-INTTL, based on the following criteria:o higher Blood Flow Delivery Rate if:■ the value of | / |0O2HHb of the analyzed TMM is greater than the value of $O2HHb|Zimsup| Zona0p, in the analyzed INTTL or R-INTTL;o optimal Blood Flow Delivery Rate if:■   the value of | / |0O2HHb of the analyzed TMM is equal or less than of$O2HHb|Zimsup| Zona0p, in the analyzed INTTL or R-INTTL;■   the value of | / |0O2HHb of the analyzed TMM is equal or greater than0O2HHb Him in / | Zona0p, in the analyzed INTTL or R-INTTL;o lower Blood Flow Delivery Rate if:■ the value of | / |0O2HHb of the analyzed TMM is less than 0O2HHb Him in / | Zona0p, in the analyzed INTTL or R-INTTL.

11. Monitoring and evaluation method according to any of claims 2 to 10, further comprising the steps of:- calculating, comparing and evaluating the maximum value of SmO2%, O2HHb and 0O2HHb of all TMsm, in at least one ID;- calculating, evaluating and determining the value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, of all TMsm, in at least one ID;- calculating, evaluating and determining the lowest value of CSV and the equivalent NSCSV of the maximum value of SmO2%, 0O2HHb and O2HHb, from the combination of at least the 70-75% of the TMSM, in at least one ID;- determining the type of performance of a functional sympatholysis factor for blood flow redistribution (B2.2), just at the moment of cessation of locomotor work, based on the following criteria:o perfect performance if:■ the maximum values of SmO2%,  O2HHb and  0O2HHb aresymmetrically perfect, between all TMSM, in the analyzed ID;o optimal performance if:2021307653   16 Sep 2026■ the maximum values of SmO2%, O2HHb and 0O2HHb, are symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID;o asymmetric Performance if:■ the maximum values of SmO2%, O2HHb and 0O2HHb, are not symmetrically optimal, between the combination of at least the 70-75% of the TMSM, in the analyzed ID.

12. Monitoring and evaluation method according to any of claims 2 to 11, further comprising the steps of:- calculating, comparing and evaluating the maximum value of SmO2% between two ID, separated by at least one IT of at least one TMM;- determining the type of performance of an evolution factor of analytical cardiovascular performance (B2.3) that develops, at least one analyzed TMM, between two ID, separated by a IT, based on the following criteria:o Significant increase:■ increase >5% SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID;o Slight Increase:■ increase between [2,01 - 5 %] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID;o Slight decrease if:■ decrease between [2,01 - 5%] SmO2% in the maximum value ofSmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID;o Significant decrease if:■ decrease >5% SmO2%, in the maximum value of SmO2% of the analyzed TMM, in the 2nd ID in compared to the 1st ID;o Maintenance if:■ decrease or increase of between [0-2%] SmO2%, in the maximum value of SmO2%, of the analyzed TMM, in the 2nd ID in compared to the 1st ID.

13. Monitoring and evaluation method according to any of claims 2 to 12, further comprising the steps of:- calculating, comparing and evaluating the TGV [(p)] of (p)| / |ThB of at least one TMM, in the R-INTTL (UAe-UANA) and (UANA-Maximum Intensity [IntMax]);2021307653   16 Sep 2026- the value of \y\SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin;- determining if the following criteria are met to establish a limitation in a muscle pumping factor of blood flow for venous return (B2.4):o the TGV (p)|y|ThB of the analyzed TMM is [<p)>0,0005], in the R-INTTL (UAe-UANA) or (UANA-Maximum Intensity [IntMax]);o the value of \y\SmO2% of the analyzed TMM is less than or equal to 45% SmO2%, in at least one INTTL or R-INTTL greater than or equal to UAmin.

14. Monitoring and evaluation method according to any of claims 2 to 13, further comprising the steps of:- evaluating the value \y\SmO2%, \y\O2HHb and \y\0O2HHb, of at least one TMM, in at least one INTTL or R-INTTL greater or equal than UAmin;- calculating the SmO2%, O2HHb and 0O2HHb values of the Upper Limit of the Optimal Zone (\limsup\ Zona0p) and the Lower Limit of the Optimal Zone (\lim inf \ Zona0p), in the determined INTTL or R-INTTL, from the following calculation:\Hmsup\ZonaOp = (Mediana de {\y\i;\y\2;\y\3;...,}) + (a {\y\i;|y\2;|y|3;...,,}) / 2\lim inf\ ZonaOp = (Mediana de {\y\i;\y\2;\y\3;...,}) - (a {|y|i;|y|2;|y|3;...,,}) / 2 where \Y\ is the value (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL and (a) the standard deviation of (SmO2%, O2HHb or 0O2HHb) of each TMM, in the determined INTTL or R-INTTL;- comparing and evaluating the values of \y\SmO2%, \y\O2HHb and \y\0O2HHb, of at least one TMM with the values of (SmO2%, O2HHb and 0O2HHb of the \lim sup\ ZonaOp and the \lim mf\ Zona0p, in at least one determined INTTL or R-INTTL greater or equal than UAmin;- determining the level of Neuromuscular Activation performed by at least one TMM (neuromuscular activation factor, being intermuscular coordination, (B3.1)), based on the following criteria:o Null or Very Low Neuromuscular Activation if:■ the value of \y\SmO2%, \y\O2HHb and \y\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and QO2HHb\lim sup\Zona0p, in the determined INTTL or R-INTTL;■ the value of \y\SmO2% of the TMM analyzed, is >75% SmO2% in the determined INTTL or R-INTTL;o Less or Low Neuromuscular Activation if:2021307653   16 Sep 2026■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb of the TMM analyzed is greater than SmO2%, O2HHb and QO2HHb\lim sup\ Zona0p, in the determined INTTL or R-INTTL;■ the value of \Y\SmO2% of the TMM analyzed, is <75% SmO2%, in the determined INTTL or R-INTTL;o Optimal Neuromuscular Activation if:■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMManalyzed, is less than SmO2%, O2HHb and 0O2HHb \limsup\ Zona0p, in the determined INTTL or R-INTTL;■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMManalyzed,  is greater  than SmO2%,  O2HHb and  0O2HHb\lim in / \ Zona0p, in the determined INTTL or R-INTTL;o Excessive or Priority Neuromuscular Activation if■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMManalyzed, is less than SmO2%, O2HHb and 0O2HHb \lim in / \ Zona0p, in the determined INTTL or R-INTTL;■ the value of \Y\SmO2% of the TMM analyzed is <25% SmO2%, in some INTTL or R-INTTL;o High Neuromuscular Activation if:■ the value of \Y\SmO2%, \Y\O2HHb and \Y\0O2HHb, of the TMManalyzed, is less than SmO2%, O2HHb and 0O2HHb \lim in / \ Zona0p, in the determined INTTL or R-INTTL;■ the value of \Y\SmO2% of the TMM analyzed is >25% SmO2%, in all the INTTL or R-INTTL greater than or equal to UAmin.

15. Monitoring and evaluation method according to any of claims 2 to 14, further comprising the steps of:- calculating the median value of ThB (Y ThB), of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin;- calculating the standard deviation (0) of at least one TMM, in at least one IT of average INTTL or R-INTTL greater than or equal to UAmin;- calculating the minimum value of ThB in at least one ID perform after an IT analyzed, of average INTTL or R-INTTL greater than or equal to UAmin;- calculating and evaluate the difference between [(YThB) - 0] of at least one IT and the minimum value of ThB of his posterior / successive ID;2021307653   16 Sep 2026- determining if the following criteria are met to establish a limitation in a neurovascular structural factor, being speed and power of muscle contraction, (B3.2) in at least one TMM:o the value [Median F ThB - oThB] of the analyzed TMM, of the analyzed IT of INTTL or R-INTTL greater than or equal to UAmin, is greater than the minimum value of ThB of the successive ID to the analyzed IT.

16. Monitoring and evaluation method according to any of claims 2 to 15, further comprising the steps of:- calculating, comparing and evaluating the median value (F) of SmO2%, O2HHb, 0O2HHb, HHb and 0HHb, of each TMM, in at least one determined INTTL or R-INTTL, in each one of the developed FCM, during the AFCM;- determining all the Optimal FCM or Optimal R-FCM, of at least one determined INTTL or R-INTTL, during AFCM, based on the fulfilment of the following criteria established for a muscle contraction speed factor (B3.3):o have the highest value of FSmO2% or a difference < (±2.5%) SmO2% with respect to the highest value FSmO2%, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM;o have the highest value of F O2HHb % or a difference < (±0,30 g / dL) O2HHb with respect to the highest value F O2HHb, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM;o have the highest value of F 0O2HHb % or a difference < (±1,00 g / dL) 0O2HHb with respect to the highest value F 0O2HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM;o have the lowest value of F HHb % or a difference < (±1,00 g / dL) HHb with respect to the lowest value F HHb, of all FCM or R-FCM, in at least the 78-81% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM;o have the lowest value of F 0HHb % or a difference < (±1,00 g / dL) 0HHb with respect to the lowest value F 0HHb, of all FCM or R-FCM, in at least the 7881% of the TMM, in the determined INTTL or R-INTTL, during the determined AFCM.2021307653   16 Sep 202617. Monitoring and evaluating system for the physical performance of one subject that comprises:- two or more near infrared sensors (NIRS);- a cardiac monitoring device;- a locomotor work intensity device or monitor; and- a data processing system connected to the two or more near infrared sensors (NIRS), the cardiac monitoring device and the locomotor work intensity device or monitor and configured to carry out the steps of the method in accordance with any of claims 1 to 16.

Images